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An introduction to the thiazole ring system is presented together with a detailed, but 
non-exhaustive review of the rapidly emerging area of palladium-mediated directed 
arylation.   
 
The direct arylation of thiazole is also discussed together with our attempts to 
improve the established methods.  A high-yielding, mild protocol has been developed 
for the functionalisation of the most electron-rich carbon-hydrogen bonds in a 
number of heterocyclic ring systems, this represents the first example of a C-H 
activation reaction being accomplished in aqueous media and allows access to a 
diverse range of functionalised aryl heterocycles.   
 
In addition, work towards functionalisation of the thiazole C4 position is described.  
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1.1. Thiazoles  
The thiazole ring system is found in a diverse range of natural products and 
functional materials.  It plays a central role in the biochemistry of life, being 
incorporated into the structure of vitamin B1,1 thiamin, 1, which is vital for neural 
function and the metabolism of carbohydrate.  Thiazoles are also found in a number 
of natural products,2-5 are increasingly being incorporated into pharmaceutical 
compounds2, and have wide use in flavourings and perfumes.6  Major agrochemical 
compounds7 have incorporated thiazoles for more than twenty years.  They possess 
interesting electronic and optical properties8 and as such have received considerable 
attention from material scientists.   
 
 
1.1.1. Use of thiazoles 
 
Whilst many heterocycles are isolated in trace amounts from crude oil, thiazoles are 
not within this number;5 they are however found in nature, generally in peptidic 
compounds.2-5  There are a number of different types of thiazole natural products, 
perhaps the most well known are the epothilones, 2a-f,9,10 originally isolated from 
soil bacteria Sorangium cellulosum, they are microtubule polymerisation promoters 
and have a similar mechanism of action to Taxol.2-5  Although structurally dissimilar 
they exhibit dramatically improved potency against multi-drug resistant tumour cell 
lines and as such have received considerable interest.  In addition to this, and, in 
contrast to Taxol, multi kilogram quantities are available from fermentation which, 
when combined with precursor-driven directed evolution has allowed extensive 











Novartis and its lactam analogue is in Phase II/III trials by Bristol-Meyers Squibb.2-5  
12,13-Deoxyepothilone B (Sloan-Kettering/Kosan/Roche) and C21-amino 




Myxobacteria have been recognised as a rich source of novel, bioactive compounds9 
including, but not limited to the promising anti tumour compounds the epothilones.  
Also of note are the cystothiazoles A-G, 3a-g, 11-14 and myxothiazole, 4,9,15 each have 





An important class of thiazole compounds are thiopeptide antibiotics.  This family of 
antibiotics are sulfur-containing, highly modified cyclic peptides containing thiazole 
rings together with, in some cases, oxazoles, unusual or dehydro amino acids around 
a central tri- or tetra- substituted pyridine (or piperidine, dehydropiperidine, or 











nocathiacins, 5a-c, isolated from the culture broth of Nocardia sp. WW-
12651(ATCC-202099).16-18  They possess potent in vitro inhibitory activity against a 
wide range of gram-positive bacteria, including organisms such as methicillin-
resistent Staphylococcus aureus (MRSA), multi-drug resistant Enterococcus faecium, 
and fully penicillin resistant Streptococcus pneumoniae.  In addition they 
demonstrated excellent in vivo efficacy against a systemic Staphylococcus aureus 





Amythiamicins such as amythiamicin A and D (6a and b), were first isolated from a 
strain of Amycolatopsis sp. MI481-42F4,2-5 and were reported to be active against a 
wide spectrum of gram-positive bacteria including MRSA. More recently they have 











wide range of structurally related cyclic peptide compounds (thiostepton, siomycin, 
sulfomycin and micrococcin anitibiotics) which all contain a related pyridine core.  
There have been a vast number of reports on the syntheses of degradation products of 
these complex molecules. These degradation products include dimethyl 
sulfomycinamate, 7,19-22 micrococcinic acid, 8,23,24 and  the core of GE2270A, 9, 
Figure 1.1.1.25-29  Each contain a pyridine ring substituted with thiazole rings and 
have been used to develop novel thiazole palladium chemistry.   
 
 
Figure 1.1.1 – Degradation products of peptidic antibiotic compounds 
 
Thiazoles are convenient bio-isosteres for carbonyl or aromatic groups in the 
pharmaceuticl induxtry.30  Carbonyl and aromatic groups can be quickly metabolised 
by the body, so replacement offers a better pharmacokinetic profile and increasing 
the concentration of drug reaching its point of action.  As such, thiazole has been 
incorporated into ritonavir, 10, an HIV1 protease inhibitor.31  The thiazole groups 
have replaced ester and pyridine groups to ameliorate the pharmacokinetic problems.  
Ritonavir is perhaps the most well known thiazole drug and is unusual that it 














It is reasonably common to utilise thiazoles in drug substances as can be seen in 
Figure 1.1.2.  
 
 
Figure 1.1.2 – Thiazole pharmaceuticals 
 
Meloxicam, 11,  is a non-steroidal anti-inflammatory compound (NSAID) developed 
by Boehringer Ingelheim and used to treat arthritis, dysmenorrhea, fever and also 
acts as an analgesic.  It has a longer half-life in vivo than similar compounds enabling 
it to be administered in a once daily dose.32   
 
Dasatinib, 12,  was developed by Bristol Myers Squibb as an ABL/SCR family 
tyrosine kinase inhibitor for the treatment of chronic myelogenous leukaemia and 
Philadelphia chromosome-positive acute lymphoblastic leukaemia.33  It is currently 
being assessed for use in the treatment of metastatic melanoma.34   
 
Cefotaxime, 13, is a third generation cephalosporin antibiotic with broad spectrum 












Nizatidine, 14, was developed by Eli Lilly, and is a histamine H2 receptor antagonist 
that inhibits the production of stomach acid.36  It is used in the treatment of peptic 
ulcer disease and gastroesophageal reflux disease.   
 
Whilst there are a variety of drugs currently on the market with thiazole motifs2 they 
are far outnumbered by agrochemicals,7 preservatives and flavourings.6   
 
 
Figure 1.1.3 – Thiazole agrochemicals 
 
A number of agrochemicals are shown in Figure 1.1.3.  Thiabendazole, metsulfovax 
and ethaboxam are fungicides used to treat mould and blight.7  Clothianidin and 
thiamethoxam are neonicitinoid insecticides,7 both are used as seed treatments and to 
treat juvenile and mature crops.   
 
The use of thiazoles in flavourings is widespread.  The signature notes of a number 
of compounds, 20-31, are described in Table 1.1.1.6  They are used in the food 
industry to provide meaty and roasted flavours.  In the perfumery industry several 












 Compound Scent  Compound Scent 
20 
 
Beef, nutty, grilled 
peanut. 26  




Meaty, nutty, yeast, 
milky. 27 
 
Chocolate, green, nutty, 
cocoa, coffee, mouldy. 
22 
 
Onion like. 28 
 









sulfur, nutty. 30  
Mouldy, earthy, tropical 




nutty, meaty. 31 
 
Green grass, tomato leaf, 
vines. 
Table 1.1.1 – Thiazole flavours and fragrances 
 
Thiazoles are even finding applications for liquid crystals and light emitting 
materials.37  The major drawbacks with regard to their use are the methods of 
preparation, which have barely changed since the 1880s.   
 
1.1.2. Synthesis, properties and reactions 
The synthesis, properties and reactions of thiazole have been extensively reviewed in 
2001 by Kikelj and Urleb.38  A brief overview is described here, together with a more 
thorough discussion of the role of thiazoles in palladium cross-coupling reactions.   
 
The thiazole ring system comprises a 5-membered aromatic heterocycle, substituted 
with a nitrogen and a sulfur atom, commonly in the 1,3 (thiazole) or 1,2 (iso-thiazole) 
positions.  Whilst π-excessive, the nature of the heteroatoms leave the thiazole ring 













The thiazole ring is substituted in the C2 and C4 positions in natural products as a 
consequence of the biosynthesis of the rings.  They are formed from cysteine 
residues that are enzymatically cyclised to thiazolines, 34,  followed by oxidation to 
form thiazoles (Scheme 1.1.1).39 
 
 
Scheme 1.1.1 – Biosynthesis of thiazoles 
 
Chemical Synthesis 
The most common method for preparing thiazoles was first developed by Hantzsch 
in 1889. (Scheme 1.1.2)40  Whilst this method works well for some thiazoles, the 
yields are generally modest at best.   
 
 
Scheme 1.1.2 – Hantzsch synthesis 
 
Modified conditions were developed by Erlenmeyer in 1947 which avoided the need 
to pre-form the thioamide, (Scheme 1.1.3).41  Again, this method suffers from 












Scheme 1.1.3 – Erlenmeyer’s conditions 
 
A modification of the Robinson Gabriel oxazole synthesis involves the reagents 
being heated in the presence of phosphorus pentasulfide or sulfur to give the thiazole 
product, 38 (Scheme 1.1.4).   
 
 
Scheme 1.1.4 – Modified Robinson Gabriel conditions 
 
Alternative syntheses involve the formation of thiazolines, 45, followed by oxidation 
to give the thiazole products (Scheme 1.1.5 and Scheme 1.1.6).15,22,42-45 







There are a wide variety of different syntheses of thiazoles but they generally take 
place at elevated temperatures under harsh conditions, often leading to many by-
products.  As such they are unsuitable for the diversity-orientated synthesis applied 
to discovery programs used in industry today.  For a reaction to be practical for 











coupling of several different components to easily incorporate diversity into a library 
of compounds.  A more subtle point is that condensation reactions involve the 
synthesis of appropriately functionalised precursor molecules where the incorporated 
functionality is destroyed in order to construct the azole ring.  The modern approach 
of chemists in industry has diverged from this and now the underlying ethos is never 
to destroy functionality but always to create it.  Functionalisation of a core molecule 
to build up a larger structure is more convenient and allows a greater range of 
compounds to be produced. 
 
Reactions and Properties 
 
 
Thiazoles are electron deficient and as such react more slowly than benzene with 
electrophiles.  The azoles are numbered as shown above. 
 
The C2 position is electron poor and acidic (pKa ~ 29.5)46 due to the proximity of the 
two heteroatoms.  The ring can easily be metallated here using a lithium reagent, as 
such this provides easy access to 2-substituted thiazoles (Scheme 1.1.7).   
 
 












The C5 position is the most electron-rich as a consequence of the resonance 
structures, it is here that the molecule will react with electrophiles (Scheme 
1.1.8).47,48   
 
 
Scheme 1.1.8 - Electrophilic addition to azoles 
 
The C4 position is neither electron-rich nor electron poor and as such will only react 
under forcing conditions when the others are blocked.48   
 
Whilst electrophilic substitution occurs in thiazole rings it is slower than for benzene, 
this is a consequence of two factors.  Firstly that the heteroatoms are electron-
withdrawing and secondly that electrophilic reagents are commonly acidic or used 
with acids.  A Lewis or Bronsted acid will complex with the ring nitrogen and this 
further deactivates the ring towards electrophilic substitution.47   
 
In the case of 2-phenyl thiazole, 51a, under standard nitration conditions, protonation 
of the nitrogen leads to substitution in the benzene ring, 51b, (Scheme 1.1.9).  
Switching to less acidic conditions allows nitration to occur in the C5 position, 54. 
 
 
Scheme 1.1.9 - Nitration of thiazoles 
 
Halogenation of thiazoles is also possible, although regioselectivity is a major 
problem.  Substitution at the 5-position occurs reasonably well although it is often 
accompanied by some substitution at the 4-position giving 4,5-dihalothiazoles.47  
Electrophilic substitution at the 2-position is notoriously difficult, having only been 











introduce a halogen at the 2- or 4-position, hydroxy-halogen exchange must be 
carried out or, in the case of C2 either diazotization or deprotonation followed by the 
reaction with an electrophilic halogen.48 
 
Thiazole rings are also susceptible to oxidation, the N-oxides of thiazoles are well-
characterised48 and their reactivity towards electrophiles has been studied.48  They 
are easily prepared from the corresponding thiazoles and mCPBA, peracetic acid, 
permaleic acid or trifluoroperacetic acid albeit in relatively poor yields (up to 52%).48  
Reactions can be carried out on the N-oxide or on the O-methylated and acylated 
compounds, with methylation and acylation occurring in excellent yields.48  
Reduction of the N-oxides can be successfully carried out using phosphorus 
trichloride in chloroform quantitatively. 
 
N-Oxides are stable for months when kept cool and dry.  N-oxidation activates the 2-
position for electrophilic attack due to delocalisation of the oxygen negative charge.  
In contrast the positive charge in the ring deactivates positions 4 and 5 to 
electrophilic attack.  All of the ring hydrogens are rendered more acidic compared to 
the parent thiazoles, hence the proton at C2 is easily abstracted using sodium hydride 
and the anion will react with a range of electrophiles.  When C2 is blocked, C5 is 
deprotonated over C4; whilst this should allow regioselective substitution at C5, the 
enhanced acidity of C4 when an electron withdrawing substituent is present at C5 
leads to a mixture of mono and di-substituted products. 
 
 
Scheme 1.1.10 – Route to 4-bromothiazoles  
 
Whilst the pattern of reactivity is similar to the parent thiazole, it is possible in this 
way to form the 4,5-disubstituted thiazole, 56, then to selectively remove the 












The ability to synthesise halothiazoles is a prerequisite for their use in palladium 
cross-coupling chemistry.  These reactions are some of the most useful reactions in 
the synthetic chemist’s toolbox.49-51  Palladium has been used with a variety of 
heterocycles for more than 20 years,52 and there are thousands of examples of cross-
couplings to pyridines, pyrroles, thiophenes, furans etc.  However there is a sharp 
decline in the number of examples as the number of heteroatoms increases.51  This 
means that compounds containing azole heterocycles are often constructed via 
multiple classical condensations rather than with concise palladium cross-couplings.  
Some isolated examples have been studied; Stille,21,24 Negishi,53 Suzuki13 and 
Sonogashira,54 couplings have all been attempted.  However, only Panek’s work on 
the Sonogashira protocol14,55 looks systematically at the potential of the reaction.  
Panek envisaged using azole triflates, 60, for the halide partner conveniently 





A range of terminal alkynes were coupled to thiazole triflates using catalytic 














The chemistry tolerated a variety of alkyl and aryl substituents on the azole ring as 
well as a variety of functional groups on the alkyne such as ethers, silyl ethers, 
alcohols and even free basic groups such as carbamates.  The reactions proceed with 
good to excellent yields.  A regioselective cross-coupling from the 2,4-ditrifloyl 





From the ditrifloylthiazole, 62, it is possible to perform a selective Sonogashira at C2 
then to utilise the monosubstituted product in a second successive palladium cross-
coupling; (Sonogashira or a Stille coupling) to form a disubstituted thiazole.  
 
Some work has been done by several groups towards Stille, Suzuki and Negishi 
couplings to azoles to develop molecules with liquid crystalline properties.56  Vachal 
and Toth demonstrated the use of thiazolyl zinc bromide and thiazolyl tributyl 
stannane in a series of reactions with aryl iodides in good yields to form 2-aryl 
thiazoles, 51.56  The products were then brominated using bromine in acetic acid and 














In a similar vein, Bach and Heuser have investigated the regioselective coupling of 
2,4-dibromothiazole, 63b.12,13,53,57  The C2 position is the most electron poor and 
reacts more quickly in palladium cross-coupling reactions than the C4 position.  The 
two step process is detailed in Scheme 1.1.15.  Selective coupling to C2 of 2,4-
dibromothiazole gives the 2-substituted-4-bromothiazole, 66.  Lithium halogen 
exchange and transmetallation gives the zincate or stannane which then reacts with 





Most impressive of all the palladium cross-coupling reaction of thiazoles is Kelly’s 
synthesis of micrococcinic acid, 8.  Micrococcinic acid was systematically 
constructed using consecutive Stille couplings between thiazoles, 69-72.24  Scheme 




Scheme 1.1.16 Retrosynthesis of micrococcinic acid 
 
Kelly’s synthesis provided a concise, convergent route to the natural product and 
demonstrates the power of palladium cross-coupling in the field of azole heterocycles.  











palladium cross-couplings being used for the synthesis of multi-azole natural 
products.12-14   
 
Whilst Suzuki, Stille and Negishi reactions are convenient in terms of 
regioselectivity one drawback is the need to preform the metallated partners.  This 
demands uneconomical extra reaction steps particularly due to the use of 
stoichiometric metals.  The compounds themselves may be toxic such as stannanes 
for the Stille reaction, which means that waste removal is expensive.  The arylation 











1.2. The use of directing groups to facilitate palladium-
mediated direct arylation reactions 
 
Palladium has been utilised as a catalyst in a wide range of cross-couplings for close 
to 30 years.  In that time, a vast number of coupling reactions have been envisaged 
and developed: Heck, Stille, Suzuki-Miyura, Kumada-Corriu, Hayashi, Negishi, and 
Sonagashira, to name but a few.  In most of these examples a stoichiometric 
organometallic reagent is necessary, which is often not commercially available.  The 
need to synthesise the precursor and convert it to the organometallic can be 
detrimental to an otherwise elegant synthesis.  The reagent may be incompatible with 
some functionality and stoichiometric amounts of metal waste which can be highly 
toxic are generated.  To address this there has been interest in developing “Direct 
Arylation” or “C-H Activation” chemistries.  These circumvent the need to form a 
stoichiometric metallated partner, or may avoid the use of any preactivated 
compound by doing the simplest of reactions, the selective reaction between two C-H 
bonds forming a C-C bond.  
 
Herein the literature regarding use of palladium to enable direct arylation in 
compounds bearing a chelating group is discussed, (until the end of March 2008).  
The review does not seek to cover the area of electronically directed arylations such 
as those seen by Fagnou58-61 and Itami,62 nor is the field of ortho-lithiation or 
deprotonation covered except where it seeks to explain the background of the current 
research (for further information on other types of C-H functionalisation please see 
the following reviews: non-directed arylation,63 carbene insertions,64 C-H 











1.2.1. Some Definitions 
 
Before discussing this area in detail it may be helpful to provide some definitions and 
parameters for a number of terms that have been used recently to describe a number 
of transformations.   
 
C-H Functionalisation 
C-H functionalisation is the reaction of a C-H bond to form a carbon-heteroatom or 
carbon-carbon bond.  This would usually be accomplished using a transition metal, 
therefore, a deprotonation with a strong base cannot be classified as a C-H 
functionalisation.  In a similar manner, an electrophilic addition to an aromatic ring 
would not be classed as a C-H functionalisation reaction, nor are photochemical or 
radical processes, or those involving carbocations.   
 
C-H Activation: 




A specific C-H functionalisation where the H of the C-H bond is replaced by an aryl 
or heteroaryl group. 
 
Directed arylation 
A specific example of a direct arylation where a temporary tether allows a formally 
intermolecular arylation to be achieved in an intramolecular fashion, giving a 












This methodology is particularly attractive from a green standpoint.  The reaction 
partners in a traditional cross-coupling reaction require differential functionalisation 
in order to react.  In a C-H activation reaction, only one reaction partner needs to be 
functionalised, which cuts out on a number of steps.  This avoids the generation of 
potentially toxic metallated intermediates and prevents the necessary formation of 
stoichiometric amounts of toxic metal waste.   
 
A directed C-H activation strategy can lead to different regioisomers to those 
available through the established methodologies, some of which would be very 
difficult to achieve by other methods.   
 
1.2.2. Background and Concepts 
 
One of the most challenging aspects of direct arylation and C-H activation chemistry 
is the question of regioselectivity.  Each molecule contains a large number of carbon 
hydrogen bonds, determining which will react, and with what selectivity can be a 
difficult task.  A possible solution to this question is the use of chelating groups to 
control and direct the metal catalyst to the C-H bond of choice.  The initial research 
in this area has its roots in directed metallation and predates palladium cross-
coupling.   
 
Ortho-lithiation was first reported independantly by Henry Gillman70 in 1939 and 
Georg Wittig71 in 1940.  It has subsequently developed as one of the most useful 
protocols for the synthesis of ortho-substituted aromatic compounds, (Scheme 1.2.1).   
 
 












More recently ortho-lithiation has been used to prepare aromatic boronic acids, 
zincates, stannanes etc. 74,  used in palladium cross-coupling reactions.  This method 
also provides a route to hindered aromatic compounds, (Scheme 1.2.2).   
 
 
Scheme 1.2.2 – Ortho-lithiation – used in palladium cross-coupling 
 
Directed arylation and C-H functionalisation reactions rely on a similar sequence . 
An aromatic compound with a suitable directing group can be functionalised using 
palladium and reacted with an arylhalide to form ortho-substituted aromatics, 
(Scheme 1.2.3).  This replaces the deprotonation and transmetallation steps with a 
single C-H activation step. 
 
 
Scheme 1.2.3 – C-H Activation as an alternative to ortho-lithiation and transmetallation 
 
Early examples of this type of C-H activation can be seen in the stoichiometric 
formation of palladacycles.  Cope et al reported the first synthesis of a palladacyclic 
compound, 77, in 1965.72  It was prepared simply by stirring the palladium salt with 
azobenzene at room temperature, (Scheme 1.2.4).  There are numerous examples of 
the formation of palladacycles under mild conditions,66 many are excellent catalysts 















The formation of  palladacycles is possible at low temperatures, which has generated 
significant interest in developing a methodology where the formation of the 
palladacycle is the first step in a catalytic cycle.  This approach forms the basis for a 
large proportion of the directed arylation chemistry currently in the literature.   
 
1.2.3. Examples 
Phenol and alcohol directing groups 
The pioneer in the area of intermolecular palladium-mediated directed arylation was 
Miura.  Miura et al reported the first example of a palladium-mediated directed 
arylation in 1996.73  The aldehyde C-H was arylated using the phenol oxygen as a 
















Subsequently the reaction was found to be amenable to the arylation of C-H bonds in 
proximity to a phenolic oxygen,74 (Scheme 1.2.6).  Initially, they found mixtures of 
the mono 83, and diarylated 84, compounds, but by restricting the equivalents of 
both base and aryl iodide they were selectively able to form the mono-arylated 
product.  This reaction proceeds through a similar mechanism (Scheme 1.2.5), but 





In addition to the arylation of the biphenyl compounds they were able to arylate both 
1- and 2-naphthol, 85 and 87.75  1-Naphthol was arylated as expected giving the 
product arising from a 5-membered palladacycle.  In the case of 2-naphthol, no 5-
membered chelate is available, and arylation occurred α to the phenol, this product 















The methodology can also be applied to the arylation of unsubstituted phenols.  In 
Up tp five arylations can be performed in the presence of excess aryl bromide 




Not only is this protocol suitable for the arylation of sp2 C-H bonds, it can also be 
used to functionalise sp3 bonds providing a mixture of the mono and diarylated 





Miura et al have shown that the directing group need not be phenolic in nature; a 
benzyl alcohol can also direct arylation to an aromatic ring, (Scheme 1.2.10).  An 
alternative pathway leads to the loss of acetone from the substrate followed by 































Aldehyde, ketone, acid, ester and enolate directing groups 
Following their work on phenol directing groups, Miura et al developed conditions to 
selectively monoarylate a number of benzyl carbonyl compounds, (Scheme 1.2.12 
































Strictly speaking, these are not examples of directed arylation, but by changing the 
solvent from dimethylformamide to o-xylene and increasing the temperature, a 















The reaction could be driven to provide the triarylated product, 101, in good yields 





Whilst the mechanism for arylation at the acidic position α to the carbonyl is well-
understood,79,80 the directing effect of the carbonyl group is less so.  Miura et al 
proposed a mechanism (Scheme 1.2.14),81 where the palladium enolates, 103 and 
105, form 5-membered palladacycles, 104 and 106.   
 
Further examples of this reaction have shown this to be a concise and mild route to 















However, unlike the majority of examples detailed above, the arylation takes place 
by a 6-membered palladacycle.  5-Membered palladacycles are thought to be more 
stable than 6-membered palladacycles67 although both are capable of promoting 




Guerbuz et al have reported a different aldehyde directing group strategy more 
recently.85  Using substituted benzaldehydes the ortho-position of the ring is 
selectively arylated.  By using aryl chlorides or bromides they are able to selectively 
obtain the mono, 113, or diarylated, 114, compounds respectively, (Scheme 1.2.16). 
Meanwhile, an ester directing group strategy has been developed for the 
regioselective arylation of 3-carbalkoxyfurans and thiophenes, 115, by Sharp et al 















The selectivity can be explained by two different mechanistic pathways, (Scheme 





The formation of the 5-arylated product goes through an electrophilic addition 
mechanism, via 118 and 119.  However, in the case of the 2-arylated compound, 
Sharp et al propose a Heck mechanism.  Carbo-palladation of 115 gives 120, 
isomerisation of intermediate 120 by way of a palladium enolate, 121, gives 122.  
Syn-elimination of the palladium hydride from 122 provides the product and 
regenerates palladium (0).  The selectivity is explained in terms of the solvents 











intermediates in the electrophilic addition mechanism.  Toluene isfar less polar so the 
reaction proceeds by the only other mechanism available.   
 
More recently, Daugulis et al have reported the arylation of benzoic acids with both 







A mechanistic investigation was carried out in addition to the development of these 
conditions.  There are a number of different mechanistic pathways available in these 
reactions.  They propose that the most likely mechanisms for aryl iodides are a 
palladium (II) to palladium (IV) catalytic cycle (Scheme 1.2.21), or a palladium (0) 
to palladium (II) catalytic cycle (Scheme 1.2.22).  Both of these mechanisms proceed 
via a 5-membered palladacycle, 125 or 127.   
 
 













Scheme 1.2.22 – Palladium (0) to palladium (II) mechanism 
 
The reactions were repeated using a palladium (0) or palladium (II) source in the 
absence of AgOAc to establish the mechanism in operation.  In the case of the 
palladium (0) source, no conversion was observed, however with the palladium (II) 
source, one turnover of the palladium occurred, lending support to the palladium (II) 





The reaction of aryl chlorides was noted to work well for both electron-rich and 
electron-poor benzoic acids.  This is unusual as the palladation step is usually 
favoured by electron-donating groups on the aromatic ring.88  Fagnou reported a 
reversal in this pattern, where a more electron-deficient ring is arylated more 
readily.58,89  Daugulis et al therefore determined the intra- and intermolecular kinetic 
isotope effect, which provided further evidence for a different C-H palladation 











formation, C-H deprotonation step, 130,90 is the C-H activation mechanism occurring 
with aryl chlorides, (Scheme 1.2.23).   
 
Amides 
As with the directing groups discussed above, Miura et al led the field in the 
development of amide directing groups.91  An extension of their work on the 
arylation of ketones and other carbonyl compounds was published in 2000.  Mulitple 
arylations were performed on benzanilides, 132, at the ortho-positions of the aryl 
ring to give 133, (Scheme 1.2.24).  Arylation occurs through a 5-membered 
palladacycle; arylation of the other aryl ring however, would occur by co-ordination 





Multiple arylation of thiophenes and thiazoles, 134, was reported in 2002, (Scheme 
1.2.25).92,93  This unusual reaction involves a decarbamoylation step in which 
palladium and base mediates the cleavage of the amide bond, followed by the 





De Vries et al use amide-directing groups to accomplish a Fujiwara-Moritani 















A related paper from Daugulis et al descibes the reaction between arylanilides, 138, 





Sanford et al have described a versatile protocol for the arylation of a number of 
different aryl amides using hypervalent iodine reagents, (Scheme 1.2.28 and Table 
1.2.2).95  Hypervalent iodine reagents give good conversions and yields by way of a 
palladium (II)–(IV) catalytic cycle.  Unfortunately, only the diphenyliodonium salt 
























Table 1.2.2 – Sanford’s amide direction 
 
In response to this, Daugulis et al have developed conditions that allow the use of 
aryl iodides with a silver acetate oxidant, (Scheme 1.2.29).96,97  As this is a palladium 
(II)-(IV) catalytic cycle, aryl iodides with bromo substituents can be used, allowing 





By making a subtle change in the directing group selective monoarylation was 
achieved.  Instead of an anilide, they used a benzamide, 144, (Scheme 1.2.30).98  
These conditions are tolerant of bromides as well as electon withdrawing and 











themselves be further arylated to give differentially substituted 2,6-diaryl 





Daugulis et al have also investigated whether amines can be used as a directing 
group.99  Amines are generally regarded as being catalyst poisons, despite this they 
were able to successfully arylate with a range of aryl iodides.  Notably iodide and 















Daugulis et al have utilised a pyridine ring to arylate both sp2 and sp3 C-H bonds.100  
Selective monoarylation was achieved using an oxidative protocol.  The reactions 
proceed more quickly with electron-rich aryl iodides which suggests the reaction 





In addition to the arylation of pyridines they have also invented a strategy to 
incorporate a directing group into simple molecules through amide bond formation, 
















The quinoline group allows β-arylation of a simple carboxylic acid, (conversion of 
152 to 153).  In a similar fashion, the picolinamide-directing group enables the 
functionalisation of an alkyl amine, 154.  Both of these amides are easily cleaved 
providing the arylated acids and amines respectively. 
 
Sanford et al have also used pyridines to direct arylation to specific sp2 and sp3 C-H 
bonds.95  A number of different pyridine and quinoline compounds were arylated 





A number of mechanistic experiments were conducted in order to determine the 
reaction mechanism.  Stoichiometric palladium acetate was reacted with a 
phenylpyridine, 160, to give the bridged dimeric palladacycle, 161.  161 was then 
treated with phenyliodide but no product was formed.  Treating the same compound 
with diphenyliodonium tetrafluoroborate gave full conversion of the palladacycle to 
the product, 162.  This indicated that the reaction is likely proceding through a 














Sanford et al have reported a highly impressive double C-H activation reaction more 





An extensive and highly detailed mechanistic study was also carried out to determine 
the nature of the C-H activation steps.  The evidence pointed to an initial palladium 
(II) cyclopalladation to give 165, followed by oxidation to palladium (IV), 166.  This 
species can then undergo a further cyclopalladation to give 167 before reductively 




Subsequent to this highly impressive double C-H activation/dimerisation reaction, a 
cross double C-H activation reaction has been reported using a similar protocol, 















The separate nature of the 2 C-H activation steps, (one at palladium (II) the other at 
palladium (IV)) allows an effective cross-coupling because homocoupleing of the 
two substrates is avoided.  These conditions have been applied to a number of other 
















Whilst pyridines are the most commonly used heterocyclic directing group, a number 
of other heterocycles have been used to direct arylation.  Daugulis has demonstrated 





You et al have utilised an oxazoline to functionalise ferrocene, 186, in the pursuit of 
planar-chiral ligands.104  In this case, rather than using an aryl halide, arenes have 





Oshima et al have reported the arylation of sp3 C-H bonds using a pyrimidine 
directing group, 189.105  Using aryl chlorides in refluxing o-xylene they are able to 















These conditions can be applied to a range of different heterocycles, a number of 
which also show a directing effect, Table 1.2.3.  Even the weakly basic benzoxazole 
and benzothiazole give the desired products in good yields. 
 






















Benzoxazole, 191, has also been shown to direct arylation by Wu et al, (Scheme 
1.2.43).106  Despite initial problems with diarylation, they prepared 16 examples of 















The reaction works particularly well when electron-donating groups are present on 
the aryl iodide and on the aryl ring.  Bromo and chloro substituents are also tolerated, 
which allows for further elaboration of the products.   
Pyridine N-oxides 
The synthesis of 2-arylpyridines is far from straightforward since 2-halopyridines 
can poison palladium catalysts by forming a dimeric palladacycle.107  In addition, 
boronic acids and esters in the 2-position are susceptible to protodeboronation,107 
which renders them of no use in Suzuki cross-coupling reactions.  Fagnou’s 
alternative, of pyridine N-oxide-directed arylation at pyridine C2,107 represents a leap 
forward in the palladium chemistry of pyridine compounds, (Scheme 1.2.44).  
Pyridine N-oxides are conveniently prepared from pyridines using mCPBA and can 
be reduced to the free pyridines by reaction with palladium on carbon in a formic 





Fagnou extended the scope of this reaction by showing that diazine N-oxides, 196, 















However, the free N in the ring showed a tendency to poison the palladium catalyst 
in some cases.  The reactions proceeded much more smoothly when 10 mol % of a 
copper (I) salt such as bromide or cyanide was added.   
 
Fagnou et al have expanded this methodology to the arylation of thiazoles.108  Whilst 
the C2 and C5 position of thiazoles can be arylated without the need for a directing 
group, arylation at the C4 position is notoriously difficult.  By synthesising thiazole 
N-oxide, not only is arylation at C2 and C5 more facile, but they also reported one of 














In addition to pyridine N-oxides, N-iminopyridinium ylides, 208, can be used to 





The reaction conditions are tolerant of electron-donating and electron-withdrawing 
substituents on the aryl bromide.  Furthermore, heteroaryl bromides such as 2- and 3-
bromopyridine can be used in the reaction with no detrimental effects.  This 















The products can be easily converted back to pyridines, reduced to piperidines, or 
elaborated in a number of different ways, which provides a convenient route to 
highly functionalised pyridine and piperidine compounds.   
 

















2. Arylation at thiazole C5 
2.1. Precedents 
 
The direct arylation of thiazole has been covered in a number of recent 
reviews.61,67,111-115  The most salient and relevant examples are discussed here: 
 
Direct arylation of an azole ring was first accomplished in 1989 by Ohta et al.116  The 
impressive foray into the direct arylation of thiazole, oxazole and imidazole yielded 
astounding results, both in terms of conversion and selectivity.  Taking thiazole and 
oxazole in dimethylacetamide, together with tetrakistriphenylphosphino palladium 
and potassium acetate, a heterocyclic chloride could be coupled at the C5 position of 
the azole ring in yields of up to 83%, (Scheme 2.1.1).   
 
 
Scheme 2.1.1 Ohta’s chloropyrazine arylations 
 
This should have marked the beginning of research into the direct functionalisation 
of these molecules.  That was not the case, in 1998 Miura’s et al developed the 
methodology put forward by Ohta.117  This expanded the range of substrates to aryl 
iodides and bromides, and investigated the regioselectivity with other substituents on 
the azole ring.  A number of other variables were investigated, including bases.  The 
research was comprehensive for the direct arylation of imidazoles, but there were 
only a limited number of examples where thiazole and substituted thiazoles were 
functionalised.  Crucially, they discovered that the regioselectivity could be reversed 
when copper (I) iodide was used as an additive, switching the preferred position of 
substitution from C5 to C2.   
 










Preliminary results showed that caesium carbonate was the most effective base for 
both oxazoles and thiazoles, (Scheme 2.1.2). Potassium carbonate was ineffective 
with an aryl iodide, whereas, it was equally effective for aryl bromides.  This was 
explained in terms of the solubilities of the inorganic salts in dimethylformamide; 
potassium iodide is particularly soluble in dimethylformamide, whereas potassium 
bromide is much less so.  They proposed that the solubility of the iodide ion was 
causing the reaction to be less efficient, this was confirmed by adding a small amount 
of potassium iodide to the aryl iodide/caesium carbonate reaction, causing the 
reaction to stall.   
 
 
Scheme 2.1.2 - Miura’s conditions 
 
The 5-substituted azole ring was the only product isolated from the reaction which is 
consistent with an electrophilic mechanism (Scheme 2.1.3). 
 
 
Scheme 2.1.3 Miura’s proposed catalytic cycle117 
 










Oxidative addition of the aryl halide, 64, to palladium followed by electrophilic 
addition of the aryl palladium, 349, to thiazole 51 gives intermediate 215.  
Deprotonation of 215 to regain the aromaticity gives intermediate 216 which can 
then undergo reductive elimination to give the substituted product, 65, and re-form 
palladium (0).  Substitution at C5 is the only observed product, this supports an 
electophilic addition mechanism.  If the mechanism followed a “Heck” type 
mechanism, (via carbopalladation followed by β-hydride elimination),118 some 
substitution at C4 would be expected.  The Heck mechanism, (Scheme 2.1.4), is also 
unlikely in this case as it would require a formal anti-elimination of the β-hydrogen 
(conversion of 218 to 54) which would be unusual but not unprecedented.119,120 
 
 
Scheme 2.1.4 – “Heck-type” mechanism for arylation of thiazole 
 
Miura et al further investigated the regioselectivity of their reaction by using thiazole, 
introducing the possibility of arylation at C2 or C5.  This led to a mixture of products, 
(namely the expected 5-phenylthiazole, 54,  and also 2,5-diphenylthiazole, 65) 
although overall yields were poor, (Scheme 2.1.5).  When two equivalents of copper 
(I) iodide had been added to the reaction with 2-methylthiazole an increase in the 
yield was observed.  Using copper (I) iodide with thiazole gave exclusively 2-
methyl-5-phenylthiazole in a shorter reaction time.   
 











Scheme 2.1.5 – Effect of Copper on regioselectivity 
 
The reaction was repeated omitting palladium acetate to establish whether copper (I) 
was catalysing the reaction.  Only the 2 substituted thiazole, 51, was obtained in 15% 
yield.  The copper may have two functions: firstly, since it is soft, it may help to 
prevent the sulphur in the thiazole ring from ligating the palladium;117 secondly it 
may partially metallate at the acidic C2 position directing substitution, in analogy to 
its role in the Sonagashira reaction.121   
 
Kondo et al immobilized iodobenzoate on solid support and applied Miura’s 
conditions to the selective synthesis of 2- or 5-arylated thiazoles, (Scheme 2.1.6).122   
 
Scheme 2.1.6 – Kondo’s solid supported route to substituted thiazoles 
 
Diarylation was not observed under these conditions, yields of the 2- or 5-aryl 
thiazoles were 65% and 54% after cleavage.  The products were further arylated 
using a solution phase aryl iodide providing a route to 2,5-diarylthiazoles.  
Unfortunately high temperatures and long reaction times were still required. 
 










Whilst investigating the fluorescent properties of thiazole compounds in 2003, Mori 
et al devised a similar catalytic system for the arylation of thiazole.  
Tetrbutylammonium fluoride was used to accelerate the reaction and reduce the 
temperature, (Scheme 2.1.7).8 
 
Scheme 2.1.7 Mori’s selective 2-arylation 
 
Regioselective C2 substitution (51) was achieved with only 2 mol % of copper (I) 
iodide, however, only two examples of this reaction were reported.  
 
Several 2,5-diarylthiazoles, 65, were constucted using their conditions8 and 
Miura’s,117 (Scheme 2.1.8).  The products were analysed for liquid crystalline 
characteristics, 2,5-diarylthiazoles have a wide temperature range in which they 
exhibit liquid crystalline behaviour.8   
 
 
Scheme 2.1.8 – Mori’s synthesis of 2,5-diarylthiazoles 
 










With a reliable proceedure for arylation at thiazole C2, Mori then developed a 
reduced temperature protocol for 5-arylation.  This was accomplished by the use of a 
silver salt as an additive in the reaction, namely silver fluoride, (Scheme 2.1.9).37   
 
 
Scheme 2.1.9 - Mori’s improved 5-arylation 
 
This modification of the reaction was milder and far quicker.  Previously reactions 
had taken at least twenty-four hours to reach completion; with silver fluoride the 
reaction was finished in five hours, albeit with an attenuated yield of 58%.  The use 
of 2-anisylthiazole constitutes a particularly good substrate for the electrophilic 
addition mechanism proposed by Miura, (Scheme 2.1.3) yet the yield was only 58%.  
As the only thiazole example, the potential applicability of these conditions for the 
arylation of other thiazoles can therefore be questioned.   
 
Whilst investigating this reaction there have been several further publications in this 
area.  Bellina et al were able to successfully arylate thiazole in the C2 position using 
a base and ligand free protocol, (Scheme 2.1.10).123,124  2-anisylthiazole was the sole 
product isolated from a reaction using stoichiometric copper in place of palladium.117  
This method was demonstrated to be applicable to a wide range of other heterocycles 
in good yields, however the high temperature remains a drawback. 
 
 
Scheme 2.1.10 - Bellina’s thiazole 2-arylation 
 
In 2007 Daugulis reported the arylation of a number of heterocycles with aryl iodides 
using a catalytic copper based system.125  Not only did they successfully arylate 










thiazole, they were also able to arylate a wide range of heterocycles in a remarkably 
short reaction time, (Scheme 2.1.11).  
 
 
Scheme 2.1.11 - Daugulis’s copper mediated system 
 
A number of mechanistic experiments were conducted, including the reaction of 4,5-
dimethylthiazole with deuterated phenyl iodide.  When potassium tert-butoxide was 
used a proton was incorporated into the ortho position of the phenyliodide.  This may 
suggest a benzyne-type intermediate was generated.  This, however, was not 
observed when lithium tert-butoxide was used.  In further support of this mechanism, 
when 4-iodotoluene was used in place of phenyliodide and using potassium tert-
butoxide, a mixture of meta and para-tolylthiazoles are obtained.   
 
The use of aryl chlorides in place of aryl iodides and bromides is becoming more 
common in cross-coupling reactions.  Not only are aryl chlorides more generally 
available, but they are considerably cheaper and their use is considered to be greener, 
as there is a higher proportion of the mass of the substrate incorporated into the 
product.  Daugulis et al have expanded the purview of their arylation of electron-rich 
heterocycles to include the use of aryl chlorides.126  These were found to be 
unreactive under the copper conditions.125  Brief investigation of a palladium-based 
system quickly led them to identify conditions for the transformation, (Scheme 
2.1.12).   
 











Scheme 2.1.12 - Daugulis’s aryl chloride arylation conditions 
 
Despite the advances reported since Mori’s silver catalysed system was published, 
there remains a need to develop a general mild protocol for the arylation of thiazole 
at the C5 position.  Daugulis’s palladium conditions did arylate at the C5 position of 
the thiazole ring but they only reported two examples.  Mori’s silver fluoride 
conditions remain the only example of thiazole C5 coupling at a temperature less 
than 100°C.   










2.2. Optimisation studies 
The drawbacks associated with the above studies prompted us to investigate the 
potential of the methods in place, with a view to optimisation and amelioration of the 
conditions.   
 
It was felt that the conditions developed by Mori, utilising silver fluoride could be 
significantly improved upon in terms of both scope and yield.  The use of two 
equivalents of silver fluoride, a particularly expensive silver salt (£44.50 for 5 g from 
Sigma-Aldrich), is prohibitive for large scale use of these conditions.   
 
To avoid the potential confusion of 2, 5 or 2,5-diarylation it was decided to utilise a 
2-substituted thiazole.  2-Phenylthiazole, 51a, was selected due to the neutral 
electron-donating ability of the phenyl group (compare with anisyl in Mori’s 
example, Scheme 2.1.9)37 to enable a methodology to be developed with wide 
applicability. 
 
2-Phenylthiazole was synthesised by a classic Hantzsch synthesis from 
thiobenzamide, 36a, and α-chloroacetaldehyde hydrate, 37a, (Scheme 2.2.1).  This 
method involved isolating the hydrate of the aldehyde from an aqueous solution 
using calcium chloride, proving to be time consuming and impractical on a small 
scale.  The use of large amounts of acetic anhydride to remove the water and drive 
the reaction to completion, required considerable amounts of base to quench and 
neutralise, leading to excessive volumes and emulsions during the workup.   
 
 
Scheme 2.2.1 – Hantzsch synthesis of 2-phenylthiazole 
 
It was found that the reaction could be run using aqueous chloroacetaldehyde in 
ethanol negating the need for the acetic anhydride altogether, and greatly simplifying 










the procedure.  Furthermore this led to higher yields and cleaner reactions, especially 
on a smaller scale.   
 
 
Scheme 2.2.2 – Model system for optimisation 
 
Using Miura’s conditions (Pd(OAc)2, PPh3, Cs2CO3, Ar-I, Scheme 2.1.2) as a 
starting point, several variables were examined including temperature and solvent, 
immediately revealing a serious problem.  2-Phenylthiazole and 2,5-diphenylthiazole 
have identical Rf values in ethyl acetate/hexane mixtures and extremely close Rf in 
dichloromethane or toluene tlc systems.  Despite a variety of differing solvent 
systems being used it was not possible to isolate the product from the reaction 
mixture without losing significant amounts to mixed fractions during column 
chromatography.  A different aryl iodide was chosen to carry out the optimisation 
studies.  Iodotoluene formed a product that co-eluted with 2-phenylthiazole however, 
whilst 4-chloroiodobenzene also gave a 2,5-diarylthiazole product that was close 
running with 2-phenylthiazole, it was possible to separate them.   
 
 
Scheme 2.2.3 – The improved model system 
 
With substrate that was reasonably easy to purify it was decided to optimise the 
system for chloroiodobenzene and 2-phenylthiazole, (Scheme 2.2.3).  Samples of the 
starting materials and products were also run by HPLC to allow in situ monitoring of 
the reaction to provide a quantitative method of analysis.   











Starting from Miura’s conditions, in dimethylformamide, the temperature was 
increased from room temperature in 10°C increments to determine at which point the 
reaction proceeds.  The reaction does not start until above 100°C and, at this 
temperature it took more than a week for the reaction to reach completion.  The 
reaction was repeated in toluene at 100°C but the conversion was poor by HPLC and 
the reaction profile messy, isolated yield 18%.   
 
Temp /°C Time to reach end point1/hr 
20 No reaction 
30 No reaction 
40 No reaction 
50 No reaction 
60 No reaction 
70 No reaction 
80 No reaction 






150 48 – yield 59% 
Table 2.2.1 – Initial findings with regard to temperature 
 
Despite the use of elevated temperatures, the reactions proceed slowly and fail to 
reach completion.  Our initial hopes to use HPLC as a method to assess the success 
of each reaction were thrown aside at this point, as there were a large number of side 
reactions.  A number of the side products have a very high UV response and skew 
the conversions measured by HPLC.  HPLC was instead used as a guide to the 
success of the reaction. Products from reactions deemed to be successful were 
                                                 
1 The reactions do not proceed to completion.  The time here measures the time until the reaction 
irreversibly stalls (measured by HPLC). 










isolated and subjected to column chromatography to quantify the results.  In some 
cases there were large disparities between the conversion (measured by HPLC) and 
isolated yield.   
 
We next began to investigate the use of additives in the reaction such as silver 
fluoride and tetrabutylammonium fluoride, both shown to be promoters by Mori.8,37  
In addition to increasing the rate, they are able to significantly reduce the 
temperature necessary for C-H activation at the C5 position of the thiazole ring.   
 
Using two equivalents of silver fluoride with palladium acetate (5 mol %), 
triphenylphosphine (10 mol %), caesium carbonate (2 equiv), 2-phenylthiazole (1 
equiv) and 4-chloroiodobenzene (1.2 equiv) in dimethylformamide at 60°C for 24 hr 
the product was isolated in 60% yield constituting a large drop in the temperature 
needed to conduct the reaction.  It was then repeated using acetonitrile rather than 
dimethylformamide.  Acetonitrile is a superior solvent in terms of removing it from 
the reaction mixture and purification of the product.  The reaction was carried out at 
60°C for 48 hours and the product isolated in 73% yield following column 
chromatography.  Whilst the reaction was slower in acetonitrile, it gave an increase 
in the yield, it was also noted that the purification was more straightforward.   
 
Although Mori’s work had suggested that using tetrabutylammonium fluoride could 
be nearly as effective as using a silver salt, it was found that this did not apply to our 
reaction system.  Furthermore, the reaction was slow and formed a number of 
unknown impurities without a trace of product being seen.   
 
The silver cation was obviously crucial to the reaction.  Being aware of the reported 
effect of iodide, it was decided to investigate a number of silver salts to determine if 
silver fluoride was the most effective. 











Silver Salt Yield 65b 
Time 
/days 
AgF 80 2 
Ag2O 17 5 
AgOSO2CF3 30 1 
Ag2CO3 41 3 
Ag2CO3 (on celite) 67 5 
Ag2CO3 (on celite)a 87 5 
AgFb 0 2 
AgFc 63 2 
Conditions: Pd(OAc)2 (5 mol %), PPh3 (10 mol %), 2-phenylthiazole  
(50 mg, 1 equiv), 4-chloroiodobenzene (1.2 equiv), Cs2CO3 (2 equiv),  
silver salt (2 equiv of Ag+), CH3CN (5 mL), 60°C.  a No Cs2CO3,  
b No Pd(OAc)2,  c 1 equiv AgF 
Table 2.2.2 – Investigation of the effect of silver salts 
 
Whilst silver fluoride works well for the reaction it is expensive, it would be 
beneficial to be able to use a cheaper silver salt; the results of the screen are shown in 
Table 2.2.2.  Silver oxide hardly affected the reaction at all, after five days very little 
product was observed.  The use of silver triflate led to a number of side products.  
Silver carbonate reacted cleanly but slowly; after a prolonged reaction time silver 
carbonate on celite gave a 67% yield.  When the reaction was repeated omitting the 
caesium carbonate and using silver carbonate on celite as both base and silver salt, 
the reaction gave an 87% yield in five days.  This was a significant increase over 
using the caesium carbonate, silver carbonate combination.   
 
To try and discover the role of the silver salt, the reaction was repeated without 
palladium to investigate whether the silver cation alone could be mediating this 
transformation.  After two days no reaction had been seen but when palladium 
acetate was added, the reaction began. 
 
Reducing the amount of silver fluoride demands longer reaction times to obtain high 
yields; this is not too surprising because the use of silver or thallium salts to 
accelerate Heck-type reactions is well precedented.127-129  The silver cation is a 










halophile causing silver iodide or bromide to precipitate out of the reaction mixture 
and therefore be unavailable to ligate the palladium.  It is thought that this gives a 
cationic palladium species which is a more active catalyst, it would seem likely that 
this is the role of the silver salt.  A cationic palladium species would be expected to 
undergo an electrophilic addition to the thiazole more readily than a neutral 
palladium complex.  Whilst the fluoride counter ion is not necessarily contributing to 
the increase in rate it is a poor ligand to the palladium and as such does not interfere 
with the cationic palladium.  Silver fluoride is also particularly soluble in acetonitrile 
when compared to other silver salts so this should increase the rate of precipitation of 
silver iodide.   
 
The fact that the yield is higher using silver carbonate without caesium carbonate is 
possibly due to the relative solubilities of caesium iodide and silver iodide.  Since 
silver iodide is less soluble than caesium iodide there would be less iodide in solution 
to ligate the palladium.  It is also feasible that in the case of caesium carbonate and 
silver fluoride, ion exchange occurs forming caesium fluoride and silver carbonate.  
This is supported by the decrease in respective yields when different bases are used.  
Sodium and potassium iodide are both particularly soluble in acetonitrile compared 
to both caesium and silver iodides and a corresponding decrease in the yield is seen 
in these cases, (Table 2.2.3). 
 




Cs2CO3 - 0 72 
Cs2CO3 AgF 75 72 
- AgF 60 72 
K2CO3 AgF 15 72 
Na2CO3 AgF 10 72 
KOAc AgF 18 72 
Table 2.2.3 – The effect of different bases. 
 
Despite the reasonable yields achieved so far, the reaction was still very slow, 
generally taking five days to reach completion.  To accelerate the reaction, the use of 










microwave heating was investigated.  Using Pd2(dba)3 we obtained the results shown 
in Table 2.2.4.  The reaction was complete in only two hours at 100°C.  
Unfortunately on isolation it proved to be a mixture of two compounds, the expected 
product, 2-phenyl-5-(4-chlorophenyl)thiazole, 65b, and 4,4-dichlorobiphenyl, 227, 
this was the first time the biphenyl compound had been observed, it co-runs with the 
product by HPLC.  Method development was attempted in order to separate the 
peaks but with the columns available this proved to be impossible.  The isolated 










5 60 13 
10 60 22 
40 60 29 
5 100 16 
10 100 20 
30 100 23 
120 100 95 
240 100 95 
Table 2.2.4 – Conversion using microwave heating 
 
As the proportion of biphenyl could not be determined by HPLC, it was decided to 
investigate different palladium sources to see how this would affect the reaction.  It 
had already been seen that Pd2(dba)3 was a slightly more active catalyst than 
palladium acetate although both were slow.  A number of different palladium sources 
were used and the conversions measured by HPLC, see Table 2.2.5.   











Pd Source Time /hr Conversion into 
65b /% 
Pd(OAc)2 72 39 
Pd2(dba)3 72 42 
PdCl2(dppf) CH2Cl2 72 81 
PdCl2(PPh3)2 72 63 
PdCl2 48 76 
PdCl2⋅CH3CN 120 66 
PdCl2(dppe) 120 40 
Pd(PPh3)4 120 69 
Conditions: Pd (5 mol %), PPh3 (10 mol %), CH3CN (5 
mL), Ag2CO3 (2 equiv), 2-phenylthiazole (1 equiv), 4-
chloroiodobenzene (1.2 equiv) 
Table 2.2.5 – Investigation of palladium sources 
 
The use of PdCl2(dppf)⋅CH2Cl2 provided excellent conversion (isolated yield 79%), 
palladium chloride also had a very clean reaction profile and reached complete 
conversion in under two days but unfortunately led to some homocoupling of the aryl 
iodide.   
 
It was interesting to note that in the case of PdCl2(dppf)⋅CH2Cl2 the addition of extra 
ligands was necessary to ensure continued catalyst turnover.  Without extra 
triphenylphosphine the conversion falls to 43%, comparable with Pd2(dba)3.  With 
these conditions in hand it was decided to attempt the coupling of other aryl iodides 
to the 2-phenylthiazole core, (Scheme 2.2.4 and Table 2.2.6).   
 
 
Scheme 2.2.4 - General library scheme 
























































Table 2.2.6 – Reactions in CH3CN 
 
A large number of different aryl iodides are viable in the reactions and overall yields 
were moderate to good.  A number of failures were, however, observed.  The 










pyridine, (291a and 65q) and pyrazine (65r) heteroaryliodides reacted poorly or not 
at all.  This is probably due to their ability to coordinate to the palladium reducing 
the efficiency of the catalytic cycle.  Similar reasoning can be applied to the 
iodobenzoic acid (65t) and the iodoanilines (65u and 65v) that were attempted.  
Iodomesitylene, 65s, also failed under these conditions demonstrating unfavourable 
steric effects.  This can also be seen in the ortho-substituted aryliodides which 
demonstrated a noticable reduction in yields over their para-substituted analogues.   
 
In order to lend further support to the electrophilic substitution mechanism put 
forward by Miura117 we looked at different aryl groups in the thiazole 2-position.  To 
examine the electronic effects at the thiazole C2 position para -CF3, -Me and MeO- 
aromatic groups were chosen, (Scheme 2.2.5 and Table 2.2.7).   
 











73 77 78 74 
 
96 93 74 32 
 
98 85 81 63 
 
64 69 62 12 














Before analysing these results it is worth looking again at the four discrete steps in 
Miura’s proposed mechanism, (Scheme 2.2.6).  Looking at each, together with the 
data collected we can dismiss the oxidative addition step as the rate determining step.  
Oxidative addition of aryl iodides is facile at room temperature so cannot be the rate 
determining step.  Likewise, there is no evidence to suggest that the reductive 
elimination is the rate determining step.  If it was, the electronic nature of the aryl 
iodide would affect the rate; a more electron-rich aryl iodide would give a more 
electron-rich palladium species, which would undergo more facile reductive 
elimination.  Likewise bulky electron-rich ligands would promote the reaction.  
Overall, no real trend was seen with regard to the aryl iodide employed in the 
reaction.   
 
 
Scheme 2.2.6 – Miura’s proposed mechanism 
 
This leaves two possible rate determining steps in the reaction sequence; 
electrophilic addition of the thiazole to the aryl palladium and deprotonation of the 
aryl thiazole intermediate to regain the aromaticity.  Dealing with the former first, the 
concentration of base in the reaction mixture is such that it is unlikely that this is the 
rate determining step.  In addition the restoration of the thiazole aromaticity should 
cause this step to be favourable, leaving the electrophilic addition as the rate 
determining step.  Indeed this would seem to be confirmed by Mori’s silver fluoride 










conditions,37 presumably giving a cationic aryl palladium species and greatly 
accelerating the reaction.   
 
The results in Table 2.2.7 showed that the actual situation is not quite as 
straightforward as might be expected.  Considering the reaction of 4-iodoanisole with 
the four 2-arylthiazoles shows essentially the same yield across electron-donating 
and withdrawing substituents.  This is likely to be due to slow oxidative addition of 
palladium (0) to 4-iodoanisole masking the substituent effect on the thiazole.  
Looking at 4-chloroiodobenzene and 4-iodotoluene there is a definite correlation 
between the electron-donating ability of the substituent at thiazole C2 and the yield 
of product isolated, 4-iodonitrobenzene also does not adhere to the expected pattern.  
Oxidative addition of 4-iodonitrobenzene is known to be very fast and it is assumed 
that it may be consumed in side reactions before being able to react with the thiazole 
substrate.  From these results it is obvious that the electrophilic addition is an 
important event in the mechanism but that it is not always the rate determining step.  
In the case of very electron-donating aryl iodides (poor substrates) the slow oxidative 
addition may even be the rate determining step. 
 
Despite these positive results we remained dissatisfied with the time that the 
reactions needed to reach completion, to improve this we decided to look at a number 
of factors.  This further investigation of the variables was started whilst on CASE 
placement at Syngenta and initially it was found that the reaction was entirely 
unreproducible and completely failed.  A systematic approach identified two main 
problems, firstly the purity of the starting material.  In Edinburgh purification of the 
starting material was accomplished by reduced pressure distillation.  At Syngenta, 
even after distillation under reduced pressure, the material, whilst appearing clean by 
NMR, failed to react.  After passing the material through a plug of silica gel, it was 
substantially more active in the reaction.  It was also found, however, that 
purification by column chromatography was not an acceptable alternative; a highly 
coloured impurity co-eluted and again, the material was unreactive in the palladium 
cross-coupling reaction.   
 










The second of the problems encountered at Syngenta was due to the solvent.  Dry 
acetonitrile purchased from Aldrich was not sufficiently dry to effect the 
transformation, nor when it had been further dried and stored, over activated 
molecular sieves.  Syngenta policy dictated that solvent stills were an unacceptable 
method for drying solvents, however, all other avenues having been explored and 
found wanting, a compromise was reached.  Acetonitrile distilled from calcium 
hydride can be stored over 3Å molecular sieves and under nitrogen for 
approximately fourteen days before reaction efficiency is significantly compromised.   
 
With these results in hand, it was found that the reaction was more reliable and 
reproducible.  This allowed an accurate and trustworthy HPLC method to be 
introduced to gauge product amounts.  Together with LC-MS this allowed a large 
amount of data to be generated about the reaction and the associated variables.   
 
Investigation of the variables commenced with a brief look at the reaction 
temperature, followed by ligand properties to further modify the steric and electronic 
environment around the aryl-palladium.  At temperatures in excess of 80°C we began 
to see a side reaction occurring in preference to our desired reaction.  This led to the 
formation of homocoupled aryl iodide, 227, (as seen in the microwave studies) 
together with a degree of homocoupling of the thiazole compound, 228a, described 




Until this point it had been determined that the addition of extra ligand was important 
to the reaction, but it had not been discovered whether there was a significant effect 
dependent on the ligand used.  We had looked at a number of different palladium 
sources, some of which contained ligands, and noticed no real advantage except in 
the case of Pd(dppf)Cl2.  In light of the mechanistic implications it was thought that 










electronic modification of the arylpalladium species might lead to accelerated 
reaction times.  A small screen of available ligands showed some interesting trends.  
These reactions were carried out with palladium acetate, to prevent possible 
interference of any ligands already present on palladium.  The catalyst and ligand 
were stirred in dry, degassed acetonitrile for 10 min prior to adding the remaining 
reagents.  The reactions were then heated to 60°C for three hours, the time being kept 
short to avoid unrepresentative results if a reaction was substantially accelerated.  
The results are depicted in Figure 2.2.1 and the nature of the ligands in Table 2.2.8.   
 
PPh3   229 
 







HPtBu3.BF4   235 
 



















Table 2.2.8 - Ligands used in the screen 
 
 
























































































Only a small ligand effect was observed.  However, in every case the use of a ligand 
did cause some improvement in conversion.   
 
The effects of the ligands themselves can be broken down into a number of variables; 
sterics, electronics and bite angle for the bidentate ligands.   
 
The steric effects of the ligands can be quantified by the Tolman cone angles,131 a 
plot of cone angle against conversion shows that the more sterically encumbered the 
ligand (and therefore the metal centre) the higher the conversion, (Figure 2.2.2).  
Dppm, dppe and dppp are substantially more active than the monodentate ligands, 
but even within these two classes of ligands it can be seen that the conversion 
increases with cone angle.  A more sterically bulky ligand promotes faster reductive 
elimination.132   
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Whilst cone angle is an intuitive method to quantify the steric effects of a particular 
ligand it is more difficult to identify a method to measure a ligand’s electronic 
contribution to a metal complex.  This is traditionally done by measuring the C≡O 
stretch (by infrared spectroscopy) of the ligand whilst part of a Ni(CO)3L complex.131  
The values associated with a number of the investigated ligands have been plotted 
against the conversion in Figure 2.2.3.   
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There is a positive correlation between the stretching frequency and the conversion, 
i.e. an increase in the conversion for less electron-donating ligands.  This supports an 
electrophilic addition mechanism, whereby an electron-poor palladium species would 
react faster than an electron-rich one.   
 
The next variable returned to was the nature of the silver salt.  As a marked counter-
ion effect had been observed it was appropriate to screen a wider range, especially 
with the more reliable procedure now in place.  Also investigated were a number of 
other additives and different bases, (Figure 2.2.4, conditions: 2-phenylthiazole, 
Pd(dppf)Cl2⋅CH2Cl2, PPh3, CH3CN, 4-ClC6H4I, 60 °C, 24 hr).   
 













































































































































































Silver fluoride was confirmed as the best silver salt followed by silver carbonate and 
silver acetate; the efficiency of silver acetate was a surprising result.  It had been 










assumed that an effective silver salt would have a non-coordinating anion.  From 
these results is not always necessary, but the silver salt should also be basic.  Of the 
other bases used, caesium carbonate and potassium acetate were shown to be good 
choices, although less efficient than the silver carbonate, fluoride and acetate.  This 
was in contrast to earlier work, which had shown caesium carbonate and potassium 
acetate to both cause the reaction to stall.  This may be due to the cleaner starting 
material which has been shown to be more active in the reaction.  In addition some of 
the results here do not match up with the earlier screen of silver salts.  This is 
probably because the original screen was done with a number of old pots of silver 
salts.  Silver salts degrade to silver over time and with exposure to light.  A common 
solution to this is the immobilisation of silver carbonate on celite to improve its 
lifetime with regard to decomposition.  This would explain why in the initial screen, 
(see Table 2.2.2), silver carbonate on celite was more active than silver carbonate.   
 
Whilst repeating the 5-arylation a curious result was observed.  The reaction was 
flooded with water when the condenser broke and left to stir at room temperature 
over the weekend.  On recovering the starting material the following Monday there 
was also a small amount of product obtained, 7%.  This was surprising as the use of 
wet solvent had usually lead to poor conversion at 60°C and the reaction had never 
been observed at room temperature.  This led to investigation of a number of 
common solvents.  The results are shown in Figure 2.2.5.  Tetrahydrofuran and 
dioxane had curious results where not only was the expected product seen but also 
small amounts of 4,5-diarylation which is entirely unprecedented in the absence of a 
directing group.93  These two results will be discussed in more detail in chapter 3.  
However, the most important and unexpected result was in the case where the 
reaction was run in water and displayed a startling efficiency.  It should be noted that 
Figure 2.2.5 shows isolated yields, not simply conversions and that the reaction in 
water was complete where as all of the others showed some 2-phenylthiazole 
remaining.   
 
Figure 2.2.5 – Solvent effects on arylation at thiazole C5 – 72 hr at 60°C 
 











































































With this rather surprising result in hand, the reaction was repeated to confirm the 
result, and three other 2,5-diarylthiazoles were made to see if this was a general 
effect.  The results are shown in Table 2.2.9 and are quite spectacular.  The increase 
in yield was also accompanied by much cleaner reactions that had reached 
completion; as there was no remaining 2-phenylthiazole the purification was 
significantly improved.   
 



















Conditions: 2-phenylthiazole, Pd(dppf)Cl2⋅CH2Cl2 (5 mol %), PPh3 (10 mol %),  
Ar-I (1.2 equiv), Ag2CO3 (2 equiv), CH3CN (5 mL) or H2O (5 mL), 60°C, 72 hr. 
Table 2.2.9 - Comparison of the reaction in acetonitrile and water 
 
We next turned our attention to the timescale needed for the reactions to reach 
completion and to try and understand the effect that the water was having on the 
reaction.  Figure 2.2.6 shows conversion with time, demonstrating a significant 
increase in rate between acetonitrile and water.  Somewhat surprisingly, the neat rate 
is quite similar to the rate in water.  As the reagents are, only sparingly soluble in 
water, it is assumed that water is acting as an “anti-solvent” essentially allowing the 
reaction to be conducted neat but retaining stirring and efficient heat transfer. 
 
























































A mixed aqueous/organic single phase system was also investigated to see if it would 
confer any advantage over the water system.  Stirring was often poor and the 










reagents would adhere to the side of the flask, thus necessitating mechanical agitation 
with dichloromethane to remove the solids at the end of the reaction.  Differing 
proportions of water and acetonitrile were combined and the conversion measured 
after five hours, see Figure 2.2.7. 
 
The data obtained were in agreement with our original findings that wet acetonitrile 
was less efficient than dry acetonitrile.  Interestingly it was also found that addition 
of a small amount of acetonitrile to the water reaction did increase the conversion 
slightly.  This can be attributed to improved stirring over water alone as there will be 
increased solubility of the various organic components and therefore improved 
kinetics of transport throughout the aqueous phase. 
 
With the improvement over the reactions in acetonitrile shown to be reproducible the 
original library of compounds was re-made using the water conditions.  The results 
are shown in Table 2.2.10. 
 
There was a significant advantage in the use of water as a solvent, not only in terms 
of yield but the considerable reduction in reaction time.   
 
The absence of an organic solvent confers a green status on the reaction.  Sharpless 
has extensively investigated the effect of water on reaction systems, dubbing certain 
reations as “on water” reactions.133  The reaction mixture benefits from an anti-
solvent effect whereby the effective concentration of the reaction is increased whilst 
maintaining efficient stirring and heat transfer.   











Compound Yield CH3CN 
Yield 
H2O 




















































- >99  
228a 
61 >99 
Conditions: 2-phenylthiazole (1 equiv), aryliodide (1.2 equiv), Pd(dppf)Cl2⋅CH2Cl2 (5 mol %), PPh3 (10 
mol %), Ag2CO3 (2 equiv), CH3CN 72 hr or H2O 24 hr, Yields: average of 2 runs 
Table 2.2.10 – Comparison of water and acetonitrile 
 










Reduction of the quantity of organic solvent is obviously a desirable characteristic 
for green chemistry, however, it is not just the reaction solvent that should be 
considered.  Aqueous chemistry cannot be considered green if large columes of 
organic solvent are necessary to extract the product out of the reaction mixture.  In 
this case, only minimal solvent is needed to remove the product.  The work up 
consists of firstly filtering the reaction mixture through celite to remove the insoluble 
salts, and washing the cake with acetone (5 mL) and dichloromethane (5 mL).  The 
residue is concentrated to remove the acetone, then the aqueous residue extracted 
into dichloromethane (5 mL) and passed through a plug of silica gel to remove any 
unreacted aryl iodide.  The need to remove the acetone and extract the product from 
the aqueous residue reduces the elegance of the procedure but proved to be 
unavoidable.   
 
A property of the 2,5-diarylthiazole products is that they azeotrope with water, hence 
attempting to remove the water from the reaction mixture by distillation leads to the 
loss of the product.  Indeed, during the reactions crystals of product were often 
observed around the top of the reaction tubes, see Figure 2.2.8.  It was hoped that it 
might be possible to cleanly isolate the product from the reaction in this fashion and 
negate the need for organic solvents entirely, however, when this was attempted, not 
only was a poorer yield obtained compared to the work-up and extraction procedure, 
but not all the 2,5-diarylthiazoles azeotrope.   










     
Figure 2.2.8 - Product crystals in water reactions 
 
With the superior water conditions in hand the stoichiometry of the reaction was 
investigated.  A catalyst loading of 5 mol % may be standard for small scale 
reactions, but only represents twenty turnovers for each molecule of catalyst.  
Gratifyingly, reducing the catalyst loading by a factor of ten did not significantly 
decrease the conversion after twenty-four hours at 60°C in water.  This is a turnover 
number of at least two hundred.  With this result in hand we further reduced the 
amount of added palladium and saw a corresponding drop off in the conversion 
which could be solved by longer reaction times.  As a control experiment the reaction 
was also run with no added palladium, in new glassware, with a new stirrer bar.  It 
was astounding to note that there was a 48% conversion to product, , see Figure 2.2.9.  
 
Investigating the purity of the silver carbonate employed (99% purity)  it was 
decided to purchase a purer grade of silver carbonate (99.999%) and repeat the 
reaction, in this case there was only 15% conversion to the product, a substantial 
drop compared to the 99% pure silver salt.  One of the major impurities in the finer 
grade silver was listed as palladium (Al 0.5, Ba 11.0, Ca 1.0, Cs 0.2, Fe 0.5, Ga 0.2, 
Pd 1.4, Sr 0.2, Th 0.8 and Zn 0.5 ppm) which could explain the conversion seen.   






























99+% Ag 99.9+% Ag
 
 
At four equivalents of silver cation, the amount of silver necessary in our reactions 
was obviously suboptimal.  Looking at the number of equivalents necessary for the 
reaction showed a stoichiometric amount of silver to be a requirement, and ideally a 
slight excess, the number of equivalents of silver carbonate can safely be reduced to 
0.75 with no detrimental effect on the reaction, see Figure 2.2.10.   
 






























With these results in hand, it was wondered if the reaction could be accomplished at 
a reduced temperature.  As such, a number of experiments were conducted at 
ambient temperature.  It was, however, found that there is a significant decrease in 
the reaction rate as the temperature is reduced.  Figure 2.2.6 shows the reaction to be 
substantially complete after only 5 hours at 60°C, whereas, at room temperature it 
takes a week to reach completion, (Figure 2.2.11). 
 




















5 mL MeCN 25°C Neat 25°C 5 mL water 25°C
 










2.3. Arylation with other electrophiles 
Ultimately it is hoped to be able to couple azole triflates to a thiazole or oxazole core 
and hence form multiple azole structures such as those in micrococcinic acid, 8, and 
telomestatin, 249.  Micrococcinic acid was first synthesised in 1991 by Kelly et al24 
in a series of Stille reactions from a triply orthogonal pyridine core.  This impressive 
synthesis perfectly demonstrated the power of palladium cross-couplings in the 
synthesis of this type of natural product.  In an analogous fashion, it could be 
envisaged that micrococcinic acid could be constructed through a series of direct 
arylation reactions.   
           
 
Azole triflates, 60, are readily obtained from the related oxo compounds, 59,  as 
shown in Scheme 2.3.1.  As such it was decided to make a preliminary investigation 
into the use of triflates and bromides as coupling partners.   
 
 
Scheme 2.3.1 – Synthesis of azole triflates 
 











Ar-X Conditions Product Yield 
Ph-I Pd2(dba)3, PPh3, Cs2CO3, CH3CN, AgF, 60°C 3 days 69 
Ph-Br Pd2(dba)3, PPh3, Cs2CO3, CH3CN, AgF, 60°C 3 days 0 
Ph-OTf Pd(OAc)2, PPh3, Cs2CO3, CH3CN, AgF, 60°C 3 days 10 





The initial results are shown in Table 2.3.1, the initial screen was carried out before 
the purity of the starting material was identified as a crucial factor.  Using 
iodobenzene the reaction proceeded as expected, but disappointingly no product was 
observed with bromobenzene.  Reaction with phenyltriflate proceeded poorly giving 
a number of side reactions.  The reaction was repeated without silver fluoride in an 
attempt to further investigate the role of the silver salt (if it is acting solely as a 
halophile then it should not be necessary in the reaction with phenyltriflate), but no 
conversion was seen.  It seems likely that as well as serving a halophile function the 
silver may also bind to the sulfur of the thiazole ring and prevent it from binding to 
the palladium thereby retaining an active form of the catalyst.  Before azole triflates 
can be coupled by this reaction further optimisation work needs to be carried out to 
couple thiazoles to other aryl triflates.   
 
Once the reaction conditions were more fully understood this area was returned to.  
No significant improvement was seen in the case of aryl triflates however, it was 
discovered that arylbromides could indeed react in this transformation, (Scheme 
2.3.2).  Aryl bromides are more attractive than aryl iodides on a number of grounds.  
Firstly they are generally less expensive, secondly a wider variety are commercially 
available and thirdly, they can be considered to be greener on the basis that the 
bromide ion has a smaller molecular weight than iodide and that a larger proportion 










of the mass of the aryl halide is incorporated into the product making the process 
more atom efficient.   
 
Scheme 2.3.2 – Reaction of aryl iodides and bromides with 2-phenylthiazole 
 
Unfortunately aryl bromides are significantly less reactive than aryl iodides even at 
the slightly elevated temperature of 80°C.  At temperatures higher than this there was 
significant amounts of homocoupling of the 2-phenylthiazole.   
 
The reaction of 2-phenylthiazole with aryl chlorides was also attempted.  However, 
even at 100°C no reaction was seen.  Aryl chlorides are reluctant to undergo 
oxidative addition and usually require both high temperatures and bulky electron-rich 
ligands.  Both aryl bromides and aryl chlorides may be shown to be valid reaction 
partners in the future with further optimisation of the reaction conditions.   










2.4. Arylation of Other Heterocycles 
We have described a powerful method of direct arylation that has been developed for 
the arylation of a range of 2-arylthiazoles.  In order to demonstrate the power of such 
a method, and the generality of a mild aqueous arylation protocol, the application of 
it to a variety of other thiazoles and indeed other heterocyclic motifs has been 
investigated.   
 
Various examples of direct arylation conditions have been reported in the 
literature.108,111,124,134-141  In general, however, these conditions are only applicable to 
a limited number of heterocycles and of these they may not have good selectivity.  
Furthermore they often involve the use of high boiling solvents such as 
dimethylacetamide, dimethylformamide or dimethylsulfoxide which can be difficult 
to remove from reaction mixtures.  In general there are few examples where the 
developed procedure has broad applicability over a wide range of compounds.   
 
We sought to apply our conditions to the synthesis of a number of other aryl 
heterocycles.  The results are shown in Figure 2.4.1, the conditions have been shown 
to not only be applicable to thiazoles, but also to oxazoles, thiophenes, 
benzothiophenes, benzoxazoles, benzimidazoles as well as benzofuran, although less 
effectively to a furan ring system.  This is unsurprising as furan is less aromatic than 
thiophene with more di-ene character.  The water chemistry has been further 
developed within the Greaney group by Stephan Ohnmacht and extended to the 
arylation of oxazoles.137  As far as I am aware, the water conditions described above 
represent the first example of catalytic direct arylation being carried out in aqueous 
media.  In addition this remains the only example of a general arylation protocol for 
the arylation of heterocycles that proceeds at a temperature less then 125°C.   
 











Figure 2.4.1 – Products from water conditions 
 










2.5. Carbonylation and other C-H activations 
In addition to the arylation of other heterocycles, and in light of the recent advances 
in arylation at unactivated aryl C-H bonds,61,62,142 it was attempted to apply the water 
conditions to the direct arylation of aryl C-H bonds in the absence of directing 
groups, (Scheme 2.5.1).   
 
 
Scheme 2.5.1 – Initial attempts at direct arylation of unactivated CH bonds 
 
Anisole (1 equiv) and iodochlorobenzene (1.2 equiv) were subjected to the 
previously developed conditions for 72 hr.  After this time a new spot was seen by 
tlc, however, when the product was isolated it was determined to be the 
homocoupled aryl iodide.  Following on from this, a large excess of anisole (20 
equiv) was used, again at 60°C, but only homocoupled aryl iodide was recovered, 
although in much smaller amounts.  Increasing the temperature to 100°C and 
conducting the reaction both under reflux in a sealed tube failed to provide any 
product other than homocoupled aryl iodide.  As no reaction had been observed, 
attention was turned back to aspects of the direct arylation of thiazoles. 
 
Carbonylation of aryl halides is a well documented area of palladium chemistry,143 it 
is frequently used to introduce aldehydes, esters and amides in a convergent and 
atom economical sense, (Scheme 2.5.2).  In other examples reaction of the aroyl 
palladium intermediate with a nucleophile can lead to the formation of ketones,144,145 
(Scheme 2.5.3).   
 











Scheme 2.5.2 – Carbonylations 
 
 
Scheme 2.5.3 – Carbonylation mechanism 
 
It was envisaged that 2-phenylthiazole could be used as the nucleophile in a 
carbonylation reaction.  Initially  2-phenylthiazole was subjected to the silver 
carbonate conditions in water, under one atmosphere of carbon monoxide supplied 
by balloon.  After five hours only 5-(4-chlorophenyl)-2-phenylthiazole was isolated, 
(Scheme 2.5.4) and repeating the reaction in acetonitrile but for seventy-two hours, 















In order to further investigate the procedure 4-iodochlorobenzene was subjected to 
carbonylation conditions (Pd(dppf)Cl2.CH2Cl2, triphenylphosphine, silver carbonate 
under one atmosphere of carbon monoxide in methanol), Scheme 2.5.5.  This 
furnished the expected methyl-4-chlorobenzoate, 262, in 75% yield proving the 





In addition to the attempted carbonylation-direct arylation we were also interested in 
a oxidative direct arylation-carbonylation sequence whereby 2-phenylthiazole could 
be carbonylated and then reacted with an alcohol to give 263 without the need for the 
thiazole to be pre-functionalised as a halide, (Scheme 2.5.6).   
 
 
Scheme 2.5.6 – Oxidative carbonylation 
 
In practice however, at 60°C in methanol only the thiazole dimer, 228a, was isolated.  
It was thought that perhaps the problem lay in the carbon monoxide pressure.  
Unfortunately, no pressure vessels were available.  As such this avenue of research 
was abandoned.   
 












To summarise, a powerful, generally applicable method has been developed for the 
direct arylation of thiazoles.  The conditions have also been shown to be applicable 
to a number of other heterocyclic motifs.  It has been attempted to apply the 
conditions to electron-rich aromatic rings but further research is necessary to 
determine whether this is possible.  In addition it has been attempted to incorporate a 
carbonylation into the direct arylation sequence.  Preliminary reactions showed that 
this does not occur under our conditions in acetonitrile or water at 60°C.  In a similar 
manner, attempted oxidative carbonylation of 2-phenylthiazole in methanol also 
failed to react in the expected manner.   
 
 










3. Arylation at thiazole C4 
The prevalence of directing group chemistry in the literature has prompted the 
investigation and development of a directing group strategy for arylation of the 
thiazole C4 position.   
 
The work towards C-H activation at thiazole C5, described in chapter 2, has shown 
little inclination of the C4 position to react, even when it is the only unfunctionalised 
position left in the thiazole ring.  It is envisaged that forcing conditions will be 
necessary to activate the C-H bond, and that the use of a directing group may also be 
necessary to effect a transformation. 
 
3.1. Precedents and strategies 
 
The first example of C-H activation at the thiazole C4 position was reported by 
Murai et al in 2000.146  They used the nitrogen in the heterocycle to direct a 
ruthenium mediated carbonylation the the thiazole C4-H, (Scheme 3.1.1).  Whilst 
highly impressive, the harsh conditions make this a prohibitive strategy for C-H 
activation.   
 
 
Scheme 3.1.1 – Murai’s thiazole C4-H functionalisation 
 










The only example of palladium mediated substitution at C4 of an azole ring comes 
from Miura et al,93 they use a sacrificial directing group to direct the palladation to 
C4, then decarbamoylation followed by cross coupling at C5 gives the 4,5-biarylated 






For thiazole this proceeds with good yields, up to 86%, but is less successful with 
oxazole, only 33% although up to 20% of the 2-phenyl-4-aryl product, 270, is 
formed as well.  This is probably the most important result of this research.  If the 
reaction can be stopped after the first arylation before the decarbamoylation, then this 
could be done in a separate step allowing access to 4-substiuted thiazoles and 
oxazoles. 
 
On first inspection of the thiazole ring there are a number of possibilities for C-H 
activation at the C4 position.  These can be divided into 3 main categories: 
 
Directing group appended to N3 
Directing group at C5 
Non-directed arylation 
 
These catagories will be discussed in the subsequent sections. 










3.2. Directing groups appended at N3 
3.2.1. Quaternised thiazoles 
It is well documented that the thiazole nitrogen can be quaternised to form a 
thiazolium salt.147,148  Appending a directing group to the ring nitrogen was identified 
as being a way to incorporate a directing group that could easily be removed in a 
pseudo-deprotection/deactivation step.  The use of a directing group in a similar way 
has been demonstrated by Crabtree et al in their synthesis of unusual imidazolium 
iridium carbenes, at the five position, 273, as opposed to the usual two position, 
272.149  In a thiazole analogy, this would correspond to an activation of the 
unreactive four position.   
 
 
Scheme 3.2.1 Crabtree’s unusual iridium carbenes, selectivity is controlled by the 
anion, A-. 
 
The first step in this strategy would be to incorporate a tethered pyridine into the 
thiazole motif, 274, followed by a C-H activation step, (Scheme 3.2.1 and Scheme 
3.2.2).  An advantage to this approach is the deactivation of the thiazole ring by the 
quaternisation step.  This should prevent the electrophilic addition mechanism from 
occurring at C5 by decreasing the electron density of the aromatic ring.  In addition 
to the ease of incorporation of the directing group, it should be readily removed.   
 











Scheme 3.2.2 Proposed reaction scheme with a methylpyridine group appended from 
the thiazole nitrogen 
 
The use of pyridines as directing groups has been demonstrated by a number of 
groups in recent years.95,100-102,111,150-154  Notably, Daugulis employed them, not only 
to arylate aromatic C-H bonds but also to effect an sp3 C-H activation under 








The synthesis of the quaternised thiazole was based on Tubaro’s synthesis of the 
oxazole analogue,155 2-(bromomethyl) pyridine was isolated as the free base, then 
heated together with 2-phenylthiazole, both by conventional means and by 
microwave radiation, rather than leading to the expected product, a dimer of 2-
(bromomethyl)pyridine, 171, was obtained, (Scheme 3.2.5). 
 











Scheme 3.2.5 – Reaction of 2-phenylthiazole and 2-bromomethylpyridine 
 
In hindsight this was to be expected, the pyridine nitrogen is far more nucleophilic 
than the thiazole nitrogen.  The reaction was therefore repeated with the 
hydrobromide pyridine salt.  Again, no product was isolated from the reaction.   
 
It is known that 2-unsubstituted thiazoles can be quaternised with benzyl 
bromides156-158 and that 2-phenylthiazole can be quaternised by methyl iodide.159  In 
order to prove that 2-phenylthiazole can be quaternised by a group larger than methyl 
iodide, the reaction was repeated with benzyl bromide, (Scheme 3.2.6). 
 
 
Scheme 3.2.6 – Attempted quaternisation of 2-phenylthiazole with benzyl bromide 
 
Again, no product was formed, either under conventional or microwave heating.  
Since it has been documented that thiazole can be quaternised with benzyl bromide it 
was decided to replicate this as a model before attempting the reaction with 2-
(bromomethyl)pyridine, (Scheme 3.2.7).   
 













This reaction did provide the expected product.  The reaction with 2-
(bromomethyl)pyridine HBr salt was attempted but no product was isolated (Scheme 
3.2.8).  As the pyridine salt was positively charged, the reaction to form the doubly 
charged species would be disfavoured.  Reacting with the free base again formed the 





With the problem of the thiazole nitrogen nucleophilicity, it was decided that 
reaction with a less nucleophilic directing group might be an alternative. 
 
A pyrazine group was chosen in place of the pyridine.  2-Halomethylpyrazines are 
not commercially available.  The synthesis was approached as follows in Scheme 
3.2.9.   
 
 
Scheme 3.2.9 – Attempted synthesis of iodomethylpyrazine 
 










The reduction of the acid proved impossible under lithium aluminium hydride 
conditions.  Instead, radical chlorination of methylpyrazine was attempted, (Scheme 
3.2.10).   
 
 
Scheme 3.2.10 – Formation of chloromethylpyrazine 
 
The desired compound was isolated as the major component of a mixture of mono, 
285, and dichlorinated compound, 286.  The crude mixture was reacted with thiazole 
but again, no product was isolated.  As a 2-unsubstituted thiazole would give 
problems of C2 or C4 regioselectivity and potentially C2 carbene formation158,160 
together with the difficulties inherent in the preparation and purification of these 
quaternised thiazole compounds it was decided to abandon this strategy.   
 
3.2.2. Thiazole N-oxides 
 
Thiazole N-oxides are well characterised and the oxide can be easily reduced back to 
the thiazole ring.  It was envisaged that directing groups could be attached to the 
thiazole nitrogen by way of an oxygen linker rather than a carbon linker.  The 














2-Phenylthiazole was successfully oxidised to 2-phenylthiazole-3-oxide, 55, with 
mCPBA in CH2Cl2, (Scheme 3.2.11).  The yield was relatively poor at only 36%, but 
the remainder of the starting material could be recovered and recycled.   
 
 
Scheme 3.2.11 – N-oxide directing group strategies 
 
Unfortunately, under a number of conditions, (DMF, 150 °C, mw, 15 min; neat 150 
°C, 2 hr; MeCN, reflux, 18 hr) the nucleophilic aromatic substitution with 2-
bromopyridine did not yield the desired product, 287.   
 
An alternative to the pyridine directing group, a carbamate, could be attached 
through the N-oxide.  This was prepared from 2-phenylthiazole-3-oxide in quantative 
yield, (Scheme 3.2.11).  With this compound in hand, it was subjected to the 
acetonitrile conditions developed for arylation at the thiazole C5, (Scheme 3.2.12), 




Following on from this a number of reactions were attempted in order to establish 
whether the compound would directly arylate at C4 in toluene, dioxane, methanol, 










DMF and DMSO.  Of these conditions not a single one gave any identifiable 
products.  A number of control reactions were therefore run with the capped thiazole-
3-oxide, 289; in acetonitrile at 60 °C the compound decomposed to an unidentifiable 
mixture.  Similarly, it decomposed under both acidic and basic conditions, in the 
presence of water and with heating.  As such, the compound was not suitable for 
directing arylation to the C4 position.   
 
Scheme 3.2.13 - Fagnou’s pyridine N-oxide arylation 
 
Following Fagnou’s work on the arylation of pyridine N-oxides,107,161 (Scheme 
3.2.13) it was decided to investigate the arylation of 2-phenylthiazole-3-oxide.  
Applying Fagnou’s conditions to 2-phenylthiazole-3-oxide did give a product albeit 
in low yield, (Scheme 3.2.14).   
 
Scheme 3.2.14 – Fagnou’s conditions applied to 2-phenylthiazole-3-oxide 
 
It proved difficult to purify the compound for characterisation.  As such, it was 
attempted to make the expected compound by other means to compare the spectra.  
4-(4-Chlorophenyl)-2-phenylthiazole, 270a, and 5-(4-chlorophenyl)-2-phenylthiazole, 
65b, were oxidised with mCPBA in CH2Cl2, (Scheme 3.2.15).  4-(4-Chlorophenyl)-
2-phenylthiaozle failed to give any product under these conditions.  When the spectra 
(1H, 13C NMR) of the product from the directed arylation reaction was compared to 
5-(4-chlorophenyl)-2-phenylthiazole-3-oxide, 291, they were found to be identical.  
This shows that any directing effect of the N-oxide does not overcome the reactivity 
of the ring towards arylation at C5.  This suggested that the C5 position may need to 










be blocked in order for arylation to occur at the C4 position.  Attention was therefore 
turned towards incorporating a directing group at the C5 position of the ring.   
 
Scheme 3.2.15 – Oxidation of 2,5- and 2,4-diarylthiazoles 
 
More recently this reaction has been reported by Fagnou et al108 and, in order to get 
arylation at the C4 position of the thiazole ring the C5 position does need to be 
blocked.  Their methodology provides an elegant and concise route to trisubstituted 
thiazoles in a convergent fashion, see Figure 3.2.1.   
 
Figure 3.2.1 – Fagnou’s thiazole N-oxide chemistry 
 










3.3. Directing Groups at C5 
3.3.1. Pyridine directing groups 
Chapter one described the use of a number of directing groups to promote direct 
arylation at specific C-H bonds.  The most commonly employed directing group is 
the pyridine ring.65,101  It is a known ligand for palladium and as such has shown 
considerable aptitude for the activation of C-H bonds.65   
 
Initial interest was focussed on the arylation of 2-pyridyl-(2-phenylthiazol-5-yl),  
291a, systems in order to assess whether pyridine could, in fact, direct palladium 
catalysed arylation to the thiazole C4 position.  It was envisaged that the reaction 
may proceed along the mechanism in Scheme 3.3.1; whereby initial coordination of 
the pyridine nitrogen to the palladium (293 or 297), would bring the palladium close 
enough to the thiazole C4-H bond to facilitate a C-H activation step, forming a five-
membered palladacycle (294 and 295).  A subsequent oxidiative addition of an aryl 
halide followed by reductive elimination and decomplexation of the pyridine would 
give the expected product.   
 
Scheme 3.3.1 – Possible mechanism for pyridine directed C-H activation 
 
 










Daugulis and co-workers reported a pyridine mediated direct arylation of sp2 and sp3 
C-H bonds.100,101  Repeating their conditions, (Pd(OAc)2, AgOAc, AcOH, 130 °C for 
72 hr)100 gave no product.  However, using Pd(dppf)Cl2. PtBu2(biphenyl-2-yl), 





The reaction was repeated in dioxane and toluene in sealed vials at 150 °C giving the 
results shown in Scheme 3.3.2.  Whilst the yield was lower in dioxane, the reaction 
was considerably cleaner.  Further to the initial results it was also found that in the 
absence of additional ligands no reaction was observed and that the added ligand 
needed to be bulky and electron rich; presumably this encourages the reductive 
elimination step in the mechanism,132 which would be expected to be slow as it 
destroys a stabilised palladacycle intermediate.  Under these conditions it was also 
found that aryl bromides were more reactive than aryl iodides.  By increasing the 
temperature to 200 °C the yields of with aryl bromides could be increased.  A 
number of 5-pyridyl-2,4-diarylthiazoles were synthesised under the conditions shown 
in Scheme 3.3.3.  The results are shown in  Table 3.3.1.   
 
 
Scheme 3.3.3 – General scheme for the synthesis of 5-pyridyl-2,4-diarylthiazoles 
 
It can be noticed that where the substrate contains an aryl chloride the reaction, in 
general, proceeds less smoothly.  It is likely that with the high temperatures and 










electron rich ligands employed that there is a certain amount of oxidative addition 
occurring into the aryl-chloride bond.162   
 
2 2 2
 Table 3.3.1 – 5-Pyridyl-2,4-diarylthiazoles 
 
In order to show that there is a directing effect, the reaction was repeated with 5-(4-
chloro)-2-phenylthiazole, 65b, but gratifyingly, no reaction was observed.   
 
 
Scheme 3.3.4 – Non-directed arylation attempt under pyridine direction conditions 
 










As the pyridine direction has shown directed arylation to work well for the arylation 
of the thiazole C4 position, it was decided to focus attention of the incorporation of a 
removable directing group at the C5 position.   











3.3.2. Phenyl amide 
In 2003, Miura et al published the first example of a palladium mediated process for 
arylation of the thiazole C4 position, (Scheme 3.3.5).93  This remained the only 
example of a palladium mediated C4 arylation of thiazole until Fagnou’s thiazole N-
oxide work was added to the area in 2008.108   
 
 
Scheme 3.3.5 – Miura’s 4,5-diarylation 
 
Miura’s strategy utilises an amide in the C5 position of the thiazole to direct 
arylation to C4 before being lost in a separate step and arylation subsequently 
occurring at the C5 position as well.   
 
 
Scheme 3.3.6 – Proposed C4 arylation 
 










If it could prove possible to separate these steps, then arylation of the thiazole C4 
position would be feasible with a group in the C5 positions that could be readily 
removed or elaborated to provide more complex molecules, (Scheme 3.3.6).   
 
The synthesis of the phenyl amide starting material was described by Miura,93 
however, in our hands the carbonylation of 5-bromo-2-phenylthiazole did not 
proceed well, (Scheme 3.3.7).  Nevertheless, an alternative route to the amide was 
envisaged, (Scheme 3.3.8), which provided the material in good yield.   
 
 
Scheme 3.3.7 – Carbonylation route to phenyl amide 
 
 
Scheme 3.3.8 – Alternative route to phenyl amide 
 
Before investigation of the stepwise arylation could be started, authentic samples of 
each of the potential products needed to be synthesised in order to allow the reactions 
to be monitored by HPLC.  The syntheses are shown in  
Scheme 3.3.9.   
 











Scheme 3.3.9 – Synthesis of HPLC samples 
 
Initally repeating Miura’s conditions, but with tributylphosphine, at a lower 
temperature gave a mixture of diarylated product,248, and unreacted starting 
material, 269, (see Table 3.3.2 for the optimisation conditions).   
 
 
Scheme 3.3.10 – Possible arylation products 
 
The number of possible products and intermediates in the reaction (Scheme 3.3.10) 
gave difficulties in identifying whether any desired products were formed.  Whilst 
samples of the majority of the compounds had been made by other means, (Scheme 
3.3.9), the compounds themselves proved difficult to separate by HPLC.  
Additionally, in the majority of cases the reaction solvent was o-xylene, itself a 
highly uv active compound, which masked the phenylamide starting material and the 
arylbromide in the HPLC traces.   















I Cs2CO3 PBu3 o-xylene 60 No reaction 
I Cs2CO3 PBu3 o-xylene 80 No reaction 
I Cs2CO3 PBu3 o-xylene 100 No reaction 
I Cs2CO3 PBu3 o-xylene 120 Small amounts of 248 
I Cs2CO3 PBu3 o-xylene 150 Larger amounts of 248 
I Cs2CO3 PtBu2(biphenyl-2-yl) o-xylene 150 64% 248 isolated yield 
Br K2CO3 PtBu2(biphenyl-2-yl) o-xylene 130 Trace of 298 
Br K2CO3 none o-xylene 130 Traces of 298 and 270 
Br K2CO3 none dioxane 
160  
mw 
Reaction too dilute, failed 
to reach set temperature 
Br K2CO3 PtBu2(biphenyl-2-yl) dioxane 
160  
mw 
Traces of 298 + 303 
reaction failed to reach 
set temperature 
Br K2CO3 PtBu2(biphenyl-2-yl) dioxane 160 Traces of 298 + 303 
Br Cs2CO3 PtBu2(biphenyl-2-yl) dioxane 180 
14% 270 large amounts 
of 269 
Br Cs2CO3 PtBu2(biphenyl-2-yl) o-xylene 180 
Starting material 
consumed.  5% 270, 60% 
248 
Table 3.3.2 – Optimisation C4 arylation using phenyl amide directing group 
 
It was quickly seen that a high temperature was necessary to effect the C-H 
activation at C4.  In addition, the reaction worked better with cesium carbonate than 
potassium carbonate, presumably due to the improved organic solubility.  The use of 
a bulky, electron rich ligand such as 2-(ditbutylphosphino)-biphenyl-2-yl enhanced 
the reaction and prevented the deposition of metallic palladium.  Presumably the 
bulky ligand promotes the the reductive elimination and collapse of the stable 
palladacyclic intermediate,132 conversion of 306 to 307 in Scheme 3.3.11.  In 
addition to the effect of base and ligand, there was a marked difference between the 
reaction being carried out in o-xylene or dioxane.  In xylene the decarbamoylation 
step seemed to be favoured giving mainly the 4,5-diarylated product, 248; in dioxane 










there was a much lower conversion of starting material, however, that which had 
reacted formed compounds 270 and 298.   
 
 
Scheme 3.3.11 – Proposed mechanism process 
 
To determine the nature of the decarbamoylation step, 298 was heated in xylene at 
180 °C overnight however, no decarbamoylation had taken place and only starting 
material remained, (Scheme 3.3.12). 
 
 
Scheme 3.3.12 – Decarbamoylation attempt 
 
The amide, 298, was also untouched in dioxane at 180 °C and in xylene in the 
presence of Cs2CO3, K2CO3, Pd(OAc)2, PBu3 and PtBu2(biphenyl-2-yl) individually 










and in combinations akin to the reaction mixture.  It was concluded that the 
decarbamoylation can only take place once the amide nitrogen has been arylated.  
With such high temperatures required to accomplish the C4-arylation, attention was 
turned to alternative amide directing groups that might cause the C4-H activation to 
be more facile.   
 










3.3.3. Quinoline amide 
 
The concept of having a doubly chelating directing group was proposed by Daugulis 
and allowed direct arylation of sp2 and sp3 C-H bonds by incorporating a quinoline or 
picolinamide directing group through a tether,101 (Scheme 3.3.13).  Adding another 
chelation point to the amide, one that is better able to bind to the palladium should 
help to facilitate the C-H activation at the thiazole C4 position.   
 
 
Scheme 3.3.13 – Daugulis’ quinoline and picolinamide directing groups 
 
In the case of thiazole C4 arylation, the incorporation of the quinoline amide would 
give the required five-membered palladacyclic ring system, 311, (Scheme 3.3.14).   
 
 
Scheme 3.3.14 – Doubly chelating directing group 
 
Taking 2-phenylthiazole-5-carboxylic acid and reacting it with 8-aminoquinoline 
gave the required 2-phenyl-N-(quinolin-8-yl)thiazole-5-carboxamide, (Scheme 










3.3.15).  This compound proved to be exceptionally difficult to purify, being only 
sparingly soluble in almost all solvents.  A number of different conditions were 
therefore attempted to identify which gave the cleanest reaction with the least need 
for further purification, see Table 3.3.3.  Despite the yield not being the highest, the 
reaction with water soluble carbodiimide (EDCI) proved to give the cleanest 
material.   
 
 
Scheme 3.3.15 – Amide formation 
 
Conditions Yield of 309 /% 
SOCl2, Δ then 8-aminoquinoline, Et3N, CH2Cl2 30 
HATU, Et3N, 8-aminoquinoline, CH2Cl2 38 
EDCI, HOBt, Et3N, 8-aminoquinoline, CH2Cl2 32 
Table 3.3.3 – Conditions for amide formation 
 
With the starting material in hand a brief screen of the variables was conducted, see 
Table 3.3.4.  These conditions were based on Daugulis’ original conditions.  The 
arylation of thiazole C4 required more forcing conditions than the arylation of the 








110 °C, 24 hr None 1.10 0 no reaction 
130 °C, 4 hr None 0.25 0 no reaction  
130 °C, 24 hr None 0.25 15 2.8:1 ratio of SM to prod 
))) 2 hr DMF 0.25 0 no reaction 
150 °C, 5 min, mw DMF 0.25 0 no reaction  
130 °C, 72 hr DMF 0.25 54 product formed but SM still present 
Table 3.3.4 – Screen of variables for quinoline directing group 
 










It was found that by adding extra palladium acetate at 24 hour intervals the reaction 
could be made to proceed further towards completion.  These newly developed 
conditions were then applied to the synthesis of a number of 4-arylthiazoles, 
(Scheme 3.3.16).   
 
Scheme 3.3.16 – Quinoline amide results 
 
The need to add extra palladium at intervals is detrimental to the overall appeal of the 
reaction.  This is probably necessary due to the highly stabilised palladacyclic 
intermediates which may sequester the palladium.  It is possible that this may be 
overcome by the use of bulky ligands which might help to break down the 
palladacyclic intermediate and turn over the catalyst, this warrants further 
investigation.   
 










3.3.4. Other amides and mechanistic considerations 
 
In both the case of the phenylamide and the quinoline amide the directed arylation 
reactions proceeded slowly despite the use of high temperatures.  In order to improve 
these reactions it could be envisaged that the amide directing group could be 
engineered to provide more favourable characteristics for the reaction mechanism.  
For example: the quinoline amide, 309, provides two chelating nitrogens there is no 
express reason for the chelated palladium complex to be aligned such that the 
thiazole C4-H bond would be in proximity to the palladium itself.  By building in a 
certain amount of steric hindrance in the backbone of the directing group, it may be 
possible to bias the orientation of the chelating groups towards the C4-H bond, 
(Scheme 3.3.17 and Scheme 3.3.18).   
 
 
Scheme 3.3.17 – The various conformations of the quinoline amide 
 
 
Scheme 3.3.18 – Steric bulk built into the directing group backbone 
 
In addition this should cause some congestion around the palladium centre, 
promoting the reductive elimination of the product and therefore allowing the 










palladium catalyst to turn over.  However, as in all palladium mechanisms, if this 
encourages reductive elimination it may discourage oxidative addition.  In essence, if 
the oxidative addition occurs whilst the palladium is bound to the chelating groups 
(320 to 321 or 328 to329) this may substantially hinder the reaction.  If, however, 
oxidative addition occurs before coordination of the directing group to the palladium 
(321 to322) then this may not be an issue, (Scheme 3.3.19).   
 
 
Scheme 3.3.19 – Palladium oxidation states and possible mechanisms 
 
There are a number of potential mechanisms that could be involved in the C-H 
activation step.  Other mechanisms for C-H activation - metal carbene insertion163 
and radical-type metal processes are known processes for C-H functionalisation.  In 
this case, however, neither is likely to be occurring.  The possible mechanisms, are as 
follows in Table 3.3.5: 











Oxidative addition of palladium (0)  
to the C4-H bond  





Oxidative addition of aryl palladium (II)  
to the C4-H bond  
Concerted C-H functionalisation with no  





Table 3.3.5 – C-H activation mechanisms 
 
The final option - deprotonation - can be discounted as Cs2CO3 is not a strong 
enough base to deprotonate the thiazole C4 proton (pKa = 36.8).46  The potential 
roles of the different C-H activation steps can been seen in Scheme 3.3.19.  There are 
three main possibilities, a palladium (0) to palladium (II) mechanism, a palladium 
(0), (II), (IV) mechanism and a palladium (II) to (IV) mechanism.   
 
In order to probe which mechanism might be in place, the stoichiometric synthesis of 
a number of intermediates was attempted, see Table 3.3.6.  Despite the use of a 
number of common conditions101 for the formation of palladacycles, none of the 
expected complexes were seen, although some evidence was observed in LCMS data 
that the complexes were formed in very small amounts but could not be isolated. It 
cannot, therefore, be concluded whether the proposed structures are or are not 
intermediates in the reaction.   











Substrate Palladium Conditions Expected Product Comments 
MeOH,  
25 °C No reaction. 
AcOH, 
reflux 
LCMS shows a 
small peak for 
palladium 
complexed to 2 

























LCMS shows a 

















deposited.  No 
recognisable 
products. 
In all cases, the expected compound represents the simplest desired product.  Each could 
form dimers and/or have bridging acetate ligands or could form solvent inclusion complexes. 
Table 3.3.6 – Stoichiometric palladacycle formation 
 
Despite being unable to draw any mechanistic conclusions the directed arylation of 
thiazole has been shown to be possible using a number of directing groups, some of 
which can be readily elaborated or removed.  Further research is needed in order to 
moderate the harsh conditions necessary and improve the catalyst turnover.   










3.3.5. α-Alkylation via norbornene shuttle 
An alternative way of introducing functionality to heteroaryliodides was reported by 
Lautens et al in 2006.164  They were able to elaborate an iodothiophene by using 
methodology developed by Catellani et al.165-167   
 
 
Scheme 3.3.20 – Lautens’ thiophene alkylation 
 
If this methodology could be adapted to the thiazole ring system it would provide a 





Scheme 3.3.21 – Proposed norbornene shuttle with thiazoles 
 










The investigation was started by repeating Lautens’ conditions, (Scheme 3.3.22).  
None of the desired product was seen.   
 
 
Scheme 3.3.22 – First attempt at norbornene shuttle 
 
Following on from this, a different alkylbromide was chosen which was more 
reactive in the oxidation of palladium (II) to palladium (IV).  It was hoped that 
trapping the final thiazol-5-yl palladium in a Heck reaction with tertiary butyl 





300b, PdCl2, PFu3, methyl 4-bromobutyrate, t-butyl acrylate, 
norbornene, DMF, Cs2CO3, 130 °C, 18 hr. 
No identifiable 
products. 
300b, PdCl2, PFu3, methyl 4-bromobutyrate, t-butyl acrylate, 
norbornene, toluene, Cs2CO3, 130 °C, 18 hr. 
No identifiable 
products. 
300b, PdCl2, PFu3, methyl 4-bromobutyrate, t-butyl acrylate, 
norbornene, DMF, Ag2CO3, 130 °C, 18 hr. 
No identifiable 
products. 
Table 3.3.7 – Norbornene shuttle attempts 
 
Unfortunately, no product was formed in any of the reactions above, nor was the 
straight Heck product observed.  Each reaction was a complex mixture of products 
from which no single product could be separated or identified.  Having encountered 
these difficulties this research was put on one side whilst attention was focussed on 
other areas.   










3.4. Non-directed arylation 
 
Whilst investigating solvent effects in the arylation of thiazole C5 (see chapter 2) it 
was noticed that a small amount of 4,5-diaryl thiazole was being produced in the case 
of tetrahydrofuran, dioxane and water, (Scheme 3.4.1).   
 
 
Scheme 3.4.1 – 5-arylation 4,5-diarylation results 
 
This was the first time 248 arising from double arylation had been observed.  In spite 
of this, when control reactions had been run during the directed arylation attempts 
with pyridine and amide directing groups, arylation did not occur at C4 when 5-(4-
chlorophenyl)-2-phenylthiazole, 65b, was used in place of the directing groups, 
(Scheme 3.4.2).  It was therefore concluded that arylation at the C4 position was 
highly dependant on the nature of the solvent, ligands and perhaps many other 
variables as well.  Taking 5-(4-chlorophenyl)-2-phenylthiazole, 65b, and subjecting 
it to the 5-arylation conditions in tetrahydrofuran, dioxane and water with an excess 
of aryl iodide it was hoped to be able to successfully arylate at the C4 positions.  
However, this proved not to be the case at 60 °C, in fact, the results demonstrated 
during the 5-arylation in tetrahydrofuran and dioxane proved to be unreproducible.   
 












Scheme 3.4.2 – Directed arylation control reactions 
 
A brief solvent screen was therefore carried out to determine whether the 
transformation would take place in any common solvent at the slightly increased 80 
°C, (Scheme 3.4.3 and Figure 3.4.1).   
 
 
Scheme 3.4.3 – Conditions for solvent screen 
 
The solvent screen confirmed that water was, in fact, the best reaction solvent.   






































































































Despite water being identified as the optimum solvent for the transformation the 
conversion remained at only 41%, even after seventy-two hours at 80 °C.  Increasing 
the temperature to 100 °C improved both the conversion and yield, (Scheme 3.4.4).   
 











Scheme 3.4.4 – 4-Arylation with iodobenzene and 4-chloroiodobenzene 
 
The reaction at thiazole C4 at 100 °C is a large step forwards in the arylation of 
unreactive C-H bonds.  Even Fagnou’s 4-arylation of the activated 2,5-diarylthiazole 
N-oxide108 requires temperatures of over 100 °C.  If this method can be proved to be 
general over a wider range of substrates this would provide an attractive route to 
2,4,5-triarylthiazoles, 248, without the need to oxidise and then reduce the thiazole 
nucleus.   
 
In addition, the application of these conditions to the directing groups used 
previously, (Scheme 3.4.5 and Table 3.4.1), showed that not only are the water based 
conditions applicable to the arylation of thiazole at the C5 position, but that there is 
the potential for them to enable arylation at the C4 position, both in the absence and 
presence of a directing group.  Whilst the yields remain moderate at best, with 
further optimisation and mechanistic insight it is hoped to be able to significantly 
improve the methodology.   
 
 
Scheme 3.4.5 – Conditions for directed arylations in water 
 











Table 3.4.1 – Application of water conditions to directed arylations 
 
 












A number of directing group strategies have been developed which allow the 
arylation of the thiazole C4 position under fairly mild conditions.  In each case, it has 
been determined that the C5 position must be blocked in order to prevent arylation at 
that position.   
 
Pyridine directing groups worked well, albeit requiring temperatures in excess of 180 
°C to effect the transformation.   
 
 
Scheme 3.5.1 – Pyridine direction (see Table 3.3.1) 
 
The phenyl amide directing group was of particular interest as it is potentially 
removable, giving a convenient route to 2,4-diarylthiazoles. However, the amide is 
partially decarbamoylated during the reaction and as such, with a complex mixture of 
products it was difficult to optimise the conditions to form a single product.   
 
Attention was then turned to an amide directing group with more than one nitrogen 
to chelate to the palladium metal.  This was accomplished using 8-aminoquinoline, 
(Scheme 3.5.2).  This method required the use of 10 mole % percent of palladium, 
presumably due to the chelating properties of both the starting material and product. 
 
 
Scheme 3.5.2 – Quinoline amide direction (see Table 3.4.1) 
 










Further to that, an attempt to alkylate at the C4 position using norbornene as an 
internal tether and directing group, furnished none of the desired product.   
 
With the newly discovered water conditions for the arylation of the thiazole C5 
position a small amount of 4,5-diarylation was observed.  These conditions were 
applied to 2,5-diarylthiazoles and it was gratifying to note that at 100 °C there was a 
significant conversion to product.  In addition, these conditions could be applied to 
the substrate incorporating directing groups at the C5 position.  The arylation at the 
thiazole C4 position at 100 °C constitutes a significant improvement over 
Fagnou’s108 arylation of thiazole N-oxides, removing the need to pre-functionalise 
the thiazole as its N-oxide.   
 
In conclusion, several strategies for the direct arylation of the thiazole C4 position 
have been investigated and proven to be effective methods for the functionalisation 






General Methods  
1H and 13C NMR spectra were recorded on a Bruker 360 MHz instrument at 25 °C 
unless otherwise stated and are calibrated to residual solvent peaks (CDCl3 7.26 ppm 
and 77.0 ppm).  The data is reported as chemical shift (ppm), then the interpretation 
of the peak with relevant coupling constants reported in Hertz.  19F NMR spectra 
were recorded on a Brucker 250 MHz instrument at 25°C.  Infra-red spectra were 
recorded on a JASCO FT/IR-460 using sodium chloride disks or a PerkinElmer 
Spectrum One FT-IR Universal ATR sampling accessory instrument as a thin film.  
Melting point measurements were obtained from a Gallencamp apparatus and are 
reported uncorrected.  Electrospray high resolution mass spectrometry was 
performed by the EPSRC National Mass Spectrometry Service Centre, Swansea, 
using a Finnigan MAT 900 XTL double focussing mass spectrometer.  FAB HRMS 
was carried out by the University of Edinburgh using a Kratos MS50 instrument, EI 
mass spectrometry was carried out on a JEOL GcmateII; Samples were introduced 
either by Direct Heated Probe or via GC from an Agilent 6890 using a Chrompack 
CPSil5 low bleed MS column.  The data is recorded as the ionisation method 
followed by the calculated and measured masses.  T.L.C. was performed on Merck 
60F254 aluminium backed silica plates and visualised by uv light (both 254 nm and 
365 nm).  The compounds were purified by wet flash chromatography using Merck 
Kieselgel 60 (particle size 35-70) silica under a positive pressure.  Acetonitrile and 
tetrahydrofuran were dried by distillation from calcium hydride and sodium 
respectively, other dry solvents were dried and purified by passage through activated 
alumina columns using a solvent purification system from www.glasscontour.com. 
Cs2CO3 was stored under vacuum at 70°C. Pd(dppf)Cl2⋅CH2Cl2 was purchased from 
Strem Chemicals, Inc. All other chemicals were purchased from a chemical supplier 





General procedures  
General procedure A: Synthesis of 2-substituted thiazoles 
 
The thioamide, 36 (5.0 g, 1 equiv) was dissolved in ethanol (25 mL, 5 mLg-1) and 
chloroacetaldehyde, 37a (monohydrate as 50% solution in water, 1.2 equiv) was 
added and the solution heated to reflux.  The reaction was monitored by T.L.C., 
when the starting material was consumed (approximately 2 hr), the ethanol was 
removed in vacuo.  The residue was partitioned between water (25 mL, 5 mL g-1) and 
CH2Cl2 (25 mL, 5 mL g-1), the aqueous phase extracted with CH2Cl2 (25 mL, 5 mL 
g-1) and the organics washed with brine (sat. aq., 25 mL, 5 mL g-1) then dried over 
MgSO4 and concentrated in vacuo.  Purification was achieved by column 
chromatography or reduced pressure distillation. 
 
General procedure B: Iodination of 2-aryl thiazoles at C5 
 
2-Arylthiazole, 51 (1 equiv) was dissolved in dry tetrahydrofuran (15 mL g-1) under 
N2 and cooled to -78°C  To this was added nBuLi (1.1 equiv) dropwise and the 
reaction left to stir for 5 min.  1,2-Diiodoethane (1.2 equiv) was dissolved in 
tetrahydrofuran (15 mL g-1 of starting material) and added slowly to the solution, this 
was stirred at -78 °C for 15 min then warmed to 0°C, quenched by the addition of 
NH4Cl (sat.aq., 15 mL g-1) and diluted with Et2O (15 mL g-1).  The phases were 
separated and the aqueous phase extracted with Et2O (15 mL g-1), the organics were 
washed with brine (sat. aq., 15 mL g-1), dried over MgSO4 and concentrated in vacuo. 





General procedure C:  5-Arylation  with 2-arylthiazole and aryl halide in 
dry solvents 
 
Ag2CO3 (2 equiv), Pd(dppf)Cl2⋅CH2Cl2 (5.0 mol %), PPh3 (10.0 mol %) and aryl 
halide (1.2 equiv) were dissolved in dry solvent (4 mL) under N2.  2-Arylthiazole, 51 
(100 mg, 1 equiv) was added as a solution in dry solvent (1 mL), and the solution 
heated to 60°C for 3 days under N2.  The reaction mixture was filtered through a pad 
of celite, washed with CH2Cl2 and acetone then concentrated in vacuo.  The crude 
product was purified by column chromatography. 
 
General procedure D: 5-Arylation  with 2-arylthiazole and aryl halide on 
water 
 
Aryl halide (1.2 equiv), Ag2CO3 (2 equiv), Pd(dppf)Cl2⋅CH2Cl2 (5.0 mol %), PPh3 
(10.0 mol %) and 2-arylthiazole, 51 (1 equiv, typical scale 100 mg) were combined2 
and then suspended in deionised water (5 mL) and the suspension heated to 60°C for 
24 hr.  The reaction mixture was filtered through a pad of celite, washed with acetone 
(5 mL) and CH2Cl2 (5 mL) then carefully concentrated in vacuo.3  CH2Cl2 (5 mL) 
and brine (5 mL) were added to the resultant solid and water mixture and the phases 
separated.  The aqueous phase was extracted with CH2Cl2 (5 mL) and the organics 
concentrated in vacuo.  The crude product was purified by column chromatography. 
 
                                                 
2 As 2-phenylthiazole is insoluble in water it is important to ensure that it is placed directly on the 
mixture of solids and not on the sides of the reaction vessel as the water will not “wash” it into the 
reaction as an organic solvent would. 
3 Some of the 2,5-diarylthiazole products azeotrope with water, hence it is important to remove only 
the CH2Cl2 and acetone by distillation and not the water also.  During the reaction with some aryl 




General procedure E:  5-Arylation  with 2-arylthiazole and aryl halide 
neat 
 
Ag2CO3 (2 equiv), Pd(dppf)Cl2⋅CH2Cl2 (5.0 mol %), PPh3 (10.0 mol %), aryl halide 
(2 equiv) were combined, shaken to mix thoroughly then 2-arylthiazole, 51 (100 mg, 
1 equiv) was added and the mixture heated to 60°C for 24 hr.4  CH2Cl2 was added to 
the reaction mixture which was filtered through a pad of celite, washed with CH2Cl2 
and acetone then concentrated in vacuo.  The crude product was purified by column 
chromatography.  
 
General procedure F: Direct arylation at C4 
 
2-(2-Arylthiazol-5-yl)-pyridine, 291 (1 equiv), Cs2CO3 (2 equiv), Pd(OAc)2 (5.0 mol 
%), tBu2P(biphenyl-2-yl) (10.0 mol %) and aryl bromide (2 equiv) were combined in 
a microwave vial (2 mL).  Anhydrous solvent (xylene, dimethylformamide, 
dimethylsulfoxide or dioxane) (1 mL) was added and the vial was sealed and heated 
to 200°C for 72 hr.  The reaction mixture was filtered through celite and washed 
through with CH2Cl2 (10 mL), concentrated in vacuo, dry loaded onto SiO2 and 
purified by column chromatography.   
 
                                                 
4 The reaction is a melt for the first several hours and stirs well but as more product forms it begins to 




General Proceedure G: Direct arylation of quinoline amide 
 
Quinoline amide, 309 (1 equiv), Pd(OAc)2 (5.0 mol %), AgOAc (2 equiv), 
dimethylformamide (5 mL) and aryl iodide (4 equiv) were heated together under N2 
at 130°C for 24 hr.  Further Pd(OAc)2 (2 mol %) was added in two portions over a 
period of 48 hr.  The reaction was then partitioned between CH2Cl2 and water, the 
organics washed twice with water, then brine,  dried over MgSO4 and concentrated in 






Following general procedure A, using thiobenzamide (22.00 g, 0.160 
mol, 1 equiv)  the title compound was obtained by reduced pressure 
distillation as a colourless oil (25.06 g, 96% yield).  BP 82°C at 0.4 mmHg;  1H 
NMR (360 MHz, CDCl3) δH 8.00-7.95 (2H, m), 7.86 (1H, d, J = 3.3, ThC4-H), 7.47-
7.40 (3H, m), 7.31 (1H, d, J = 3.3, ThC5-H);  13C NMR (90 MHz, CDCl3) δC 168.38 
(quat, ThC2), 143.63 (CH, ThC4-H), 133.52 (quat), 129.96 (CH), 128.93 (2 CH), 
126.53 (2 CH), 118.80 (CH).  
5-Iodo-2-phenylthiazole 300b 
Following general procedure B, using 2-phenylthiazole, (2.00 g, 
0.012 mol, 1 equiv) the title compound was obtained following 
purification by column chromatography (0-10% ethyl acetate/iso-hexane) and 
obtained as a brown solid (2.68 g, 75% yield).  MP (CHCl3) 101°C;  1H NMR (360 
MHz, CDCl3) δH 7.86-7.83 (3H, m), 7.42-7.38 (3H, m);  13C NMR (90 MHz, CDCl3) 
δC 173.24 (quat, TC2), 151.19 (CH, ThC4-H), 132.68 (quat), 130.21 (CH), 128.82 
(2CH), 126.17 (2CH), 70.12 (quat, TC5-I);  IR (thin film, cm-1) νmax  3054, 2987, 
1421, 1265, 896, 739, 705;  HRMS (EI) calculated for [C9H7INS]+ 286.9266, found 
286.9259.   
5-Iodo-2-(4-methoxyphenyl)thiazole 300c 
Following general procedure B, using 2-anisylthiazole, (300 mg, 
1.569 mmol, 1 equiv), the title compound was obtained 
following purification by column chromatography (0-10% ethyl acetate/iso-hexane) 
as a yellow solid (334 mg, 67% yield).  MP (CHCl3) 105-106°C;  1H NMR (360 
MHz, CDCl3)  7.83-7.80 (3H, m), 6.97-6.93 (2H, m), 3.86 (3H, s, OCH3);  13C NMR 
(90 MHz, CDCl3) δC 173.46 (quat, ThC2), 161.42 (quat, CAr-OCH3), 151.15 (CH, 
ThC4-H), 127.91 (2CH), 126.00 (quat), 114.38 (2CH), 68.49 (quat, ThC5-I), 55.42 
(OCH3);  IR (thin film, cm-1) νmax 1607, 1475, 1410, 1257, 1177, 1110, 1034, 807, 












Following general procedure D, using 2-phenylthiazole, (100 
mg, 0.620 mmol, 1 equiv) and iodochlorobenzene (178 mg, 
0.744 mmol, 1.2 equiv), purification by column 
chromatography (CH2Cl2) gave the title compound as a yellow solid (160 mg, 95% 
yield).  MP (Et2O) 137°C;  1H NMR (360 MHz, CDCl3) δH 7.92 (1H, s, ThC4-H), 
7.90-7.87 (2H, m), 7.47-7.45 (2H, m), 7.39-7.37 (3H, m), 7.32-7.30 (2H, m);  13C 
NMR (90 MHz, CDCl3) δC 167.49 (quat, ThC2), 139.44 (CH, ThC4-H), 137.94 
(quat), 134.10 (quat), 133.45 (quat), 130.16 (CH), 129.88 (quat), 129.28 (2CH), 
128.99 (2CH), 127.77 (2CH), 126.36 (2CH);  IR (thin film,  cm-1) νmax  3054, 2986, 
1265, 1095, 896, 739, 705;  HRMS (ES +ve) Calculated for [C15H1035ClNS+H]+ 
272.0295, found 272.0293.   
5-(4-Methylphenyl)-2-phenylthiazole168,169 65c 
Following general procedure D, using 2-phenylthiazole (200 
mg, 1.240 mmol, 1 equiv) and iodotoluene (325 mg, 1.488 
mmol, 1.2 equiv), purification by column chromatography 
(toluene) gave the title compound as a yellow oil (281 mg, 90% yield).  1H NMR 
(360 MHz, CDCl3) δH 7.99-7.96 (3H, m), 7.51-7.42 (5H, m), 7.23-7.21 (2H, m), 2.39 
(3H, s, CH3);  13C NMR (90 MHz, CDCl3) δC 166.53 (quat, TC2), 139.35 (quat), 
138.62 (CH, ThC4-H), 138.23 (quat), 133.65 (quat), 129.79 (CH), 129.68 (2CH), 
128.85 (2CH), 128.44 (quat), 126.45 (2CH), 126.22 (2CH), 21.16 (CH3).   
5-(4-Nitrophenyl)-2-phenylthiazole 65d 
Following general procedure C, using 2-phenylthiazole (100 
mg, 0.620 mmol, 1 equiv) and 4-iodonitrobenzene (185 mg, 
0.744 mmol, 1.2 equiv), purification by column 
chromatography (2% ethyl acetate/hexane) gave the title compound as a yellow solid 
(108 mg, 62% yield).  MP (CHCl3) 173°C;  1H NMR (360 MHz, CDCl3) δH 8.30-
8.26 (2H, m), 8.16 (1H, s, ThC4-H), 8.00-7.97 (2H, m), 7.76-7.73 (2H, m), 7.51-7.48 
(3H, m);  13C NMR (90 MHz, CDCl3) δC 169.50 (quat, ThC2), 147.11 (quat, CAr-













(CH), 129.13 (2CH), 126.88 (2CH), 126.58 (2CH), 124.56 (2CH);  IR (thin film, cm-
1) νmax 3054, 2986, 1596, 1520, 1422, 1340, 1265, 896, 739, 706;  HRMS (EI) 
calculated for [C15H10N2O2S]+ 282.0463, found 282.0462.   
5-(4-Methoxyphenyl)-2-phenylthiazole 65e 
Following general procedure C, using 2-phenylthiazole (100 
mg, 0.620 mmol, 1 equiv) and 4-iodoanisole (174 mg, 0.744 
mmol, 1.2 equiv), purification by column chromatography 
(2% ethyl acetate/hexane) gave the title compound as a colourless solid (129 mg, 
78% yield).  MP (EtOH) 85-87°C;  1H NMR (360 MHz, CDCl3) δH 7.90-7.86 (2H, 
m), 7.84, (1H, s, ThC4-H), 7.48-7.44 (2H, m), 7.38-7.35 (3H, m), 6.90-6.86 (2H,m), 
3.77 (3H, s, OCH3);  13C NMR (90 MHz, CDCl3) δC 166.11 (quat, ThC2), 159.65 
(quat), 139.09 (quat), 138.05 (CH, ThC4-H), 133.62 (quat), 129.70 (CH), 128.95 
(2CH), 128.82 (2CH), 127.84 (2CH), 126.13 (quat), 114.40 (2CH), 55.25 (OCH3);  
IR (thin film, cm-1) νmax 3049, 2960, 2837, 1609, 1533, 1489, 1453, 1255, 1034, 827, 
761, 738, 689, 631;  HRMS (FAB) calculated for [C16H13NOS+H]+ 268.0796, found 
268.0795.   
5-(4-Fluorophenyl)-2-phenylthiazole 65h 
Following general procedure C, using 2-phenylthiazole (100 
mg, 0.620 mmol) and 4-iodofluorobenzene (165 mg, 0.744 
mmol), purification by column chromatography (CH2Cl2) 
afforded the title compound as a colourless solid (141 mg, 89% yield).  MP (Et2O) 
124°C;  1H NMR (360 MHz, CDCl3) δH 7.97-7.94 (3H, m), 7.56-7.52 (2H, m), 7.45-
7.42 (3H, m), 7.12-7.07 (2H, m);  13C NMR (90 MHz, CDCl3) δC 167.01 (quat, 
ThC2), 162.68 (quat, d, J = 248.6, CAr-F), 138.92 (CH, ThC4-H), 137.99 (quat), 
133.37 (quat), 129.97 (CH), 128.87 (2CH), 128.20 (2CH, d, J = 8.1, CHCHCF),  
127.43 (quat, d, J = 3.5, CArCHCHCF), 126.19 (2CH), 116.02 (2CH, d, J = 21.9, 
CHCF);  19F NMR (235 MHz, CDCl3) δF -114 (1F, s);  IR (thin film, cm-1) νmax 3054, 
2986, 1534, 1505, 1489, 1453, 1423, 1265, 1237, 1159, 896, 834, 739, 705;  HRMS 











Following general procedure C, using 2-phenylthiazole (100 
mg, 0.620 mmol, 1 equiv) and 3-iodofluorobenzene (165 mg, 
0.744 mmol, 1.2 equiv), purification by column 
chromatography (10-20% ethyl acetate/hexane) afforded the product as a yellow 
solid, (103 mg, 65% yield).  MP (EtOH) 112-114°C;  1H NMR (360 MHz, CDCl3) 
δH 8.02 (1H, s, ThC4-H), 7.98-7.95 (2H, m), 7.47-7.43 (3H, m), 7.38-7.35 (2H, m), 
7.30 (1H, m), 7.03 (1H, m);  13C NMR (90 MHz, CDCl3) δC 167.70 (quat, ThC2), 
163.00 (quat, d, J = 246.9, CAr-F), 139.75 (CH, ThC4-H), 137.82 (quat, d, J = 2.6, 
ThC5CCHCF), 133.39 (quat, d, J = 8.3, CCHCF), 133.38 (quat), 130.65 (CH, d, J = 
8.6, CHCHCF), 130.19 (CH), 128.97 (2CH), 126.37 (2CH), 122.30 (CH, d, J = 2.8, 
CHCHCHCF), 115.05 (CH, d, J = 21.2, CHCF), 113.41 (CH, d, J = 23.0, CHCF);  
19F NMR (235 MHz, CDCl3) δF -113.0 (1F, s);  IR (thin film, cm-1) νmax 3054, 2986, 
2305, 1610, 1585, 1421, 1265, 896, 738;  HRMS (EI) calculated for [C15H10FNS]+ 
255.0518, found 255.0509.   
5-(2-Fluorophenyl)-2-phenylthiazole 65j 
Following general procedure C, using 2-phenylthiazole (100 mg, 
0.620 mmol, 1 equiv) and 2-iodofluorobenzene (165 mg, 0.744 
mmol, 1 equiv), purification by column chromatography (10-
20% ethyl acetate/hexanes) afforded the title compound as a yellow solid (93 mg, 
59% yield).  MP (EtOH) 92-94°C;  1H NMR (360 MHz, CDCl3) δH 8.19 (1H, d, J = 
1.2, TC4-H), 8.01-7.98 (2H, m), 7.63 (1H, ddd, J = 1.9, 7.6, 7.9, CHCHCF), 7.49-
7.43 (3H, m), 7.31 (1H, m), 7.22-7.15 (2H, m);  13C NMR (90 MHz, CDCl3) δC 
167.93 (quat, d, J = 3.4, ThC2), 158.90 (quat, d, J = 250.5, CAr-F), 141.95 (CH, d, J 
= 7.3), 133.44 (quat), 131.98 (quat, d, J = 4.2), 130.09 (CH), 129.47 (CH, d, J = 8.4), 
128.94 (2CH), 128.89 (CH), 126.38 (2CH), 124.63 (CH, d, J = 3.4), 119.41 (quat, d, 
J = 13.6), 116.32 (CH, d, J = 22.1, CHCF);  19F NMR (235 MHz, CDCl3) δF -113.00 
(1F, s);  IR (thin film, cm-1) νmax 3054, 2986, 1422, 1264, 896, 748;  HRMS (EI) 










Following general procedure C, using 2-phenylthiazole (100 mg, 
0.620 mmol, 1 equiv) and 2-iodoanisole (174 mg, 0.744 mmol, 
1.2 equiv), purification by column chromatography (CH2Cl2) 
afforded the title compound as a yellow solid (118 mg, 71% yield).  MP (CHCl3) 58-
60°C;  1H NMR (360 MHz, CDCl3) δH 8.24 (1H, s, ThC4-H), 8.03-8.00 (2H, m), 7.67 
(1H, dd, J = 1.7, 7.6), 7.46-7.41 (3H, m), 7.32 (1H, ddd, J = 1.7, 7.6, 8.3), 7.02 (2H, 
ddd, J = 1.3, 7.6, 15.1), 3.95 (3H, s, OCH3);  13C NMR (90 MHz, CDCl3) δC 167.37 
(quat, ThC2), 155.37 (quat, CArOMe), 141.25 (CH, ThC4), 134.15 (quat), 133.87 
(quat), 129.63 (CH), 129.19 (CH), 128.82 (2CH), 128.33 (CH), 126.22 (2CH), 
121.00 (CH), 120.41 (quat), 111.46 (CH), 55.51 (OCH3);  IR (thin film, cm-1) νmax 
3053, 1479, 1465, 1265, 1025, 982, 896, 740, 705;  HRMS (EI) calculated for 
[C16H13NOS]+ 267.0718, found 267.0728.   
5-(3’-Methoxyphenyl)-2-phenylthiazole 65f 
Following general procedure C, using 2-phenylthiazole (100 
mg, 0.620 mmol, 1 equiv) and 3-iodoanisole (174 mg, 0.744 
mmol, 1.2 equiv), purification by column chromatography 
(CH2Cl2) afforded the title compound as a colourless solid (87 mg, 53% yield).  MP 
(CHCl3) 69-70°C;  1H NMR (360 MHz, CDCl3) δH 8.01 (1H, s, ThC4-H), 7.99-7.96 
(2H, m), 7.45-7.43 (3H, m), 7.33 (1H, t, J = 7.9, CHCHCOCH3), 7.17 (1H, ddd, J = 
1.0, 1.7), 7.13 (1H, dd, J = 1.7, 2.3), 6.89 (1H, ddd, J = 1.0, 2.6, 8.3), 3.86 (3H, s, 
CH3);  13C NMR (90 MHz, CDCl3) δC 167.12 (quat, ThC2), 159.96 (quat, CArOCH3), 
139.27 (CH, ThC4-H), 139.07 (quat), 133.57 (quat), 132.56 (quat), 130.09 (CH), 
129.97 (CH), 128.91 (2CH), ,126.29 (2CH), 119.13 (CH), 113.63 (CH), 112.31 (CH), 
55.29 (CH3);  IR (thin film, cm-1) νmax 3054, 2986, 1600, 1579, 1478, 1457, 1422, 
1265, 1209, 1170, 896, 738, 705;  HRMS (EI) calculated for [C16H13NOS]+ 267.0718, 










Following general procedure C using 2-phenylthiazole (100 
mg, 0.620 mmol, 1 equiv) and 4-iodobenzotrifluoride (203 
mg, 0.744 mmol, 1.2 equiv), purification by column 
chromatography (CH2Cl2) gave the title compound as a colourless solid (117 mg, 
62% yield).  MP (Et2O) 154°C;  1H NMR (360 MHz, CDCl3) δH 8.10 (1H, s, ThC4-
H), 8.01-7.97 (2H, m), 7.73-7.67 (4H, m), 7.51-7.46 (3H, m);  13C NMR (90 MHz, 
CDCl3) δC 168.40 (quat, ThC2), 140.36 (CH, ThC4-H), 137.48 (quat), 134.88 (quat), 
133.33 (quat), 130.41 (CH), 130.04 (quat, q, J = 32.7, CArCF3), 129.05 (2CH), 
126.71 (2CH), 126.47 (2CH), 126.12 (2CH, q, J = 3.7, CHCCF3), 123.93 (quat, q, J 
= 272.0, CF3);  19F NMR (235 MHz, CDCl3) δF -63.9 (3F, s);  IR (thin film, cm-1) 
νmax 3399, 1996, 1614, 1425, 1326, 1265, 1110, 1070, 896, 832, 739;  HRMS (EI) 
calculated for [C16F3H10NS]+ 305.0486, found 305.0498.   
5-(4-Bromophenyl)-2-phenylthiazole 65y 
Following general procedure D using 2-phenylthiazole (100 
mg, 0.620 mmol, 1 equiv) and 4-iodobromobenzene (211 mg, 
0.744 mmol, 1.2 equiv), purification by column 
chromatography (10-20% ethyl acetate/hexane) gave the title compound as a pale 
yellow solid (196 mg, >99%).  MP (EtOH) 146-148°C;  1H NMR (360 MHz, CDCl3) 
δH 7.99 (1H, s, ThC4-H), 7.97-7.94 (2H, m), 7.55-7.51 (2H, m), 7.47-7.42 (5H, m);  
13C NMR (90 MHz, CDCl3) δC 167.50 (quat, ThC2), 139.46 (CH, ThC4-H), 137.94 
(quat), 133.43 (quat), 132.20 (2CH), 130.31 (quat), 130.15 (CH), 128.98 (2CH), 
127.99 (2CH), 126.35 (2CH), 122.16 (quat);  IR (thin film, cm-1) νmax 3076, 1525, 
1478, 1449, 1426, 1398, 1163, 1070, 979, 822, 760, 686, 629;  HRMS (EI) 
calculated for [C15H10NS79Br]+ 314.9717, found 314.9718.   
2-Phenylthiazol-5-yl-2-benzyl alcohol 65p 
Following general procedure C, using 2-phenylthiazole (100 
mg, 0.620 mmol, 1 equiv) and 2-iodobenzylalcohol (174 mg, 











chromatography (CH2Cl2) gave the title compound as a yellow oil (108 mg, 65% 
yield).  1H NMR (360 MHz, CDCl3) δH 7.94-7.91 (2H, m), 7.84 (1H, s, ThC4-H), 
7.60-7.57 (1H, m), 7.44-7.40 (4H, m), 7.38-7.30 (2H, m), 4.72 (2H, s, CH2OH);  13C 
NMR (90 MHz, CDCl3) δC 168.39 (quat, ThC2), 142.03 (CH, ThC4-H), 138.82 
(quat), 136.18 (quat), 133.26 (quat), 130.78 (CH), 130.04 (CH), 129.70 (quat), 
128.98 (CH), 128.91 (2CH), 128.85 (CH), 127.83 (CH), 126.32 (2CH), 62.84 (CH2);  
IR (thin film, cm-1) νmax 3349, 1478, 1455, 1422, 1265, 982, 737, 703, 636;  HRMS 
(EI) calculated for [C16H13NOS]+ 267.0718, found 267.0728.   
5-(2,4,6-Trimethylphenyl)-2-phenylthiazole 65s 
Following general procedure D, using 2-phenylthiazole (100 
mg, 0.620 mmol, 1 equiv) and 2,4,6-trimethyliodobenzene 
(183 mg, 0.744 mmol, 1.2 equiv), purification by column 
chromatography (CH2Cl2) afforded the title compound as a yellow oil (173 mg, 
quantitative yield).  1H NMR (360 MHz, CDCl3) δH 8.03-8.00 (2H, m), 7.58 (1H, s, 
ThC4-H), 7.50-7.43 (3H, m), 6.99 (2H, s, CArHCCH3), 2.36 (3H, s, p-CH3), 2.20 (6H, 
s, 2 o-CH3);  13C NMR (90 MHz, CDCl3) δC 168.46 (quat, ThC2), 142.22 (CH, 
ThC4-H), 138.59 (quat), 138.38 (2 quat), 135.53 (quat), 133.72 (quat), 129.83 (CH), 
128.91 (2CH), 128.31 (2CH), 126.81 (quat), 126.26 (2CH), 21.06 (CH3, p-CH3), 
20.78 (2CH3, 2 o-CH3);  IR (thin film, cm-1) νmax 2918, 1456, 978, 851, 761, 689, 635;  
HRMS (EI) calculated for [C18H17NS]+ 279.1082, found 279.1080.   
2-(2-Phenylthiazol-5-yl)pyridine 291a 
Following general procedure C, using 2-phenylthiazole (100 mg, 
0.620 mmol, 1 equiv) and 2-iodopyridine (153 mg, 0.744 mmol, 
1.2 equiv), purification by column chromatography (CH2Cl2) 
gave the title compound as a colourless solid (84 mg, 57% yield).  MP (CHCl3) 99-
101°C;  1H NMR (360 MHz, CDCl3) δH 8.59 (1H, m), 8.27 (1H, s, ThC4-H), 8.01-
7.99 (2H, m), 7.71-7.67 (2H, m), 7.48-7.43 (3H, m), 7.20 (1H, m);  13C NMR (90 
MHz, CDCl3) δC 169.27 (quat, ThC2), 150.47 (CH), 149.78 (CH, ThC4-H), 140.44 
(quat), 140.01 (quat), 136.70 (CH), 133.48 (quat), 130.21 (CH), 128.93 (2CH), 










1466, 1450, 1434, 1420, 1265, 1162, 779, 738, 705;  HRMS (ES +ve) calculated for 
[C14H10N2S+H]+ 239.0637, found 239.0636.   
3-(2-Phenylthiazol-5-yl)pyridine 65q 
Following general procedure D using 2-phenylthiazole (100 mg, 
0.620 mmol, 1 equiv) and 3-iodopyridine (153 mg, 0.744 mmol, 
1.2 equiv), purification by column chromatography (10-20% 
ethyl acetate/hexane) gave the title compound as a pale yellow solid (148 mg, 
quantitative yield).  MP (CH2Cl2) 90-91°C;  1H NMR (360 MHz, CDCl3) δH 8.87 
(1H, d, J = 2.3, py), 8.57 (1H, dd, J = 1.6, 4.8, py), 8.06 (1H, s, ThC4-H), 7.98-7.96 
(2H, m), 7.87 (1H, ddd, J = 1.6, 2.3, 7.9, py), 7.48-7.44 (3H, m), 7.35 (1H, ddd, J = 
0.7, 4.8, 7.9, py);  13C NMR (90 MHz, CDCl3) δC 168.15 (quat, ThC2), 149.06 (CH, 
ThC4-H), 147.30 (CH), 140.02 (CH), 135.07 (quat), 133.42 (CH), 133.14 (quat), 
130.22 (CH), 128.89 (2CH), 127.49 (quat), 126.32 (2CH), 123.63 (CH);  IR (thin 
film, cm-1) νmax 1561, 1522, 1467, 1450, 1415 1150, 1022, 974, 958, 843, 803, 759, 
705;  HRMS (EI) calculated for [C14H10N2S]+ 238.0565, found 238.0558.   
Ethyl 4-(2-phenylthiazol-5-yl)benzoate 65n 
Following general procedure C, using 2-phenylthiazole 
(100 mg, 0.620 mmol, 1 equiv) and ethyl iodobenzene-4-
carboxylate (205 mg, 0.744 mmol, 1.2 equiv), purification 
by column chromatography (CH2Cl2) gave the title 
compound as a colourless solid (122 mg, 53% yield).  MP (CHCl3) 119-120°C;  1H 
NMR (360 MHz, CDCl3) δH 8.11-8.08 (3H, m), 8.00-7.97 (2H, m), 7.67-7.64 (2H, 
m), 7.49-7.45 (3H, m), 4.42 (2H, q, J = 7.1, CH2CH3), 1.44 (3H, t, J = 7.1, CH2CH3);  
13C NMR (90 MHz, CDCl3) δC 168.08 (quat, ThC2), 165.84 (quat, CO2Et), 140.21 
(CH, ThC4-H), 137.87 (quat), 135.42 (quat), 133.20 (quat), 130.22 (2CH and CH), 
129.72 (quat), 128.89 (2CH),  126.29 (2CH), 126.05 (2CH), 61.01 (CH2), 14.23 
(CH3);  IR (thin film, cm-1) νmax 3054, 2987, 1714, 1608, 1531, 1452, 1425, 1368, 
1266, 1185, 1155, 1109, 1022, 981, 896, 851; HRMS (EI) calculated for 












Following general procedure D using 2-phenylthiazole (100 mg, 
0.620 mmol, 1 equiv) and iodopyrazine (153 mg, 0.744 mmol, 
1.2 equiv), and purification by column chromatography (10-50% 
ethyl acetate/hexane) gave the title compound as a pale yellow solid (148 mg, 
quantitative yield).  MP (CHCl3) 159-161°C;  1H NMR (360 MHz, CDCl3) δH 8.98 
(1H, d, J = 1.6, CCHN), 8.53 (1H, dd, J = 1.6, 2.6, CHCHNC), 8.45 (1H, d, J = 2.6, 
CHNC), 8.36 (1H, s), 8.01-7.98 (2H, m), 7.47-7.43 (3H, m);  13C NMR (90 MHz, 
CDCl3) δC 170.51 (quat, ThC2), 146.80 (quat), 144.25 (CH), 142.92 (CH), 141.66 
(CH), 141.08 (CH), 136.56 (quat), 133.20 (quat), 130.61 (CH), 129.02 (2CH), 126.59 
(2CH);  IR (thin film, cm-1) νmax 1526, 1469, 1449, 1418, 1406, 1316, 1167, 1011, 
848, 754, 683, 633;  HRMS (EI) calculated for [C13H9N3S]+ 239.0517, found 
239.0514.   
2-Phenyl-5-(2-phenylthiazol-5-yl)thiazole 228a 
Following general procedure D, using 2-phenylthiazole 
(100 mg, 0.620 mmol, 1 equiv) and 5-iodo-2-
phenylthiazole (214 mg, 0.744 mmol, 1.2 equiv), 
purification by column chromatography (1-5% acetone/CH2Cl2) afforded the title 
compound as a yellow solid (198 mg, quantitative yield).  MP (CHCl3) 182°C;  1H 
NMR (360 MHz, CDCl3) δH 7.97-7.93 (6H, m), 7.48-7.44 (6H, m);  13C NMR (90 
MHz, CDCl3) δC 167.60 (2 quat, 2ThC2), 141.12 (2CH, 2ThC4-H), 133.11 (2 quat), 
130.41 (2CH), 129.05 (4CH), 128.40 (2 quat), 126.48 (4CH);  IR (thin film, cm-1) 
νmax 3019, 2400, 1479, 1417, 1216, 1149, 975, 929, 770;  HRMS (ES +ve) calculated 
for [C18H12N2S2+H]+, 321.0515 found 321.0512.   
2'-(4-Methoxyphenyl)-2-phenyl-[5,5']bithiazolyl 228b 
Following general procedure D, using 2-
phenylthiazole (100 mg, 0.620 mmol, 1 equiv) and 5-
iodo-2-anisylthiazole (236 mg, 0.744 mmol, 1.2 
equiv), purification by column chromatography (1-5% acetone/CH2Cl2) afforded the 
title compound as a yellow solid (123 mg, 56% yield).  MP (CHCl3) 155-157°C;  1H 












NMR (360 MHz, CDCl3) δH 7.95-7.92 (2H, m), 7.89-7.86 (4H, m), 7.47-7.44 (3H, 
m), 6.98-6.94 (2H, m), 3.85 (3H, s, OCH3);  13C NMR (90 MHz, CDCl3) δC 167.54 
(quat, ThC2), 167.27 (quat, ThC2), 161.43 (quat, CArOCH3), 140.92 (CH, ThC4-H), 
140.85 (CH, ThC4-H), 133.15 (quat), 130.31 (CH), 129.01 (2CH), 128.61 (quat), 
127.99 (2CH), 127.36 (quat), 126.43 (2CH), 126.03 (quat), 114.38 (2CH), 55.40 
(OCH3);  IR (thin film, cm-1) νmax 1607, 1482, 1435, 1417, 1258, 1033, 846, 831, 763, 
689, 629;  HRMS (EI) calculated for [C19H14N2S2O]+ 350.0548, found 350.0552.   
2-Phenyl-5-(3,4-dimethoxy)thiazole 65x 
Following general procedure D using 2-phenylthiazole (100 
mg, 0.620 mmol, 1 equiv), 3,4-dimethyliodobenzene (197 
mg, 0.744 mmol, 1.2 equiv) and purification by column 
chromatography (10-20% ethyl acetate/hexane), the title compound was isolated as a 
pale yellow solid (162 mg, 88% yield).  MP (CHCl3) 108-110°C;  1H NMR (360 
MHz, CDCl3) δH 7.93-7.90 (2H, m), 7.88 (1H, s, ThC4-H), 7.43-7.36 (3H, m), 7.10 
(1H, m), 7.03 (1H, m), 6.82 (1H, m), 3.90 (3H, s, OCH3), 3.89 (3H, s, OCH3);  13C 
NMR (90 MHz, CDCl3) δC 166.01 (quat, ThC2), 149.11 (quat, CArOCH3), 149.03 
(quat, CArOCH3), 139.14 (quat), 138.08 (CH, ThC4-H), 133.47 (quat), 129.63 (CH), 
128.72 (2CH), 126.00 (2CH), 123.96 (quat), 119.24 (CH), 111.30 (CH), 109.51 (CH), 
55.76 (OCH3), 55.72 (OCH3);  IR (thin film, cm-1) νmax 2937, 2836, 1533, 1507, 
1491, 1455, 1256, 1238, 1145, 1026, 841, 763, 691, 629;  HRMS (ES +ve) 
calculated for [C17H15NO2S+H]+ 298.0896, found 298.0893.   
4-(2-Phenylthiazol-5-yl)benzonitrile 65m 
Following general procedure C, using 2-phenylthiazole (100 
mg, 0.620 mmol, 1 equiv) and iodobenzonitrile (205 mg, 
0.744 mmol, 1.2 equiv), purification by column 
chromatography (CH2Cl2) afforded the title compound as a colourless solid (143 mg, 
88% yield).  MP (Et2O) 183°C;  1H NMR (360 MHz, CDCl3) δH 8.12 (1H, s, ThC4-
H), 7.99-7.96 (2H, m), 7.70 (4H, s, C6H4CN), 7.49-7.47 (3H, m);  13C NMR (90 
MHz, CDCl3) δC 168.94 (quat, ThC2), 140.91 (CH, ThC4-H), 136.93 (quat), 135.76 











126.46 (2CH), 118.43 (quat), 111.40 (quat);  IR (thin film, cm-1) νmax 3055, 2223, 
1996, 1601, 1532, 1488, 1449, 1422, 1265, 1168, 977, 896, 834, 737;  HRMS (ES 
+ve) calculated for [C16H10N2S+H]+ 263.0637, found 263.0638.   
2,5-Diphenylthiazole170 65a 
Following general procedure D, using 2-phenylthiazole (200 mg, 
1.240 mmol, 1 equiv) and iodobenzene (303 mg, 1.488 mmol, 1.2 
equiv), purification by column chromatography (0.5% ethyl 
acetate/hexane) gave the title compound as a colourless oil (255 mg 87% yield).  1H 
NMR (360MHz, CDCl3) δH 8.03 (1H, s), 8.00-7.97 (2H, m), 7.62-7.60 (2H, m), 7.47-
7.32 (6H, m);  13C NMR (90 MHz, CDCl3) δC 166.95 (quat, ThC2), 139.12 (quat), 
139.02 (CH, ThC4-H), 133.51 (quat), 131.21 (quat), 129.84 (CH), 128.94 (2CH), 
128.81 (2CH), 128.12 (CH), 126.47 (2CH), 126.20 (2CH).   
5-(4-Acetylphenyl)-2-phenylthiazole 65l 
Following general procedure C using 2-phenylthiazole (100 
mg, 0.620 mmol, 1 equiv) and 4-iodoacetophenone (183 mg, 
0.744 mmol, 1.2 equiv), purification by column 
chromatography (CH2Cl2) gave the title compound as a 
yellow solid (163 mg, 94% yield).  MP (CHCl3) 147°C;  1H NMR (360 MHz, CDCl3) 
δH 8.17 (1H, s, ThC4-H), 8.06-8.01 (4H, m), 7.74-7.72 (2H, m), 7.53-7.49 (3H, m), 
2.67 (3H, s, CH3);  13C NMR (90 MHz, CDCl3) δC 196.98 (quat, COCH3), 168.34 
(quat, ThC2), 140.43 (CH, ThC4-H), 137.79 (quat), 136.28 (quat), 135.76 (quat), 
133.26 (quat), 130.32 (CH), 129.13 (2CH), 128.97 (2CH), 126.38 (2CH), 126.35 
(2CH), 26.51 (CH3);  IR (thin film, cm-1) νmax 1681, 1603, 1420, 1265, 825, 738, 705, 
590;  HRMS (EI) calculated for [C17H13NOS]+ 279.0718, found 279.0719.   
2-(4-Methoxyphenyl)thiazole171 51c 
Following general procedure A, using 4-methoxythiobenzamide 
(859 mg, 6.000 mmol), purification by column chromatography 
(0-20% ethyl acetate/iso-hexane) gave the title compound as a colourless oil (792 mg, 











ThC4-H), 7.25 (1H, d, J = 3.3, ThC5-H), 6.97-6.93 (2H, m), 3.85 (3H, s, OCH3);  13C 
NMR (90 MHz, CDCl3) δC 168.28 (quat, ThC2), 161.05 (quat, CArOCH3), 143.34 
(CH, ThC4-H), 128.00 (2CH), 126.55 (quat, ThC2-C), 117.83 (CH, ThC5-H), 114.25 
(2CH), 55.36 (OCH3).   
2-(4-Trifluoromethylphenyl)thiazole 51e 
Following general procedure A using 4-trifluoromethylbenzamide 
(5.00 g, 0.024 mol), purification by column chromatography (0-
20% ethyl acetate/iso-hexane) gave the title compound as a colourless solid (3.19 g, 
37% yield).  MP (CHCl3) 74°C;  1H NMR (360 MHz, CDCl3) δH 8.00-7.98 (2H, m), 
7.85 (1H, d, J = 3.2, ThC4-H), 7.63-7.61 (2H, m), 7.32 (1H, d, J = 3.2, ThC5-H);  13C 
NMR (90 MHz, CDCl3) δC 166.21 (quat, ThC2), 143.98 (CH, ThC4-H), 136.49 
(quat), 131.33 (quat, q, J = 36.7, CCF3), 126.56 (2CH), 125.82 (2CH, q, J = 3.7, 
2CHCCF3), 123.80 (quat, q, J = 272.2, CF3), 119.75 (CH, ThC5-H);  19F NMR (235 
MHz, CDCl3) δF -64.0 (3F, s);  IR (thin film, cm-1) νmax 3122, 3054, 1616, 1485, 
1421, 1326, 1265, 1170, 1129, 1109, 1067, 1019, 978, 848, 741, 706;  HRMS (EI) 
calculated for [C10F3H6NS]+ 229.0173, found 229.0180.   
2-(4-Methylphenyl)thiazole172 51d 
Following general procedure A using 4-methylthiobenzamide (2.00 
g, 0.013 mol, 1 equiv), purification by column chromatography (0-
20% ethyl acetate/iso-hexane) gave the title compound as a yellow oil (2.23 g, 91% 
yield).  1H NMR (360 MHz, CDCl3) δH 7.88-7.84 (2H, m), 7.84 (1H, d, J = 3.3, 
ThC4-H), 7.29 (1H, d, J = 3.3, ThC5-H), 7.26-7.24 (2H, m), 2.40 (3H, s, CArCH3);  
13C NMR (90 MHz, CDCl3) δC 168.58 (quat, ThC2), 143.46 (CH, ThC4-H), 140.19 
(quat), 130.92 (quat), 129.60 (2CH), 126.46 (2CH), 118.30 (CH, ThC5-H), 21.38 
(CArCH3).   
5-(4-Chlorophenyl)-2-(methoxyphenyl)thiazole 65aa 
Following general procedure C, with 2-anisylthiazole 
(100 mg, 0.523 mmol, 1 equiv) and 4-iodochlorobenzene 











chromatography (CH2Cl2) afforded the title compound as a yellow solid (155 mg, 
98% yield).  MP (CHCl3) 150°C;  1H NMR (360 MHz, CDCl3) δH 7.92 (1H, s, ThC4-
H), 7.90-7.86 (2H, m), 7.51-7.47 (2H, m), 7.37-7.34 (2H, m), 6.97-6.93 (2H, m), 
3.85 (3H, s, OCH3); 13C NMR (90 MHz, CDCl3) δC 167.40 (quat, ThC2), 161.22 
(quat, CArOCH3), 139.15 (CH, ThC4-H), 136.91 (quat), 133.80 (quat), 130.02 (quat), 
129.19 (2CH), 127.83 (2CH), 127.60 (2CH), 126.39 (quat), 114.30 (2CH), 55.37 
(OCH3);  IR (thin film, cm-1) νmax 3054, 1606, 1482, 1265, 1175, 1094, 896, 827, 743, 
705;  HRMS (EI) calculated for [C16H1235ClNOS]+ 301.0328, found 301.0315.   
2-(4-Methoxyphenyl)-5-(4-methylphenyl)thiazole8 65ab 
Following general procedure C, with 2-anisylthiazole 
(100 mg, 0.523 mmol, 1 equiv) and 4-iodotoluene (137 
mg, 0.627 mmol, 1.2 equiv), purification by column 
chromatography (10-20% ethyl acetate/hexane) afforded the title compound as a 
yellow solid (141 mg, 96% yield).  1H NMR (360 MHz, CDCl3) δH 7.89 (1H, s, 
ThC4-H), 7.85-7.83 (2H, m), 7.53-7.49 (2H, m), 7.26-7.23 (2H, m), 6.95-6.91 (2H, 
m), 3.83 (3H, s, OCH3), 2.39 (3H, s, CArCH3);  13C NMR (90 MHz, CDCl3) δC 
166.62 (quat, ThC2), 161.05 (quat, CArOCH3), 138.43 (CH, ThC4-H), 138.11 (quat), 
129.72 (2CH), 128.68 (quat), 127.77 (2CH), 126.71 (quat), 126.44 (2CH), 114.29 
(2CH), 55.40 (OCH3), 21.22 (CArCH3), one quaternary not found.   
2-(4-Methoxyphenyl)-5-(4-nitrophenyl)thiazole 65ac 
Following general procedure C, with 2-anisylthiazole 
(100 mg, 0.523 mmol, 1 equiv) and 4-iodonitrobenzene 
(156.2 mg, 0.627 mmol, 1.2 equiv), purification by 
column chromatography (10-50% ethyl acetate/hexane) afforded the title compound 
as a yellow solid (105 mg, 64% yield).  MP (CHCl3) 213°C;  1H NMR (360 MHz, 
CDCl3) δH 8.29-8.25 (2H, m), 8.11 (1H, s, ThC4-H), 7.94-7.90 (2H, m), 7.75-7.71 
(2H, m), 7.01-6.97 (2H, m), 3.88 (3H, s, OCH3);  13C NMR (90 MHz, CDCl3) δC 
169.46 (quat, ThC2), 161.72 (quat, CArOCH3), 146.92 (quat, CArNO2), 141.29 (CH, 
ThC4-H), 137.99 (quat), 135.54 (quat), 128.14 (2CH), 126.68 (2CH), 126.03 (quat), 












1596, 1520, 1422, 1340, 1265, 896, 739, 706;  HRMS (EI) calculated for 
[C16H12N2O3S]+ 312.0569, found 312.0574.   
2,5-Di(4-methoxyphenyl)thiazole93 65ad 
Following general procedure C, with 2-anisylthiazole 
(100 mg, 0.523 mmol, 1 equiv) and 4-
iodochlorobenzene (150 mg, 0.627 mmol, 1.2 equiv), 
purification by column chromatography (10-20% ethyl acetate/hexane) afforded the 
title compound as a yellow solid (114 mg, 73% yield).  1H NMR (360 MHz, CDCl3) 
δH 7.91-7.87 (2H, m), 7.85 (1H, s, ThC4-H), 7.53-7.49 (2H, m), 6.98-6.92 (4H, m), 
3.86 (3H, s, OCH3), 3.84 (3H, s, OCH3);  13C NMR (90 MHz, CDCl3) δC 166.23 
(quat, ThC2), 161.01 (quat, CArOCH3), 159.62 (quat, CArOCH3), 138.22 (quat), 
137.90 (CH, ThC4-H), 127.85 (2CH), 127.72 (2CH), 126.74 (quat), 124.17 (quat), 
114.48 (2CH), 114.29 (2CH), 55.40 (OCH3), 55.38 (OCH3).   
5-(4-Chlorophenyl)-2-(4-trifluoromethylphenyl)thiazole 65ae 
Following general procedure C, with 2-(4-
trifluoromethylphenyl)thiazole (100 mg, 0.436 mmol) and 
4-iodochlorobenzene (125 mg, 0.524 mmol), purification 
by column chromatography (0-4% acetone/CH2Cl2) afforded the title compound as a 
yellow solid (93 mg, 63% yield).  MP (CHCl3) 132°C;  1H NMR (360 MHz, CDCl3) 
δH 8.08-8.05 (2H, m), 8.03 (1H, s, ThC4-H), 7.72-7.70 (2H, m), 7.55-7.53 (2H, m), 
7.42-7.38 (2H, m);  13C NMR (90 MHz, CDCl3) δC 165.39 (quat, ThC2), 139.86 (CH, 
ThC4-H), 139.25 (quat), 136.54 (quat), 134.58 (quat), 131.68 (quat, q, J = 32.8, 
CArCF3), 129.48 (quat), 129.41 (2CH), 127.89 (2CH), 126.54 (2CH), 126.03 (2CH, q, 
J = 3.6, 2CHCCF3), 123.85 (quat, q, J = 272.2, CArCF3); 19F NMR (235 MHz, 
CDCl3) δF -64.0 (3F, s);  IR (thin film, cm-1) νmax 3054, 2986, 1412, 1326, 1265, 
1067, 896, 741, 706;  HRMS (EI) calculated for [C16F3H935ClNOS]+ 339.0096, found 













Following general procedure C, with 2-(4-
trifluoromethylphenyl)thiazole (100 mg, 0.436 mmol, 1 
equiv) and 4-iodotoluene (114 mg, 0.524 mmol, 1.2 
equiv), purification by column chromatography (0-2% acetone/CH2Cl2) afforded the 
title compound as a yellow solid (44.6 mg, 32% yield).  MP (CHCl3) 179°C;  1H 
NMR (360 MHz, CDCl3) δH 8.08-8.06 (2H, m), 8.02 (1H, s, ThC4-H), 7.72-7.69 (2H, 
m), 7.52-7.49 (2H, m), 7.25-7.23 (2H, m), 3.40 (3H, s, CArCH3);  13C NMR (90 MHz, 
CDCl3) δC 164.55 (quat, ThC2), 140.77 (quat), 139.15 (CH, ThC4-H), 138.82 (quat), 
136.83 (quat), 131.30 (quat, q, J = 32.7, CArCF3), 129.87 (2CH), 128.13 (quat), 
126.67 (2CH), 126.44 (2CH), 125.97 (2CH, q, J = 3.7, CHCArCF3), 124.02 (quat, q, 
J = 272.3, CArCF3), 21.26 (CH3, CArCH3);  19F NMR (235 MHz, CDCl3) δF -64.0 (3F, 
s);  IR (thin film, cm-1) νmax 3054, 2986, 2253, 1421, 1325, 1265, 907, 728, 651;  
HRMS (EI) calculated for [C17F3H12NS]+ 319.0643, found 319.0643.   
5-(4-Nitrophenyl)-2-(4-trifluoromethylphenyl)thiazole 65ag 
Following general procedure D with 2-(4-
trifluoromethylphenyl)thiazole (100 mg, 0.436 mmol, 1 
equiv) and 4-iodonitrobenzene (130 mg, 0.524 mmol, 
1.2 equiv), purification by column chromatography (0-10% acetone/CH2Cl2) 
afforded the title compound as a yellow solid (121 mg, 79% yield).  MP (EtOH) 175-
176°C;  1H NMR (360 MHz, CDCl3) δH 8.31-8.28 (2H, m), 8.20 (1H, s, ThC4-H), 
8.11-8.08 (2H, m), 7.78-7.72 (4H, m);  13C NMR (90 MHz, CDCl3) δC 167.31 (quat, 
ThC2), 147.36 (quat), 141.73 (CH), 137.57 (quat), 137.30 (quat), 136.14 (quat), 
132.17 (quat, q, J = 32.8, CArCF3), 127.06 (2CH), 126.76 (2CH), 126.13 (2CH, q, J = 
3.6, 2CHCArCF3), 124.60 (2CH), 123.74 (quat, q, J = 272.4, CArCF3);  19F NMR (235 
MHz, CDCl3) δF -64.0 (3F, s);  IR (thin film, cm-1) νmax 1594, 1521, 1340, 1322, 
1133, 1110, 1065, 845, 751, 688, 631;  HRMS (EI) calculated for [C16H9N2O2F3S]+  













Following general procedure C, with 2-(4-
trifluoromethylphenyl)thiazole (100 mg, 0.436 mmol, 1 
equiv) and 4-iodoanisole (123 mg, 0.524 mmol, 1.2 
equiv), purification by column chromatography (0-2% acetone/CH2Cl2) afforded the 
title compound as a yellow solid (108 mg, 74% yield).  MP (CHCl3) 160°C;  1H 
NMR (360 MHz, CDCl3) δH 8.07-8.04 (2H, m), 7.96 (1H, s, ThC4-H), 7.71-7.69 (2H, 
m), 7.56-7.51 (2H, m), 6.98-6.94 (2H, m), 3.85 (3H, s, OCH3);  13C NMR (90 MHz, 
CDCl3) δC 164.09 (quat, ThC2), 160.04 (quat, CArOCH3), 140.55 (quat), 138.60 (CH, 
ThC4-H), 136.83 (quat), 131.31 (quat, q, J = 32.7, CArCF3), 128.09 (2CH), 126.38 
(2CH), 125.95 (2CH, q, J = 3.8, 2CHCArCF3), 123.92 (quat, q, J = 272.2, CArCF3), 
123.55 (quat), 114.60 (2CH), 55.39 (CH3);  19F NMR (250 MHz, CDCl3) δF -64.0 
(3F, s);  IR (thin film, cm-1) νmax 3054, 2986, 1325, 1265, 1067, 896, 741, 706;  
HRMS (EI) calculated for [C17F3H12NOS]+ 335.0592, found 335.0588.   
5-(4-Chlorophenyl)-2-(4-methylphenyl)thiazole 65ai 
Following general procedure C with 2-(4-
methylphenyl)thiazole (100 mg, 0.570 mmol, 1 equiv) and 
4-iodonitrobenzene (154 mg, 0.646 mmol, 1.2 equiv), 
purification by column chromatography (10-20% ethyl acetate/hexane) afforded the 
title compound as a yellow solid (139 mg, 85% yield).  MP (CHCl3) 151°C;  1H 
NMR (360 MHz, CDCl3) δH 7.95 (1H, s, ThC4-H), 7.85-7.83 (2H, m), 7.51-7.47 (2H, 
m), 7.38-7.34 (2H, m), 7.25-7.23 (2H, m), 2.39 (3H, s, CArCH3);  13C NMR (90 MHz, 
CDCl3) δC 167.67 (quat, ThC2), 140.44 (quat), 139.26 (CH, ThC4-H), 137.38 (quat), 
133.91 (quat), 130.80 (quat), 129.95 (quat), 129.64 (2CH), 129.20 (2CH), 127.66 
(2CH), 126.25 (2CH), 21.41 (CH3);  IR (thin film, cm-1) νmax 3054, 2986, 1483, 1421, 
1265, 896, 828, 747, 705;  HRMS (EI) calculated for [C16H1235ClNS] 285.0379, 













Following general procedure C, with 2-(4-
methylphenyl)thiazole (100 mg, 0.570 mmol, 1 equiv) and 
4-iodotoluene (141 mg, 0.646 mmol, 1.2 equiv),  
purification by column chromatography (10-20% ethyl acetate/hexane) afforded the 
title compound as a yellow solid (147 mg, 97% yield).  MP (CHCl3) 144°C;  1H 
NMR (360 MHz, CDCl3) δH 7.96 (1H, s, ThC4-H), 7.87-7.84 (2H, m), 7.50-7.48 (2H, 
m), 7.26-7.21 (4H, m), 2.40 (3H, s, CH3), 2.39 (3H, s, CH3);  13C NMR (90 MHz, 
CDCl3) δC 166.87 (quat, TC2), 140.12 (quat), 138.88 (quat), 138.52 (CH, ThC4-H), 
138.19 (quat), 131.08 (quat), 129.71 (2CH), 129.60 (2CH), 128.61 (quat), 126.48 
(2CH), 126.20 (2CH), 21.40 (CH3), 21.21 (CH3);  IR (thin film, cm-1) νmax 3053, 
2986, 1493, 1421, 1265, 896, 819, 741;  HRMS (EI) calculated for [C17H15NS] 
265.0925, found 265.0925.   
5-(4-Nitrophenyl)-2-(4-methylphenyl)thiazole 65ak 
Following general procedure C with 2-(4-
methylphenyl)thiazole (100 mg, 0.570 mmol, 1 equiv) 
and 4-iodonitrobenzene (171 mg, 0.646 mmol, 1.2 equiv), 
purification by column chromatography (10-50% ethyl acetate/hexane) afforded the 
title compound as a yellow solid (68 mg, 40% yield).  MP (CHCl3) 173°C;  1H NMR 
(360 MHz, CDCl3) δH 8.28-8.24 (2H, m), 8.12 (1H, s, ThC4-H), 7.88-7.83 (2H, m), 
7.74-7.70 (2H, m), 7.28-7.26 (2H, m), 2.41 (3H, s, CH3);  13C NMR (90 MHz, CDCl3) 
δC 169.67 (quat, ThC2), 146.94 (quat), 141.31 (CH, ThC4-H), 141.18 (quat), 137.84 
(quat), 135.98 (quat), 130.42 (quat), 129.76 (2CH), 126.72 (2CH), 126.45 (2CH), 
124.49 (2CH), 21.47 (CH3);  IR (thin film, cm-1) νmax 3055, 2986, 1598, 1519, 1434, 
1347, 1328, 1264, 1109, 896, 840, 817, 738, 633;  HRMS (EI) calculated for 













Following general procedure C with 2-(4-
methylphenyl)thiazole (100 mg, 0.570 mmol, 1 equiv) 
and 4-iodoanisole (151 mg, 0.646 mmol, 1.2 equiv), 
purification by column chromatography (10-20% ethyl acetate/hexane) afforded the 
title compound as a yellow solid (124 mg, 77% yield).  1H NMR (360 MHz, CDCl3) 
δH 7.89 (1H, s, ThC4-H), 7.85-7.83 (2H, m), 7.53-7.49 (2H, m), 7.26-7.23 (2H, m), 
6.95-6.91 (2H, m), 3.83 (3H, s, OCH3), 2.39 (3H, s, CH3);  13C NMR (90 MHz, 
CDCl3) δC 166.40 (quat), 159.62 (quat), 139.99 (quat), 138.62 (quat), 137.95 (CH), 
131.07 (quat), 129.55 (2CH), 127.83 (2CH), 126.11 (2CH), 124.04 (quat), 114.43 
(2CH), 55.29 (OCH3), 21.36 (CH3).   
2-Isobutyl-5-phenylthiazole93 251e 
Following general procedure D with 2-isobutylthiazole (100 mg, 
0.708 mmol, 1 equiv ) and iodobenzene (173 mg, 0.850 mmol, 
1.2 equiv), purification by column chromatography (0-5% ethyl 
acetate/hexane) gave the title compound as a colourless oil (153 mg, quantitative 
yield).  1H NMR (360 MHz, CDCl3) δH 7.82 (1H, s, ThC4-H), 7.51 (2H, m), 7.37-
7.33 (2H, m), 7.28 (1H, m), 2.86 (2H, d, J = 7.2, CH2), 2.14 (1H, m, CH), 1.01 (6H, 
d, J = 6.6, 2CH3);  13C NMR (90 MHz, CDCl3) δC 169.46 (quat, ThC2), 138.32 
(quat), 137.44 (CH, ThC4-H), 131.51 (CH), 128.85 (2CH), 127.79 (CH), 126.41 
(2CH), 42.39 (CH2), 29.67 (CH), 22.17 (2CH3).   
4,5-Di(4-chlorophenyl)-2-phenylthiazole93 248a 
Following general procedure D with 4-(4-chlorophenyl)-2-
phenylthiazole (100 mg, 0.368 mmol, 1 equiv) and 
iodochlorobenzene (105 mg, 0.442 mmol, 1.2 equiv), 
purification by column chromatography (10% ethyl 
acetate/hexane) gave the title compound as a colourless solid (118 mg, 83% yield).  
1H NMR (360 MHz, CDCl3) δH 8.01-7.98 (2H, m), 7.55-7.51 (2H, m), 7.48-7.45 (3H, 













(quat), 134.45 (quat), 133.96 (quat), 133.30 (quat), 133.10 (quat), 131.95 (quat), 
130.80 (2CH), 130.37 (2CH), 130.28 (CH), 130.27 (quat), 129.16 (2CH), 128.98 
(2CH), 128.62 (2CH), 126.43 (2CH).   
2,4-Dimethyl-5-phenylthiazole 251h 
Following general procedure D with 2,4-dimethylthiazole (100 mg, 
0.884 mmol, 1 equiv) and iodobenzene (216 mg, 1.060 mmol, 1.2 
equiv), purification by column chromatography (20% ethyl 
acetate/hexane) gave the title compound as a yellow oil (140 mg, 84% yield).  1H 
NMR (360 MHz, CDCl3) δH 7.43-7.31 (5H, m), 2.70 (3H, s, ThC2CH3), 2.49 (3H, m, 
ThC4CH3);  13C NMR (90 MHz, CDCl3) δC 163.02 (quat, ThC2), 146.86 (quat), 
132.17 (quat) 131.18 (quat), 128.94 (2CH), 128.46 (2CH), 127.27 (CH), 18.93 (CH3, 
ThC2CH3), 15.89 (CH3, ThC4CH3);  IR (thin film, cm-1) νmax 3057, 2922, 1601, 1494, 
1438, 1377, 1250, 1180, 7589, 698;  HRMS (FAB) calculated for [C11H11NS+H]+ 
190.0691, found 190.0690.   
1-(5-Phenylthiazol-2-yl)ethanone 251f 
Following general procedure D with 2-acetylthiazole (100 mg, 
0.786 mmol, 1 equiv) and iodobenzene (193 mg, 0.944 mmol, 1.2 
equiv), purification by column chromatography (10% ethyl 
acetate/hexane) gave the title compound as a colourless solid (113 mg, 70% yield).  
MP (CHCl3) 113-115°C;  1H NMR (360 MHz, CDCl3) δH 8.13 (1H, s, ThC4-H), 
7.64-7.62 (2H, m), 7.47-7.41 (3H, m), 2.72 (3H, s, COCH3);  13C NMR (90 MHz, 
CDCl3) δC 191.69 (quat, COCH3), 165.47 (quat, ThC2), 147.10 (quat), 140.17 (CH), 
130.47 (quat), 129.57 (CH), 129.32 (2CH), 127.19 (2CH), 25.67 (CH3, COCH3);  IR 
(thin film, cm-1) νmax 1681, 1450, 1421, 1406, 1261, 1056, 1019, 760, 687;  HRMS 
(FAB) calculated for [C11H9NOS+H]+ 204.0483, found 204.0481.   
2-Phenylbenzothiazole174 251a 
Following general procedure D with benzothiazole (100 mg, 0.740 
mmol, 1 equiv) and iodobenzene (181 mg, 0.888 mmol, 1.2 equiv), 













compound as a colourless solid (156 mg, quantitative yield).  1H NMR (360 MHz, 
CDCl3) δH 8.12-8.09 (3H, m), 7.89 (1H, m), 7.52-7.48 (4H, m), 7.38 (1H, m);  13C 
NMR (90 MHz, CDCl3) δC 167.96 (quat, N=C-S), 154.05 (quat), 134.97 (quat), 
133.52 (quat), 130.87 (CH), 128.92 (2CH), 127.46 (2CH), 126.22 (CH), 125.09 (CH), 
123.14 (CH), 121.53 (CH).   
2-Phenylbenzoxazole174 251b 
Following general procedure D with benzoxazole (100 mg, 0.839 
mmol, 1 equiv) and iodobenzene (206 mg, 1.007 mmol, 1.2 equiv), 
purification by column chromatography (20% ethyl acetate/hexane) gave the title 
compound as a colourless solid (130 mg, 79% yield).  1H NMR (360 MHz, CDCl3) 
δH 8.26-8.23 (2H, m), 7.78 (1H, m), 7.55 (1H, m), 7.49-7.47 (3H, m), 7.33-7.31 (2H, 
m);  13C NMR (90 MHz, CDCl3) δC 162.85 (quat, N=C-O), 150.60 (quat), 141.98 
(quat), 131.34 (CH), 128.74 (2CH), 127.46 (2CH), 127.02 (quat), 124.94 (CH), 
124.42 (CH), 119.87 (CH), 110.44 (CH).   
N-Methyl-2-phenylbenzimidazole175 251c 
Following general procedure D with N-methylbenzimidazole (100 
mg, 0.757 mmol, 1 equiv) and iodobenzene (185 mg, 0.908 mmol, 
1.2 equiv), purification by column chromatography (50% ethyl 
acetate/hexane) gave the title compound as a colourless solid (157 mg, quantitative 
yield).  1H NMR (360 MHz, CDCl3), δH 7.83 (1H, m), 7.72-7.69 (2H, m), 7.49-7.44 
(3H, m), 7.32-7.29 (3H, m), 3.74 (3H, s, NCH3);  13C NMR (90 MHz, CDCl3) δC 
153.43 (quat, N-C=N), 142.62 (quat), 136.29 (quat), 129.87 (quat), 129.46 (CH), 
129.14 (2CH), 128.40 (2CH), 122.50 (CH), 122.16 (CH), 119.46 (CH), 109.45 (CH), 
31.37 (NCH3).   
2,5-Diphenyloxazole176 251i 
Following general procedure D with 2-phenyloxazole (100 mg, 
0.689 mmol, 1 equiv) and iodobenzene (169 mg, 0.827 mmol, 1.2 
equiv), purification by column chromatography (CH2Cl2) gave 










CDCl3) δH 8.13-8.11 (2H, m), 7.74-7.72 (2H, m), 7.52-7.43 (6H, m), 7.35 (1H, m);  
13C NMR (90 MHz, CDCl3) δC 161.13 (quat, OxC2), 151.24 (quat), 130.31 (CH, 
OxC4-H), 128.92 (2CH), 128.80 (2CH), 128.42 (CH), 128.00 (quat), 127.43 (quat), 
126.26 (2CH), 124.18 (2CH), 123.43 (CH).   
2-Methoxy-5-phenylthiophene177 251g 
Following general procedure D with 2-methoxythiophene (100 mg, 
0.876 mmol, 1 equiv) and iodobenzene (214 mg, 1.051 mmol, 1.2 
equiv), purification by column chromatography (5% ethyl acetate/hexane) gave the 
title compound as a colourless oil (136 mg, 82% yield).  1H NMR (360 MHz, CDCl3) 
δH 7.55-7.53 (2H, m, Ph), 7.40-7.35 (2H, m, Ph), 7.26 (1H, m, Ph), 7.00 (1H, d, J = 
4.0, Th), 6.22 (1H, d J = 4.0, Th), 3.94 (3H, s, OCH3);  13C NMR (90 MHz, CDCl3) 
δC 165.88 (quat, ThC2OMe), 134.65 (quat) 130.13 (quat), 128.73 (2CH), 126.51 
(CH), 124.76 (2CH), 120.48 (CH), 104.66 (CH), 60.08 (OCH3).   
2-Phenyloxazole178 51f 
Benzamide (5.00 g, 0.041 mol, 1 equiv) was dissolved in acetic 
anhydride (10 mL) under N2.  Chloroacetaldehyde monohydrate5 (6.40 
g, 0.082 mmol, 2 equiv) was added dropwise and the reaction mixture heated to 50 
°C.  The solution was further heated to reflux for 5 hr, then concentrated in vacuo to 
a brown oil.  Water (40 mL) was added and the pH adjusted (to pH 8) with NaOH 
(1.0 M, ~40 mL).  The product was extracted into CH2Cl2 (2 × 40 mL) then dried 
with brine (40 mL) and over MgSO4, and finally concentrated to a brown oil.  
Purification by column chromatography (5% ethyl acetate/hexane) afforded the title 
compound as a brown oil (3.51 g, 59% yield).  1H NMR (360 MHz, CDCl3) δH  8.12-
8.08 (2H, m), 7.74 (1H, d, J = 0.7, OxC4-H), 7.53-7.47 (3H, m), 7.18 (1H, d, J = 0.7, 
OxC5-H);  13C NMR (90 MHz, CDCl3) δC 167.76 (quat, O-C=N), 138.37 (CH, 
OxC4-H), 130.14 (CH), 128.35 (2CH), 128.21 (CH), 127.29 (quat), 126.14 (2CH).   
                                                 
5 Chloroacetaldehyde monohydrate was isolated from the commercially available aqueous solution 
(50%) by stirring for 1 hr with anhydrous calcium chloride (approximately 0.35 g per mL) and 








4-Iodochlorobenzene (178 mg, 0.744 mmol, 1.2 equiv), 
Cs2CO3 (303 mg, 0.930 mmol, 1.5 equiv), Pd2(dba)3 (14 mg, 
0.016 mmol, 0.025 equiv), PPh3 (16 mg, 0.062 mmol, 0.10 equiv) and AgF (157 mg, 
1.240 mmol, 2 equiv) were combined in MeCN (5 mL) together with 2-
phenylthiazole (100 mg, 0.620 mmol, 1 equiv) and heated to 100 °C under 
microwave radiation for 2 hr.  The reaction mixture was filtered through celite, 
washed with CH2Cl2 and acetone and concentrated in vacuo.  Following 
chromatography (5% ethyl acetate/hexane) the product was isolated as a colourless 
solid, (77 mg, 92% yield6).  1H NMR (360 MHz, CDCl3) δH 7.44-7.30 (8H, q t, J = 
9.1, 4.3);  13C NMR (90 MHz, CDCl3) δC 138.83 (2 quat), 134.14 (2 quat), 129.44 
(4CH), 128.62 (4CH).   
5-(4’-Chlorophenyl)-2-phenyloxazole180 251j 
Following general procedure C using 2-phenyloxazole (100 
mg, 0.689 mmol, 1 equiv), 4-iodochlorobenzene (197 mg, 
0.827 mmol, 1.2 equiv), Cs2CO3 (337 mg, 1.033 mmol, 1.5 
equiv), Pd2(dba)3 (16 mg, 0.017 mmol, 0.025 equiv), PPh3 (18 mg, 0.069 mmol, 0.10 
equiv) and AgF (175 mg, 1.378 mmol, 2 equiv), were heated at 60 °C for 120 hr.  
Following purification by column chromatography (2% ethyl acetate/hexane) the title 
compound was isolated as a colourless solid (76 mg, 43% yield).  1H NMR (360 
MHz, CDCl3) δH 8.05-8.01 (2H, m), 7.59 (2H, m), 7.43-7.33 (6H, m);  13C NMR (90 
MHz, CDCl3) δC 161.78 (quat, O-C=N), 150.67 (quat), 134.59 (quat), 130.93 (CH, 
OxC4-H), 129.63 (2CH), 129.27 (2CH), 127.63 (quat), 126.90 (quat), 126.74 (2CH), 
125.81 (2CH), 124.22 (CH).   
                                                 









Sodium acetate (5.10 g, 0.062 mol, 2 equiv) and 2-phenylthiazole 
(5.00 g, 0.031 mol, 1 equiv) were dissolved in glacial acetic acid 
(25 mL) and bromine (1.59 mL, 0.031 mol, 1 equiv) was added 
dropwise.  After 2 hr starting material remained and further bromine (3.18 mL, 0.062 
mol, 2 equiv) was added and the reaction was left to stir for 3 days.  Sodium 
thiosulfate (30 mL) was added to quench the unreacted bromine followed by NaOH 
(1.0 M, ~40 mL) to adjust to pH 9 and the aqueous phase was extracted into CH2Cl2 
(200 mL).  The organics were washed with brine, dried over MgSO4 and 
concentrated in vacuo to a yellow solid.  Purification by column chromatography 
(2% ethyl acetate/hexane) gave the title compound as a colourless solid (4.02 g, 54% 
yield).  1H NMR (360 MHz, CDCl3) δH 7.87-7.84 (2H, m), 7.73 (1H, s, ThC4-H), 
7.44-7.41 (3H, m);  13C NMR (90 MHz, CDCl3) δC 169.42 (quat, ThC2), 144.76 (CH, 
ThC4-H), 132.99 (quat), 130.31 (CH), 128.95 (2CH), 126.12 (2CH), 108.44 (quat, 
ThC5-Br).   
Methyl 2-phenylthiazole-5-carboxylate 263 
2-Phenylthiazole (200 mg, 1.240 mmol, 1 equiv) was dissolved 
in tetrahydrofuran (5 mL) at -78°C.  nBuLi (0.775 mL, 1.6 M in 
hexanes, 1.240 mmol, 1 equiv) was added dropwise causing the 
colourless solution to become pale yellow.  This was stirred at -78°C for 15 min 
followed by dropwise addition of methylchloroformate (115 μL, 1.490 mmol, 1.2 
equiv).  After a further 15 min at -78°C no reaction was observed and the reaction 
was warmed to ambient temperature and stirred for 30 min.  NH4Cl(sat.aq) (20 mL) 
was added together with ethyl acetate (20 mL) and the phases separated.  The 
aqueous phase was extracted with ethyl acetate (20 mL), then the combined organics 
were washed with brine (40 mL), dried over MgSO4, filtered and concentrated in 
vacuo.  Purification by recrystallisation from diethylether gave the title compound as 
a colourless solid (266 mg, yield 98%).  MP (Et2O) 102°C;  1H NMR (360 MHz, 
CDCl3) δH 8.21 (1H, s, ThC4-H), 7.78-7.74 (2H, m), 7.25-7.11 (3H, m), 3.70 (3H, s, 









ThC4-H), 133.87 (quat), 132.23 (CH), 130.13 (2CH), 129.53 (quat), 127.91 (2CH), 
53.52 (CO2CH3);  IR (thin film, cm-1) νmax 3399, 1996, 1708, 1518, 1454, 1313, 1254, 
1150, 1092, 902, 751;  HRMS (ES +ve) calculated for [C11H9NO2S+H]+ 220.0427, 
found 220.0426.   
2-Phenylthiazole-5-carboxylic acid182 301 
Methyl 2-phenylthiazole-5-carboxylate (1.00 g, 4.561 mmol, 1 
equiv) was dissolved in methanolic KOH (1.0 M, 10 mL) and 
heated to reflux for 10 min.  The resulting potassium salt was 
recovered by filtration then CH2Cl2 (20 mL) and water (20 mL) were added to the 
solid and the pH of the aqueous layer adjusted to pH 2 with HCl (2.0 M, ~5 mL).  
The layers were separated and the organics dried over MgSO4 and concentrated in 
vacuo to give the title compound as a white solid (0.94 g, quantitative yield).  1H 
NMR (360 MHz, CD3OD) δH 8.34 (1H, s, ThC4-H), 7.98-7.95 (2H, m), 7.51-7.44 
(3H, m);  13C NMR (90 MHz, CDCl3) δC 174.45 (quat), 163.55 (quat), 149.53 (CH, 
ThC4-H), 133.68 (quat), 132.06 (CH), 129.93 (2CH), 127.51 (2CH).  (One 
quaternary not found).   
N,2-Diphenylthiazole-5-carboxamide93 269 
2-Phenylthiazole-5-carboxylic acid (3.00 g, 0.014 mol, 1 
equiv) was suspended in thionyl chloride (25 mL) and heated 
to reflux for 45 min under N2.  Excess thionyl chloride was 
removed under vacuum and the last traces removed by a stream of dry N2 being 
passed over the solid for 2 hr.  The solid was then suspended in dry CH2Cl2 under N2 
and aniline (5.0 mL, 0.058 mmol, 4 equiv) was added dropwise with cooling.  The 
suspension was concentrated in vacuo and the resultant solid stirred with diethyl 
ether (50 mL) overnight and the title compound collected by filtration as an off white 
solid (3.27 g, 81% yield).  1H NMR (360 MHz, CDCl3) δH 10.48 (1H, s, NH), 8.69 
(1H, s, ThC4-H), 8.04-8.01 (2H, m), 7.74-7.72 (2H, d, J = 7.6), 7.55-7.53 (3H, m), 
7.38 (2H, t, J = 7.9), 7.13 (1H, t, J = 7.4);  13C NMR (90 MHz, CDCl3) δC 170.71 











(quat), 132.45 (quat), 131.12 (CH), 129.32 (2CH), 128.71 (2CH), 126.47 (2CH), 
124.07 (CH), 120.40 (2CH).   
 
4-(4’-Chlorophenyl)-2-phenylthiazole 270 
Thiobenzamide (5.00 g, 0.036 mol, 1 equiv) was dissolved in 
acetic anhydride (20 mL) and toluene (20 mL) and 4’-chloro-
2-bromoacetophenone (10.20 g, 0.044 mol, 1.2 equiv) was 
added in portions.  The solution was heated to reflux for 30 min then cooled to 
ambient temperature. Water was added and the pH was adjusted to pH 9 with NaOH 
(5.0 M, ~30 mL).  The product was extracted into CH2Cl2 (2 × 100 mL), washed 
with brine (150 mL),  dried over MgSO4 and finally concentrated to a brown solid.  
Purification by column chromatography (2% ethyl acetate/hexane) provided the title 
compound as a yellow solid (5.35 g, 54% yield).  MP (ethyl acetate) 130°C;  1H 
NMR (360 MHz, CDCl3) δH 8.05-8.02 (2H, m), 7.95-7.91 (2H, m), 7.50-7.39 (6H, 
m);  13C NMR (90 MHz, CDCl3) δC 168.02 (quat, ThC2), 154.96 (quat, ThC4), 
133.84 (quat), 133.49 (quat), 132.92 (quat), 130.11 (CH), 128.89 (2CH), 128.82 
(2CH), 127.63 (2CH), 126.53 (2CH), 112.83 (CH);  IR (thin film, cm-1) νmax 3054, 
2986, 1476, 1440, 1265, 1091, 1055, 1014, 979, 897, 838, 739, 708;  HRMS (EI) 
Calculated for [C15H1035ClNS]+ 271.0222, found 271.0216.   
Methyl 4-(4’-chlorophenyl)-2-phenylthiazole-5-carboxylate 302 
4-(4’-Chlorophenyl)-2-phenylthiazole (1.00 g, 3.680 mmol, 1 
equiv) was dissolved in tetrahydrofuran (50 mL) at -78 °C.  
nBuLi (2.30 mL, 1.6 M in hexanes, 3.680 mmol, 1 equiv) was 
added dropwise causing the colourless solution to become pale 
yellow.  This was stirred at -78 °C for 15 min followed by dropwise addition of 
methylchloroformate (0.43 mL, 5.520 mmol, 1.5 equiv) causing a solid to precipitate.  
After a further 15 min at -78 °C the reaction mixture was warmed to ambient 
temperature causing the solid to dissolve and stirred for 15 min.  The reaction was 
quenched by dropwise addition of NH4Cl(sat.aq) (50 mL) together with ethyl acetate 
(50 mL) and the phases separated.  The aqueous phase was extracted with ethyl 











over MgSO4, filtered and concentrated in vacuo.  The yellow solid was recrystallised 
from diethylether to provide the product as a colourless solid (1.15 g, 95% yield).  
MP (Et2O) 162°C;  1H NMR (360 MHz, CDCl3) δH 8.04-8.01 (2H, m), 7.83-7.80 (2H, 
m), 7.50-7.42 (5H, m), 3.85 (3H, s, OCH3);  13C NMR (90 MHz, CDCl3) δC 171.23 
(quat, CO2CH3), 162.93 (quat, ThC2), 160.80 (quat, ThC4), 136.36 (quat), 133.70 
(quat), 133.50 (quat), 132.41 (CH), 132.40 (2CH), 130.17 (2CH), 129.13 (2CH), 
127.99 (2CH), 122.97 (quat), 53.54 (OCH3);  IR (thin film, cm-1) νmax 1996, 1731, 
1481, 1429, 1325, 1272, 1141, 1079, 838, 763;  HRMS (EI) calculated for 
[C17H1235ClNO2S]+ 329.0277, found 329.0268.   
4-(4-Chlorophenyl)-N,2-diphenylthiazole-5-carboxamide 298 
Methyl 4-(4’-Chlorophenyl)-2-phenylthiazole-5-carboxylate 
(1.00 g, 3.030 mmol, 1 equiv) was dissolved in methanolic 
KOH (1.0 M, 20 mL) and heated to reflux for 10 min.  The 
resulting potassium salt was recovered by filtration then 
CH2Cl2 (20 mL) and water (20 mL) were added to the solid and the pH of the 
aqueous layer adjusted to pH 2 with HCl (2.0 M, ~10 mL).  The layers were 
separated and the organics dried over MgSO4 and concentrated in vacuo to give the 
free acid in quantitative yield as a white solid.  This was suspended in thionyl 
chloride (25 mL) and heated to reflux for 45 min under N2.  Excess thionyl chloride 
was removed under vacuum and the last traces removed by a stream of dry N2 being 
passed over the solid for 2 hr.  The solid was then suspended in dry CH2Cl2 under N2 
and aniline (2 mL, 22.7 mmol, 7.5 equiv) was added dropwise with cooling.  The 
suspension was concentrated in vacuo and the resultant solid stirred with toluene (20 
mL) overnight and the title compound collected by filtration as a cream solid and 
recrystallised from toluene to give an off white solid (1.04 g, 88% over two steps).  
MP (toluene) 164°C;  1H NMR (360 MHz, CDCl3) δH 8.03-8.00 (2H, m), 7.78-7.44 
(2H, m), 7.55-7.45 (5H, m), 7.43 (1H, br s, NH), 7.32-7.30 (2H, m), 7.15-7.11 (1H, 
m);  13C NMR (90 MHz, CDCl3) δC 169.59 (quat, CO2NHPh), 153.34 (quat, ThC2), 
142.27 (quat, ThC4), 137.02 (quat), 136.09 (quat), 132.63 (quat), 132.13 (quat), 
131.19 (CH), 130.98  (2CH), 130.12 (quat), 129.37 (2CH), 129.17 (2CH), 129.12 









νmax 3304, 1641, 1519, 1442, 1335, 1092, 890, 838, 753, 739;  HRMS (ES+ve) 
calculated for [C22H1535ClN2OS+H]+ 391.0666, found 391.0665.   
3-Benzylthiazolium bromide183 279 
Thiazole (100 mg, 1.180 mmol, 1 equiv) and benzyl bromide (2.5 mL) 
were heated in a microwave for 15 min at 150°C.  The solution was 
concentrated in vacuo and the solid triturated in cold MeCN (5 mL) and 
washed with Et2O to give the product as a yellow solid (228 mg, 76% 
yield).  1H NMR (360 MHz, CD3OD) δH 10.24 (1H, m, ThC2-H), 8.49 (1H, m, ThC4-
H), 8.31 (1H, m, ThC5-H), 7.54-7.45 (5H, m), 5.83 (2H, s);  13C NMR (90 MHz, 
CDCl3) δC 160.10 (CH, ThC2-H), 138.34 (quat), 134.30 (CH), 130.93 (CH), 130.68 
(2CH), 130.20 (2CH), 128.01 (CH), 59.64 (CH2).   
2-Phenylthiazole-3-oxide181 55 
2-Phenylthiazole (1.00 g, 6.203 mmol, 1 equiv) was dissolved in ethyl 
acetate (6 mL) at ambient temperature and an ice cold solution of 
mCPBA (2.14 g, 12.406 mmol, 2 equiv) in ethyl acetate (3 mL) was 
added dropwise.  The reaction was left to stir for 5 days at ambient temperature.  The 
reaction mixture was partitioned between CH2Cl2 (50 mL) and NaOH (1.0 M, 50 
mL).  The combined aqueous layers were extracted with CHCl3 (3 × 50 mL), dried 
over MgSO4 and concentrated in vacuo.  The residue was dissolved in ethyl acetate 
(10 mL), loaded onto silica, washed with ethyl acetate (50 mL) to elute the remaining 
starting material (0.66 g, 66%) and then with ethyl acetate/methanol (1:1, 100 mL) to 
elute the product, which was obtained as a pale yellow oil that crystallised on 
standing (0.37 g, 34% yield).  1H NMR (360 MHz, CDCl3) δH 8.27-8.24 (2H, m), 
7.65 (1H, d, J = 4.0, ThC4-H), 7.45-7.38 (3H, m), 7.24 (1H, d, J = 4.0, ThC5-H);  13C 
NMR (90 MHz, CDCl3) δC 143.49 (quat, ThC2), 139.22 (CH, ThC4-H), 130.39 (CH), 










3-Diisopropylcarbamoyloxy-2-phenylthiazol-3-ium chloride 288 
2-Phenylthiazole-3-oxide (200 mg, 1.129 mmol, 1 equiv) was 
dissolved in tetrahydrofuran (2 mL) at ambient temperature.  
Diisopropylcarbamoyl chloride  (369 mg, 2.257 mmol, 2 equiv) was 
added as a solution in tetrahydrofuran (4 mL) dropwise and the 
reaction stirred at ambient temperature for 1 hr.  The product was collected by 
filtration and washed with diethylether (50 mL) to give a white solid (383 mg, 
quantitative yield).  MP (tetrahydrofuran) 136°C decomp.;  1H NMR (360 MHz, 
CDCl3) δH 8.97 (1H, d, J = 4.2, ThC4-H), 8.72 (1H, d, J = 4.2, ThC5-H), 7.71-7.63 
(3H, m), 7.57-7.53 (2H, m), 4.22 (1H, sept, J = 6.7, CH), 3.56 (1H, sept, J = 6.7, 
CH), 1.79 (6H, d, J = 6.7, 2 CH3), 1.10 (6H, d, J = 6.7, 2 CH3);  13C NMR (90 MHz, 
CDCl3) δC 165.75 (quat, ThC2), 147.15 (quat, CO2NiPr2), 134.39 (CH), 133.91 (CH), 
129.68 (2CH), 129.17 (2CH), 126.54 (CH), 122.94 (quat), 48.69 (CH), 47.75 (CH), 
20.61 (2CH3), 19.69 (2CH3); IR (thin film, cm-1) νmax 3398, 2976, 2717, 2476, 1780, 
1631, 1539, 1453, 1430, 1374, 1303, 1203, 1155, 1114, 1036, 1015, 985, 924, 883, 
859, 835, 764, 732;  MS: this compound decomposed to 2-phenylthiazole-3-oxide 
under FAB, ES and EI conditions, as such HRMS was unobtainable.   
5-(4’-Chlorophenyl)-2-phenylthiazole-N-oxide 291 
5-(4-Chlorophenyl)-2-phenylthiazole (1.00 g, 3.680 mmol, 1 
equiv) was dissolved in CH2Cl2 (10 mL) at ambient 
temperature and an ice cold solution of mCPBA (1.81 g, 7.359 
mmol, 2 equiv) in CH2Cl2 (5 mL) was added dropwise.  The 
reaction was left to stir for 5 days at ambient temperature.  The reaction mixture was 
partitioned between CH2Cl2 (50 mL) and NaOH (1.0 M, 2 × 25 mL).  The combined 
aqueous layers were extracted with CH2Cl2 (3 × 50 mL),the organics were dried over 
MgSO4 and concentrated in vacuo.  Following purification by column 
chromatography (5% methanol/ethyl acetate) the title compound was isolated as a 
colourless solid (95 mg, 9% yield).  MP (CHCl3) 168°C;  1H NMR (360 MHz, 
CDCl3) δH 8.33-8.30 (2H, m), 7.92 (1H, s), 7.48-7.39 (7H, m);  13C NMR (90 MHz, 














129.63 (2CH), 128.84 (2CH), 127.61 (quat), 127.35 (quat), 126.96 (2CH), 126.80 
(2CH);  IR (thin film, cm-1) νmax 3043, 1358, 1241, 1207, 820, 803, 747, 681, 648;  
HRMS (EI) calculated for [C15H1035ClNOS]+ 287.0166, found 287.0163.   
5-(4’-Chlorophenyl)-4-(2’-pyridyl)-2-phenylthiazole 292c 
2-(2-Phenylthiazol-5-yl)pyridine (100 mg, 0.420 mmol) was 
dissolved in toluene (5 mL) together with Pd(dppf)Cl2⋅CH2Cl2 
(17 mg, 0.021 mmol), P(tBu)2biphenyl (13 mg, 0.042 mmol), 
Cs2CO3 (410 mg, 1.259 mmol) and 4-iodochlorobenzene (200 
mg, 0.839 mmol) and heated to reflux for 3 days.  The reaction mixture was cooled 
to ambient temperature and filtered through celite.  The filtrate was concentrated in 
vacuo and purified by column chromatography (30% Et2O/hexanes) to afford the title 
compound as a pale yellow solid (94 mg, 64% yield).  MP (Et2O) 106°C;  1H NMR 
(360 MHz, CDCl3) δH 8.63 (1H, ddd, J = 1.1, 1.8, 4.9), 8.04-8.01 (2H, m), 7.61-7.58 
(2H, m), 7.52 (1H, ddd, J = 1.8, 7.6, 8.1), 7.47-7.43 (3H, m), 7.41-7.37 (2H, m), 7.24 
(1H, ddd, J = 1.1, 1.1, 8.1), 7.17 (1H, ddd, J = 1.1, 4.9, 7.6);  13C NMR (90 MHz, 
CDCl3) δC 167.55 (quat, ThC2), 151.26 (quat), 151.05 (quat), 149.87 (CH), 136.26 
(CH), 134.73 (quat), 134.51 (quat), 133.80 (quat), 133.39 (quat), 130.68 (2CH), 
130.33 (CH), 128.94 (2CH), 128.86 (2CH), 128.50 (2CH), 122.40 (CH), 122.29 
(CH);  IR (thin film, cm-1) νmax 3398, 2067, 1996, 1709, 1519, 1456, 1313, 1254, 
1151, 1093, 751;  HRMS (EI) calculated for [C20H1335ClN2S]+ 348.0488, found 
348.0472.   
2-Phenylthiazole-5-carboxylic acid quinolin-8-ylamide 309 
2-Phenylthizole-5-carboxylic acid (200 mg, 0.975 mmol, 1 
equiv), was suspended in thionyl chloride (1.67 mL) and 
the mixture was refluxed for 45 min under nitrogen.  
Excess thionyl chloride was removed under vacuum and the last traces removed by a 
stream of dry nitrogen being passed over the solid for 2 hr.  The solid was then 
suspended in CH2Cl2 (5 mL) under a nitrogen atmosphere and 8-aminoquinoline 
(560 mg, 3.898 mmol, 4 equiv) was added slowly with cooling.  The suspension was 












overnight and collected by filtration.  The product was dissolved in CH2Cl2 to 
remove an insoluble impurity, purified by column chromatography (0-5% 
methanol/CH2Cl2) and recrystallised from chloroform to give the title compound as a 
green solid (82 mg, 30%).   
Alternative Method   
2-Phenylthiazole-5-carboxylic acid (100 mg, 0.487 mmol, 1 equiv), EDCI (112 mg, 
0.585 mmol, 1.2 equiv), CH2Cl2 (5 mL), triethylamine (0.20 mL, 1.462 mmol, 3 
equiv) and HOBt (66 mg, 0.487 mmol, 1 equiv) were stirred for 1 hr under nitrogen.  
8-Aminoquinoline (78 mg, 0.536 mmol, 1.1 equiv) was added and the reaction 
stirred for a further 48 hr. The reaction was quenched by the addition of Na2CO3 (sat. 
aq., 10 mL), the phases separated and the organics dried over MgSO4, the crude 
product was recrystallised from chloroform to give the title compound as a green 
solid (44 mg, 32%).  MP (CHCl3) 180°C;  1H NMR (360 MHz, CDCl3) δH 10.59 (1H, 
s, NH), 8.88 (1H, dd, J = 4.3, 1.8), 8.82 (1H, dd, J = 6.5, 2.3), 8.51 (1H, s, ThC4-H), 
8.20 (1H, dd, J = 8.3, 1.8), 8.05-8.03 (2H, m), 7.59-7.57 (2H, m), 7.52-7.48 (4H, m);  
13C NMR (90 MHz, CDCl3) δC 173.17 (quat, CONHR), 159.65 (quat, ThC2), 149.51 
(CH, ThC4-H), 145.66 (CH), 139.40 (quat), 137.50 (CH), 135.95 (quat), 135.02 
(quat), 134.09 (quat), 132.09 (CH). 130.17 (2CH), 129.01 (quat), 128.45 (CH), 
127.95 (2CH), 123.13 (CH), 122.89 (CH), 117.78 (CH);  IR (thin film, cm-1) νmax 
3019, 1663, 1531, 1217, 772, 669;  HRMS (EI) calculated for [C19H13N3OS]+ 
331.0774, found 331.0771.   
4-(4-Methoxyphenyl)-2-phenylthiazole-5-carboxylic acid quinolin-8-yl amide 
312a 
Following procedure G using 2-phenylthiazole-5-
carboxylic acid quinolin-8-yl amide (100 mg, 0.302 mmol, 
1 equiv) and  4-iodoanisole (283 mg, 1.207 mmol, 4 equiv).  
The title compound was isolated as a yellow solid (71 mg, 
54%).  MP (CHCl3) 195°C;  1H NMR (360 MHz, CDCl3) δH 10.31 (1H, s, NH), 8.82 
(1H, dd, J = 7.2, 1.4), 8.36 (1H, dd, J = 3.2, 1.8), 8.06 (3H, m), 7.70 (2H, dt, J = 9.0, 





(3H, s, OCH3);  13C NMR (90 MHz, CDCl3) δC 169.07 (quat, CONHR), 160.74 (quat, 
ThC2), 159.63 (quat), 155.54 (quat), 147.51 (CH), 138.28 (quat), 135.84 (CH), 
134.177 (quat), 133. 03 (quat), 131.13 (2CH), 130.75 (CH), 130.08 (quat), 128.91 
(2CH), 127.67 (quat), 127.21 (CH), 126.78 (2CH), 126.25 (quat), 121.68 (CH), 
121.39 (CH), 116.38 (CH), 114.51 (2CH), 55.51 (OCH3);  IR (thin film, cm-1) νmax 
3019, 2963, 1530, 1219, 1212, 1098, 1015, 784, 737, 669; HRMS (EI) calculated for 
[C26H19N3O2S]+ 437.1193, found 437.1191.   
2,4-Diphenylthiazole-5-carboxylic acid quinolin-8-yl amide 312b 
Following procedure G using 2-phenylthiazole-5-
carboxylic acid quinolin-8-yl amide (100 mg, 0.302 mmol, 
1 equiv) and  iodobenzene (246 mg, 1.207 mmol, 4 equiv).  
The title compound was isolated, following column 
chromatography (0-10% ethyl acetate/hexane) as a yellow solid (103 mg, 84%).  MP 
(CHCl3) 142°C;  1H NMR (360 MHz, CDCl3) δH 10.23 (1H, s, NH), 8.82 (1H, dd, J 
= 7.6, 1.4), 8.33 (1H, dd, J = 4.3, 1.8), 8.08-8.05 (3H, m), 7.81 (2H, dt, J = 6.1, 1.8), 
7.55-7.46 (8H, m), 7.32 (1H, dd, J = 8.3, 4.3); 13C NMR (90 MHz, CDCl3) δC 169.34 
(quat, CONHR), 159.49 (quat, ThC2), 155.63 (quat), 147.67 (CH), 138.37 (quat), 
135.90 (CH), 134.15 (quat), 133.94 (quat), 133.04 (quat), 131.95 (quat), 131.95 (CH), 
129.82 (2CH), 129.29 (CH), 129.09 (2CH), 129.01 (2CH), 127.72 (quat), 127.24 
(CH), 126.88 (2CH), 121.83 (CH), 121.42 (CH), 116.48 (CH);  IR (thin film, cm-1) 
νmax 3019, 1530, 1216, 756, 669;  HRMS (EI) calculated for [C25H17N3OS]+ 
407.1087, found 407.1080.   
2-Phenyl-4-(4-methylphenyl)thiazole-5-carboxylic acid quinolin-8-yl amide 
312d 
Following procedure G using 2-phenylthiazole-5-
carboxylic acid quinolin-8-yl amide (100 mg, 0.302 mmol, 
1 equiv) and  4-iodotoluene (263 mg, 1.207 mmol, 4 
equiv).  The title compound was isolated, following 
column chromatography (0-10% ethyl acetate/hexane) as a yellow solid (112 mg, 










(1H, dd, J = 7.2, 1.4), 8.32 (1H, dd, J = 4.0, 1.4), 8.08-8.05 (3H, m), 7.70 (2H, dt, J = 
8.2, 1.8), 7.55-7.46 (5H, m), 7.35-7.29 (3H, m), 2.46 (3H, s);  13C NMR (90 MHz, 
CDCl3), δC 169.14 (quat, CONHR), 159.62 (quat, ThC2), 155.87 (quat), 147.43 (CH), 
139.28 (quat), 138.35 (quat), 135.89 (CH), 134.24 (quat), 133.08 (quat), 131.05 
(quat), 130.81 (CH), 130.42 (quat), 129.74 (2CH), 129.68 (2CH), 128.97 (2CH), 
127.72 (quat), 127.26 (CH), 126.85 (2CH), 121.76 (CH), 121.39 (CH), 116.48 (CH), 
21.47 (CH3);  IR (thin film, cm-1) νmax 4214, 3019, 1530, 1219, 782, 735, 669;  
HRMS (EI) calculated for [C26H19N3OS]+ 421.1243, found 421.1246.   
4-(3-Nitro-phenyl)-2-phenyl-thiazole-5-carboxylic acid quinolin-8-yl amide 
312e 
Following procedure G using 2-phenylthiazole-5-
carboxylic acid quinolin-8-yl amide (100 mg, 0.302 mmol, 
1 equiv) and  3-iodonitrobenzene (301 mg, 1.207 mmol, 4 
equiv).  The title compound was isolated, following 
column chromatography (0-90% ethyl acetate/hexane) as a 
yellow solid (105 mg, 77%).  MP (CHCl3) 219°C;  1H NMR (360 MHz, CDCl3) δH 
10.15 (1H, s, NH), 8.81-8.79 (2H, m), 8.38-8.35 (2H, m), 8.17 (1H, dt, J = 7.9, 1.8), 
8.12 (1H, dd, J = 8.3, 1.4), 8.09-8.05 (2H, m), 7.65-7.47 (6H, m), 7.38 (1H, dd, J = 
8.3, 4.3);  13C NMR (90 MHz, CDCl3) δC 169.55 (quat, CONHR), 158.68 (quat, 
ThC2), 152.87 (quat), 148.48 (quat), 147.76 (CH), 138.07 (quat), 136.29 (quat), 
135.78 (CH), 135.54 (quat),133.61 (quat),132.50 (CH), 131.22 (CH), 131.07 (quat), 
129.77 (CH), 129.09 (2CH), 127.77 (CH), 127.27 (CH), 126.84 (2CH), 124.95 (CH), 
123.78 (CH), 122.26 (CH), 121.61 (CH), 116.75 (quat);  IR (thin film, cm-1) νmax 
3019, 1529, 1216, 754, 669;  HRMS (EI) calculated for [C25H16N4O3S+H]+ 452.0938, 
found 452.0945.   
2-Phenyl-4-thiophen-3-yl-thiazole-5-carboxylic acid quinolin-8-yl amide 312c 
Following procedure G using 2-phenylthiazole-5-
carboxylic acid quinolin-8-yl amide (100 mg, 0.302 mmol, 











equiv).  The title compound was isolated, following column chromatography (0-10% 
ethyl acetate/hexane) as a white solid (82 mg, 66%).  MP (CHCl3) 176°C;  1H NMR 
(360 MHz, CDCl3) δH 10.44 (1H, s, NH), 8.85 (1H, dd, J = 7.2, 1.8), 8.57 (1H, dd, J 
= 4.0, 1.8), 8.12 (1H, dd, J = 8.3, 1.8), 8.07-8.04 (2H, m), 7.94 (1H, dd, J = 3.2, 1.3), 
7.59-7.47 (6H, m), 7.44 (1H, dd, J = 5.4, 3.2), 7.40 (1H, dd, J = 8.3, 4.3);  13C NMR 
(90 MHz, CDCl3) δC 168.85 (quat, CONHR), 159.45 (quat, ThC2), 150.58 (quat), 
147.90 (CH), 138.36 (quat), 135.99 (CH), 134.38 (quat), 134.08 (quat), 132.87 (quat), 
130.84 (CH), 130.00 (quat), 128.94 (2CH), 128.55 (CH), 127.76 (quat), 127.25 (CH), 
127.21 (CH), 126.79 (2CH), 126.39 (CH), 121.89 (CH), 121.49 (CH), 116.58 (CH);  
IR (thin film, cm-1) νmax 3295, 3016, 1649, 1529, 1216, 7545, 668;  HRMS (EI) 
calculated for [C23H14N3OS2]+ 413.0651, found 413.0651.   
5-(3,4-Dimethoxy-phenyl)-2-phenyl-oxazole (Balsoxin)170 251k 
Following general procedure D using 2-phenyloxazole (50 
mg, 0.344 mmol, 1 equiv) and 3,4-dimethoxyiodobenzene 
(109 mg, 0.413 mmol, 1.2 equiv), purification by column 
chromatography (5% ethyl acetate/hexane) gave the title compound as a colourless 
solid  (73 mg, 76% yield); 1H NMR (250 MHz, CHCl3) δ 8.11-8.07 (2H, m), 7.50-
7.44 (3H, m), 7.33 (1H, s), 7.30 (1H, dd, J = 8.4, 2.0), 7.19 (1H, d, J = 2.0), 6.93 
(1H, d, J = 8.4), 3.90 (3H, s, OCH3), 3.85 (3H, s, OCH3); 13C NMR (63 MHz, 
CDCl3) δ 160.47 (quat), 151.22 (quat), 149.38 (quat), 149.31 (quat), 130.09 (CH), 
128.66 (CH), 127.48 (quat), 126.13 (CH), 122.24 (CH), 120.98 (quat), 117.22 (CH), 
111.41 (CH), 107.37 (CH), 56.04 (CH3), 55.85 (CH3).  
2-(2-(4-Chlorophenyl)thiazol-5-yl)-pyridine 291b 
Following general procedure D with 2-(4-
chlorophenyl)thiazole (2.00 g, 0.010 mol, 1 equiv) and 2-
bromopyridine (3.23 g, 0.020 mol, 2 equiv), purification by 
column chromatography (CH2Cl2) gave the title compound as a yellow solid (1.25 g, 
45% yield).  MP (toluene) 163°C;  1H NMR (360 MHz, CDCl3) δH 8.59 (1H, ddd, J 
= 4.9, 1.6, 1.0), 8.24 (1H, s, ThC4-H), 7.93-7.89 (2H, m), 7.74-7.66 (2H, m), 7.43-









167.93 (quat, ThC2), 150.43 (quat), 149.93 (CH, ThC4-H), 140.55 (CH), 140.54 
(quat), 136.78 (CH), 136.21 (quat), 132.11 (quat), 129.23 (2CH), 127.64 (2CH), 
122.65 (CH), 119.54 (CH);  IR (thin film, cm-1) νmax 1562, 1425, 1170, 824, 770, 734, 
631;  HRMS (EI) calculated for [C14H935ClN2S]+ 272.0170, found 272.0169.   
2-(2-(4-Methoxyphenyl)thiazol-5-yl)-pyridine 291c 
Following general procedure D with 2-(4-
methoxyphenyl)thiazole (2.00 g, 0.010 mol, 1 equiv) and 2-
bromopyridine (3.23 g, 0.020 mol, 2 equiv) and purification 
by column chromatography (CH2Cl2) gave the title compound as a yellow solid (1.73 
g, 62% yield).  MP (toluene) 129°C;  1H NMR (360 MHz, CDCl3) δH 8.59 (1H, ddd, 
J = 4.9, 1.6, .1.1), 8.22 (1H, s, ThC4-H), 7.96-7.92 (2H, m), 7.74-7.67 (2H, m), 7.18 
(1H, ddd, J = 6.7, 4.9, 1.8), 6.99-6.95 (2H, m), 3.87 (3H, s);  13C NMR (90 MHz, 
CDCl3) δC 169.34 (quat, ThC2), 161.36 (quat,CArOCH3), 150.79 (quat), 149.84 (CH), 
140.36 (CH), 139.12 (quat), 136.69 (CH), 128.58 (2CH), 126.58 (quat), 122.32 (CH), 
119.42 (CH), 114.35 (2CH), 55.42 (OCH3);  IR (thin film, cm-1) νmax 1607, 1586, 
1516, 1469, 1430, 1415, 1301, 1254, 1175, 1023, 825, 771, 733;  HRMS (EI) 
calculated for [C15H12N2OS]+ 268.0665, found 268.0668.   
2-(2,4-Diphenylthiazol-5-yl)-pyridine 292a 
Following general procedure F using 2-(2-phenylthiazol-5-yl)-
pyridine (100 mg, 0.420 mmol, 1 equiv) and bromobenzene (132 
mg, 0.839 mmol, 2 equiv), purification by column 
chromatography (2% ethyl acetate/toluene) gave the title 
compound as a yellow oil (116 mg, 88% yield).  1H NMR (360 MHz, CDCl3) δH 8.61 
(1H, ddd, J = 4.9, 1.8, 1.0), 8.07-8.04 (2H, m), 7.67-7.64 (2H, m), 7.48-7.39 (7H, m), 
7.22 (1H, dt, J = 8.0, 1.0), 7.12 (1H, ddd, J = 7.5, 4.9, 1.0);  13C NMR (90 MHz, 
CDCl3) δC 167.25 (quat, ThC2), 152.41 (quat), 151.44 (quat), 149.62 (CH), 136.01 
(CH), 135.35 (quat), 134.49 (quat), 133.49 (quat), 130.13 (CH), 129.25 (2CH), 
128.92 (2CH), 128.80 (2CH), 128.50 (CH), 126.45 (2CH), 122.11 (CH), 122.07 
(CH);  IR (thin film, cm-1) νmax 3059, 1582, 1488, 1462, 1442, 1432, 771, 689, 666;  










Following general procedure F using 2-(2-phenylthiazol-5-
yl)-pyridine (100 mg, 0.420 mmol, 1 equiv) and 
bromotoluene (171 mg, 0.839 mmol, 2 equiv), purification by 
column chromatography (0-5% acetone/CH2Cl2) gave the title 
compound as a yellow gum (96 mg, 70% yield).  1H NMR 
(360 MHz, CDCl3) δH 8.61 (1H, ddd, J = 4.9, 1.8, 1.1), 8.07-8.04 (2H, m), 7.56-7.53 
(2H, m), 7.49-7.42 (4H, m), 7.27 (1H, ddd, J = 8.1, 1.1, 1.1), 7.24-7.22 (2H, m), 7.12 
(1H, ddd, J = 7.5, 4.9, 1.0), 2.41 (3H, s);  13C NMR (90 MHz, CDCl3) δC 167.10 
(quat), 152.56 (quat), 151.62 (quat), 149.58 (CH), 138.38 (quat), 135.98 (CH), 
134.06 (quat), 133.56 (quat), 132.45 (quat), 130.07 (CH), 129.29 (2CH), 129.12 
(2CH), 128.80 (2CH), 126.44 (2CH), 122.04 (CH), 122.02 (CH), 21.32 (CH3);  IR 
(thin film, cm-1) νmax 1583, 1495, 1461, 1432, 823, 779,688, 666;  HRMS (EI) 
calculated for [C21H16N2S]+ 328.1029, found 328.1029.   
2-(4-(4-Methoxyphenyl)-2-phenylthiazol-5-yl)-pyridine 292d 
Following general procedure F using 2-(2-phenylthiazol-5-
yl)-pyridine (100 mg, 0.420 mmol, 1 equiv) and 
bromoanisole (157 mg, 0.839 mmol, 2 equiv), purification 
by column chromatography (0-5% acetone/CH2Cl2) gave the 
title compound as a yellow oil (64 mg, 44% yield) together with recovered starting 
material (51 mg).  1H NMR (360 MHz, CDCl3) δH 8.61 (1H, ddd, J = 4.9, 1.8, 1.0), 
8.05-8.03 (2H, m),7.60-7.56 (2H, m), 7.48 (1H, m), 7.45-7.42 (3H, m), 7.27 (1H, dt, 
J = 8.1, 1.0), 7.13 (1H, ddd, J = 7.5, 4.9, 1.0), 6.97-6.93 (2H, m), 3.86 (3H, s);  13C 
NMR (90 MHz, CDCl3) δC 167.13 (quat, ThC2), 159.85 (quat, CArOCH3), 152.30 
(quat), 151.74 (quat), 149.65 (CH), 136.05 (CH), 133.63 (quat), 133.60 (quat), 
130.58 (2CH), 130.11 (CH), 128.85 (2CH), 127.81 (quat), 126.47 (2CH), 122.05 
(CH), 122.03 (CH), 114.05 (2CH), 55.29 (CH3);  IR (thin film, cm-1) νmax 1609, 1584, 
1495, 1463, 1251, 1174, 1030, 836, 780, 665;  HRMS (EI) calculated for 











Following general procedure F using 2-(2-phenylthiazol-5-
yl)-pyridine (100 mg, 0.420 mmol, 1 equiv) and 
bromonitrobenzene (170 mg, 0.839 mmol, 2 equiv), 
purification by column chromatography (0-15% 
acetone/toluene) gave the title compound as a yellow gum (133 mg, 88% yield).  1H 
NMR (360 MHz, CDCl3) δH 8.66 (1H, ddd, J = 4.8, 1.8, 1.1), 8.26-8.22 (2H, m), 
8.04-7.99 (2H, m), 7.85-7.81 (2H, m), 7.59 (1H, ddd, J = 8.0, 7.5, 1.8), 7.48-7.44 
(3H, m), 7.27-7.23 (2H, m);  13C NMR (90 MHz, CDCl3) δC 168.00 (quat, ThC2), 
150.60 (quat), 150.07 (CH), 149.57 (quat), 147.49 (quat), 141.47 (quat), 136.63 (CH), 
136.14 (quat), 132.98 (quat), 130.62 (CH), 130.13 (2CH), 129.02 (2CH), 126.50 
(2CH), 123.74 (2CH), 122.99 (CH), 122.91 (CH);  IR (thin film, cm-1) νmax 1582, 
1517, 1345, 845, 761, 688, 665;  HRMS (EI) calculated for [C20H13N3O2S]+ 
359.0723, found 359.0726.   
2-(4-Phenyl-2-(4-chlorophenyl)thiazol-5-yl)-pyridine 292f 
Following general procedure F using 2-(2-(4-
chlorophenyl)thiazol-5-yl)pyridine (100 mg, 0.367 mmol, 1 
equiv) and bromobenzene (115 mg, 0.733 mmol, 2 equiv), 
purification by column chromatography (1-5% 
acetone/toluene) afforded the title compound as a yellow oil (117 mg, 92%).  1H 
NMR (360 MHz, CDCl3) δH 8.62 (1H, ddd, J = 4.9, 1.8, 1.0), 8.00-7.96 (2H, m), 
7.64-7.62 (2H, m), 7.51-7.41 (6H, m), 7.22 (1H, dt, J = 8.1, 1.0), 7.12 (1H, ddd, J = 
7.5, 4.9, 1.0);  13C NMR (90 MHz, CDCl3) δC 167.52 (quat, ThC2), 150.36 (quat), 
151.00 (quat), 149.97 (CH), 136.16 (CH), 134.77 (quat), 134.46 (quat), 133.93 (quat), 
133.33 (quat), 131.78 (2CH), 129.42 (2CH), 128.92 (CH), 128.75 (2CH), 125.65 
(2CH), 123.03 (CH), 122.42 (CH);  IR (thin film, cm-1) νmax 1682, 1583, 1478, 1398, 
1092,1012, 827, 700, 665;  HRMS (EI) calculated for [C20H1335ClN2S]+ 348.0483, 











Following general procedure F using 2-(2-(4-
chlorophenyl)thiazol-5-yl)pyridine (100 mg, 0.367 mmol, 
1 equiv) and bromotoluene (125 mg, 0.733 mmol, 2 equiv), 
purification by column chromatography (1-5% 
acetone/toluene) afforded the title compound as a yellow oil (59 mg, 44% yield).  1H 
NMR (360 MHz, CDCl3) δH 8.62 (1H, ddd, J = 4.9, 1.8, 1.0), 7.99-7.95 (2H, m), 
7.53-7.46 (3H, m), 7.44-7.40 (2H, m), 7.27-7.22 (3H, m), 7.15, (1H, ddd, J = 7.5, 4.9, 
1.0), 2.41 (3H, s);  13C NMR (90 MHz, CDCl3) δC 165.82 (quat, ThC2), 152.76 (quat), 
151.47 (quat), 149.67 (CH), 138.62 (quat), 136.15 (CH), 136.10 (quat), 134.42 (quat), 
132.30 (quat), 132.12 (quat), 129.41 (2CH), 129.14 (2CH), 129.12 (2CH), 127.70 
(2CH), 122.23 (CH), 122.13 (CH), 21.38 (CH3);  IR (thin film, cm-1) νmax 3050, 2921, 
1750, 1584, 1455, 1092, 825, 779, 736;  HRMS (EI) calculated for [C21H1535ClN2S]+ 
362.0639, found 362.0638.   
2-(4-(4-Methoxyphenyl)-2-(4-chlorophenyl)thiazol-5-yl)-pyridine 292i 
Following general procedure F using 2-(2-(4-
chlorophenyl)thiazol-5-yl)pyridine (100 mg, 0.367 mmol, 
1 equiv) and bromoanisole (137 mg, 0.733 mmol, 2 
equiv), purification by column chromatography (1-5% 
acetone/toluene) afforded the title compound as a yellow oil (29 mg, 21% yield).  1H 
NMR (360 MHz, CDCl3) δH 8.61 (1H, ddd, J = 4.9, 1.8, 1.0), 7.98-7.94 (2H, m), 
7.58-7.54 (2H, m), 7.49 (1H, ddd, J = 8.0, 7.6, 1.8), 7.43-7.39 (2H, m), 7.27 (1H, ddd, 
J = 8.0, 1.0, 1.0), 7.14 (1H, ddd, J = 7.6, 4.9, 1.0), 6.97-6.93 (2H, m), 3.86 (3H, s);  
13C NMR (90 MHz, CDCl3) δC 165.76 (quat, ThC2), 159.95 (quat, CArOCH3), 
152.44 (quat), 151.54 (quat), 149.68 (CH), 136.15 (CH), 136.08 (quat), 133.98 (quat), 
132.11 (quat), 130.57 (2CH), 129.11 (2CH), 127.67 (2CH), 127.60 (quat), 122.19 
(CH), 122.05 (CH), 114.12 (2CH), 55.32 (CH3);  IR (thin film, cm-1) νmax 1748, 1584, 
1493, 1459, 1250, 1173, 1091, 1030, 833, 779;  HRMS (EI) calculated for 













Following general procedure F using 2-(2-(4-
methoxyphenyl)thiazol-5-yl)pyridine (100 mg, 0.373 mmol, 
1 equiv) and bromobenzene (117 mg, 0.745 mmol, 2 equiv), 
purification by column chromatography (1-5% 
acetone/toluene) afforded the title compound as a yellow oil (112 mg, 87% yield);  
1H NMR (360 MHz, CDCl3) δH 8.60 (1H, ddd, J = 4.9, 1.8, 1.0), 8.01-7.97 (2H, m), 
7.65-7.63 (2H, m), 7.46-7.39 (4H, m), 7.20 (1H, ddd, J = 8.1, 1.0, 1.0), 7.12 (1H, m), 
6.98-6.94 (2H, m), 3.85 (3H, s);  13C NMR (90 MHz, CDCl3) δC  167.18 (quat, 
ThC2), 161.26 (quat, CArOCH3), 152.24 (quat), 151.60 (quat), 149.58 (CH), 135.96 
(CH), 135.50 (quat), 133.54 (quat), 129.26 (2CH), 128.59 (2CH), 128.45 (CH), 
127.99 (2CH), 126.47 (quat), 121.96 (CH), 121.93 (CH), 114.18 (2CH), 55.32 (CH3);  
IR (thin film, cm-1) νmax 2931, 1605, 1459, 1254, 1173, 1030, 833, 769, 701;  HRMS 
(EI) calculated for [C21H16N2OS]+ 344.0978, found 344.0976. 
2-(4-(4-Methylphenyl)-2-(4-methoxyphenyl)thiazol-5-yl)-pyridine 292l 
Following general procedure F using 2-(2-(4-
methoxyphenyl)thiazol-5-yl)pyridine (100 mg, 0.373 
mmol, 1 equiv) and bromotoluene (127 mg, 0.745 mmol, 
2 equiv), purification by column chromatography (1-5% 
acetone/toluene) afforded the title compound as a yellow oil (75 mg, 56% yield); 1H 
NMR (360 MHz, CDCl3) δH 8.60 (1H, ddd, J = 4.9, 1.8, 1.0), 8.00-7.96 (2H, m), 
7.54-7.51 (2H, m), 7.46 (1H, ddd, J = 8.1, 7.5, 1.8), 7.26-7.21 (3H, m), 7.11 (1H, ddd, 
J = 7.5, 4.9, 1.0), 6.98-6.94 (2H, m), 3.86 (3H, s, OMe), 2.41 (3H, s, Me);  13C NMR 
(90 MHz, CDCl3) δC 168.15 (quat), 162.34 (quat), 153.52 (quat), 152.91 (quat), 
150.66 (CH), 139.43 (quat), 137.05 (CH), 133.72 (quat), 130.40 (2CH), 130.23 
(2CH), 130.17 (quat), 129.10 (quat), 127.68 (CH), 123.06 (CH), 122.95 (CH), 115.28 
(2CH), 56.45 (CH3, OMe), 22.44 (CH3, CArCH3);  IR (thin film, cm-1) νmax 1605, 













Following general procedure F using 2-(2-(4-
methoxyphenyl)thiazol-5-yl)pyridine (100 mg, 0.373 
mmol, 1 equiv) and bromochlorobenzene (127 mg, 0.745 
mmol, 2 equiv), purification by column chromatography 
(1-5% acetone/toluene) afforded the title compound as a 
yellow oil (51 mg, 36% yield);  1H NMR (360 MHz, CDCl3) δH 8.60 (1H, ddd, J = 
4.9, 1.8, 1.0), 7.97-7.93 (2H, m), 7.60-7.56 (2H, m), 7.48 (1H, ddd, J = 8.0, 7.6, 1.8), 
7.39-7.36 (2H, m), 7.21 (1H, ddd, J = 8.0, 1.0, 1.0), 7.13 (1H, ddd, J = 7.6, 4.9, 1.0), 
6.97-6.93 (2H, m), 3.83 (3H, s);  13C NMR (90 MHz, CDCl3) δC 168.49 (quat), 
162.48 (quat), 152.44 (quat), 151.90 (quat), 150.86 (CH), 137.24 (CH), 135.47 (quat), 
135.01 (quat), 131.75 (2CH), 129.89 (2CH), 129.09 (2CH), 127.40 (quat), 123.28 
(CH), 123.21 (CH), 115.34 (2CH), 56.45 (CH3);  IR (thin film, cm-1) νmax 2836, 1605, 
1485,1458, 1254, 1173, 833;  HRMS (EI) calculated for [C21H1535ClN2OS]+ 
378.0588, found 378.0588. 
2-(2,4-Di(4-methoxyphenyl)thiazol-5-yl)-pyridine 292n 
Following general procedure F using 2-(2-(4-
methoxyphenyl)thiazol-5-yl)pyridine (100 mg, 0.373 
mmol, 1 equiv) and 4-bromoanisole (139 mg, 0.745 
mmol, 2 equiv), purification by column 
chromatography (1-5% acetone/toluene) afforded the title compound as a yellow 
gum (31 mg, 22% yield);  1H NMR (360 MHz, CDCl3) δH 8.48 (1H, ddd, J = 4.9, 1.8, 
1.0), 7.88-7.84 (2H, m), 7.48-7.44 (2H, m), 7.36 (1H, ddd, J = 8.0, 7.5, 1.8), 7.14 
(1H, ddd, J = 8.0, 1.0, 1.0), 7.00 (1H, ddd, J = 7.5, 4.9, 1.0), 7.87-7.81 (4H, m), 3.74 
(3H, s), 3.73 (3H, s);  13C NMR (90 MHz, CDCl3) δC 167.13 (quat, ThC2), 161.26 
(quat, CArOCH3), 159.85 (quat, CArOCH3), 152.30 (quat), 151.74 (quat), 149.65 
(CH), 136.05 (CH), 133.63 (quat), 133.60 (quat), 130.58 (2CH), 130.11 (CH), 127.99 
(2CH), 127.81 (quat), 122.05 (CH), 114.19 (2CH), 114.05 (2CH), 55.29 (CH3), 55.31 
(CH3);  IR (thin film, cm-1) νmax 3438, 2837, 1606, 1497, 1459, 1252,1173, 1031, 836; 













Following general procedure F using 2-(2-(4-
methoxyphenyl)thiazol-5-yl)pyridine (100 mg, 0.373 
mmol, 1 equiv) and 4-bromonitrobenzene (151 mg, 
0.745 mmol, 2 equiv), purification by column 
chromatography (1-5% acetone/toluene) afforded the 
title compound as a yellow gum (81 mg, 56% yield);  1H NMR (360 MHz, CDCl3) 
δH 8.65 (1H, ddd, J = 4.8, 1.8, 1.1), 8.25-8.21 (2H, m), 7.98-7.94 (2H, m), 7.85-7.81 
(2H, m), 7.56 (1H, ddd, J = 8.0, 7.5, 1.8), 7.24-7.20 (2H, m, py), 6.99-6.95 (2H, m), 
3.87 (3H, s, OMe);  13C NMR (90 MHz, CDCl3) δC 167.86 (quat, ThC2), 161.62 
(quat, CArOCH3), 150.82 (quat), 150.08 (CH), 149.35 (quat), 147.46 (quat), 141.72 
(quat), 136.48 (2CH), 135.35 (quat), 130.15 (CH), 128.07 (2CH), 125.97 (quat), 
123.74 (2CH), 122.76 (CH), 122.71 (CH), 114.36 (2CH), 55.41 (CH3, OMe);  IR 
(thin film, cm-1) νmax 1604, 1517,1458, 1344, 1253, 1172, 845;  HRMS (EI) 
calculated for [C21H15N3O3S]+ 389.0829, found 389.0826. 
N-Acetyl-4-iodoaniline184 64 
Iodoaniline (2.00 g, 9.13 mmol, 1 equiv) was dissolved in AcOH 
(50 mL) and Ac2O (1.04 mL, 10.96 mmol, 1.2 equiv) was added 
dropwise.  The mixture was allowed to stir for 1 hr and then 
NaHCO3 (sat. aq.) was added slowly until gas evolution ceased.  The mixture was 
left to stir for a further 30 min and then CH2Cl2 (2 × 100 mL) was added to extract 
the product.  The organic layer was washed with brine and dried over MgSO4 before 
concentrating in vacuo to give the product as a purple solid.  This was dissolved in 
CH2Cl2, filtered through silica which was washed with CH2Cl2/acetone (200 mL, 1:1) 
to give the product as a white solid (2.29 g, 96% yield.  MP (CHCl3) 184°C; 1H 
NMR (360 MHz, CDCl3) 7.60 (2H, d, J = 8.8), 7.28 (2H, d, J = 8.8), 2.12 (3H, s). 
Chloromethylpyrazine185 285 
Methyl pyrazine (200 mg, 2.13 mmol), NCS (284 mg, 2.13 mmol) and AIBN (35 mg, 
0.21 mmol) were dissolved in CCl4 (10 mL) and heated to reflux for 48 hr.  The 












cake washed with further CCl4 (10 mL) and the solvent removed in 
vacuo to give 148 mg of a mixture of unreacted methyl pyrazine, 
chloromethylpyrazine and 2,2-dichloromethylpyrazine in the molar ratio 6:3:1, (41.5 
mg, 15% of the desired compound).  This was used without further purification.  1H 
NMR (360 MHz, CDCl3), δH 8.73 (1H, s), 8.54-8.52 (2H, m), 4.66 (2H, s). 
4-(4-Chlorophenyl)-2,5-diphenylthiazole 248c 
Following general procedure D using 4-(4-chloropehnyl)-2-
phenylthiazole (100 mg, 0.368 mmol), iodobenzene (90 mg, 
0.442 mmol), purification by column chromatography (0-5% 
acetone/toluene) gave the title compound as a colourless solid 
(149 mg, >99% yield).  MP (CHCl3) 108°C;  1H NMR (360 MHz, CDCl3) δH 8.03-
8.00 (2H, m), 7.58-7.54 (2H, m), 7.48-7.44 (3H, m), 7.41-7.35 (5H, m), 7.30-7.27 
(2H, m);  13C NMR (90 MHz, CDCl3) δC 165.71 (quat, ThC2), 149.45 (quat), 133.66 
(quat), 133.45 (quat), 133.40 (2 quat), 131.75 (quat), 130.37 (2CH), 130.10 (CH), 
129.56 (2CH), 128.92 (2CH), 128.86 (2CH), 128.46 (2CH), 128.39 (CH), 126.39 
(2CH);  IR (thin film, cm-1) νmax 3060, 1493, 1475, 1090, 1014, 981, 833, 760, 690;  
HRMS (EI) calculated for [C21H1435ClNS]+ 347.0530, found 347.0526.   
5-(4-Chlorophenyl)-2,4-diphenylthiazole 248b 
5-(4-Chlorophenyl)-2-phenylthiazole (136 mg, 0.500 mmol), 
Pd(dppf)Cl2⋅CH2Cl2 (21 mg, 0.025 mmol), triphenylphosphine 
(13 mg, 0.050 mmol), Ag2CO3 (276 mg, 1.000 mmol) were 
combined then iodobenzene (122 mg, 0.600 mmol) and water 
(5 mL) were added.  The suspension was stirred at 100°C for 72 hr.  The reaction 
was filtered through celite, washed first with acetone (10 mL) then with CH2Cl2 (10 
mL) and the resultant mixture concentrated in vacuo being careful to removed only 
acetone and CH2Cl2 and not the water.  The resultant oil was partitioned between 
water and CH2Cl2 and the phases separated, the organics dried over MgSO4 and 
concentrated to a brown oil.  This was dry loaded onto silica and purified by column 
chromatography (0-5% acetone/toluene) to give the title compound as a colourless 













8.01 (2H, m), 7.61-7.58 (2H, m), 7.49-7.44 (3H, m), 7.34-7.32 (7H, m);  13C NMR 
(90 MHz, CDCl3) δC 165.75 (quat, ThC2), 151.20 (quat), 134.65 (quat), 134.13 
(quat), 133.45 (quat), 131.58 (quat), 130.80 (2CH), 130.58 (quat), 130.13 (CH), 
129.10 (2CH), 128.98 (2CH), 128.92 (2CH), 128.39 (2CH), 128.04 (CH), 126.44 
(2CH);  IR (thin film, cm-1) νmax 3061, 1495, 1477, 1442, 1091, 983, 824, 762, 698;  
HRMS (EI) calculated for [C21H1435ClNS]+ 347.0530, found 347.0529.   
Bis-triphenylphosphino phenyl palladium(II)iodide186 349 
Tetrakis triphenylphosphino palladium (1.00 g, 0.865 mmol) was 
dissolved in dry, degassed toluene (2.5 mL) under N2 and iodobenzene 
(177 mg, 0.865 mmol) in toluene (2.5 mL) was added dropwise.  The 
solution was stirred for 1 hr at room temp under N2.  The toluene was removed in 
vacuo to give a yellow solid.  This was triturated with Et2O to remove any PPh3 and 
recrystallised from CH2Cl2/hexane to give the product as a yellow solid (701 mg, 
97%).  1H NMR (360 MHz, CDCl3) δH 7.61-7.32 (30H, m), 6.71-6.67 (2H, m), 6.42-
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Direct Arylation of Thiazoles on Water**
Gemma L. Turner, James A. Morris, and Michael F. Greaney*
The intermolecular coupling of p-excessive heteroarenes with
aryl halides is a principal reaction system in the rapidly
growing area of transition-metal-catalyzed direct aryla-
tion.[1, 2] The approach contrasts with traditional sp2–sp2
cross-coupling chemistry involving stoichiometric organome-
tallic compounds, such as ArB(OH)2, ArSnR3, ArZnCl, as
nucleophilic components. In direct arylation, formally unac-
tivated CH bonds are used as the functionalization site on
the nucleophilic coupling partner. Regioselectivity between
different CH bonds is frequently high; in the absence of
directing-group effects the 2-substituted heteroarenes shown
in Scheme 1 undergo arylation at the most electron-rich 5-
position through a postulated SEAr mechanism.
[3,4]
Nearly all intermolecular (and many intramolecular)
heteroarene direct arylations require harsh reaction condi-
tions in terms of high temperatures and corresponding high-
boiling solvents, such as dimethylformamide (DMF). Indeed,
the reaction conditions developed by the groups of Ohta and
Miura in their pioneering work on heteroarene direct
arylations (anhydrous DMF, 140 8C, inorganic base, Pd(OAc)2
plus phosphine ligand)[3a,5] have become the standard operat-
ing procedure, being heavily represented amongst existing
reports.[1,6] Whilst these vigorous conditions may not cause
undue difficulty in the functionalization of simple heteroar-
enes for medicinal chemistry screening programmes, they
represent a serious limitation when applied to the synthesis of
more-complex heteroarenes of the type found in natural
products. With this in mind, we were interested in developing
new ways of conducting heteroarene direct arylation that
exemplify mildness and ease-of-use. We report herein our
results on the direct arylation of thiazoles, featuring the first
direct arylation system that works “on water”.
Arylated and alkenylated thiazoles have vast application,
being prominent components of biologically active natural
products (Scheme 2) as well as agrochemicals, drug mole-
cules, and novel optical materials. As a result, they have been
popular substrates in direct arylation studies.[3a,7]
We were aware at the outset of the report by Mori et al.[8]
on the arylation of 2-anisylthiazole in DMSO under the
relatively mild temperature of 60 8C in the presence of AgF,
suggesting that there may be scope for developing a more
general arylation methodology under mild conditions. We
chose to study the arylation of 2-phenylthiazole (1) with p-
chloroiodobenzene (2a).[9] The choice of a less-strongly
electron-donating group in the 2-position (compared to
anisyl) was made with a view to developing a robust arylation
methodology that would have broad applicability.
Initial optimization studies established that the reaction
could proceed in the more user-friendly acetonitrile as solvent
at 60 8C over 3 days (Table 1), and that the cheaper Ag2CO3
could be employed as both silver source and base (2 equiv).
The exact role of the silver additive in the reactionmechanism
is unclear at this stage, however we note that an inhibitory
effect of iodide has been recorded in a number of arylation
Scheme 1. Generalized intermolecular azole direct arylation.
Y=O,S,NR.
Scheme 2. Selected examples of bioactive thiazole-containing natural
products.
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systems mandating the addition of Ag+ sequestering
agents.[2c,10] Arylation was entirely unsuccessful in the absence
of Ag2CO3 under these conditions. We found a combination
of [Pd(dppf)Cl2]·CH2Cl2/PPh3, dppf= (diphenylphosphanyl)-
ferrocene) to be an effective catalyst system, although there
was good tolerance for a number of Pd salt/ligand combina-
tions. Most importantly, the reaction is successful for a wide
variety of electrophiles, effectively arylating 1 with the
complete spectrum of aryl iodides. Both electron-rich
(R=Me,OMe) and electron-poor (R=
F,Cl,CF3,CN,CO2Et,COMe,NO2) reacting partners coupled
in generally good yields, with substitution being tolerated at
each of the o,m, and p-positions. We were pleased to observe
that certain heterocyclic iodides were viable for direct
arylation, forming the pyridyl thiazoles 3n and 3o and the
novel 5–5 linked symmetrical dithiazole 3r ; albeit in moder-
ate yield. The only failures we observed in the system were
the hindered mesityl iodide (2m) and the heterocyclic
pyrazine (2q) and thiazole (2s) iodides, all of which com-
pletely failed to react to give the product. Aryl bromides were
less-effective than iodides in every case, and triflates were not
viable at all in the reaction.
We next varied the electronics of the thiazole substrate by
changing the 2-phenyl substituent, studying the electron-
withdrawing p-CF3 (4b) group along with the electron-
donating p-OMe (4a) and p-Me (4c) groups (Table 2 and
the Supporting Information). The results are consistent with
the SEAr mechanism commonly put forward for direct
arylation of the azole 5-position, with the electron-rich
anisyl-substituted thiazole 4a clearly providing the higher
yields of arylation (64–98%) when compared with the
electron-poor substrate 4b (12–74%). The p-Me series
produces comparable arylation yields (69–85%) to the
parent phenyl series (62–81%, entries 1–4 in Table 1). Exam-
ining the electrophile, we observe that p-nitro-iodobenzene
2c is somewhat anomalous, producing the lowest yields (3c,
Table 1, 5c,g, Table 2; 12–64%). This result is likely due to the
high reactivity of this iodide promoting deleterious side-
reactions.
The reaction system compares very favorably with exist-
ing thiazole arylations,[7] working in higher yield for a far
greater substrate range, embracing polarity differences across
electrophile and nucleophile, being considerably milder at
T= 60 8C, and using a simple and relatively inexpensive
catalyst system. With this methodology in hand, we turned
our attention to improving the reaction time, which at three
days was sub-optimal. Interestingly, our reaction system
appears dichotomous with the established Ohta/Miura con-
Table 1: Arylation of 2-phenylthiazole (1).
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ditions as it did not respond well to increasing temperature;
microwave heating of the reaction in excess of 100 8C, for
example, lead to extensive homocoupling of the aryl iodide
with little if any direct arylation.
A more productive approach was to change the solvent. A
screen indicated that direct arylation was viable in each of
THF, CHCl3, dioxane, MeOH, and toluene. We were sur-
prised to find, however, that water gave by far the best results
of all—very clean conversions were observed after 24 h at
60 8C, with the arylated products being isolated in high yield.
Repeating the arylations of the compounds in Table 1 and
Table 2 in water resulted in substantially higher yields in every
case. For some substrates, the difference was remarkable. The
mesityl thiazole (3m, Table 1), which was not formed at all
using acetonitrile, was produced in quantitative yield under
aqueous conditions. Likewise, synthesis of the bithiazoles 3r
and 3s, problematic inMeCN, was substantially improved.We
extended the aqueous procedure to the novel pyrazine
thiazole 3q (Table 1) and the p-bromo compound 3k
(Table 1), featuring a versatile handle for further functional-
ization through cross-coupling. We also synthesized the 5-
(3,4-dimethoxyphenyl)thiazole 3t, the thio analogue of bal-
soxin, an oxazole natural product isolated from the plant
A. Balsamifera.[11] The average yield using water as solvent
was very high—90% across the complete spectrum of aryl
iodides used in the study.
Given the lack of solubility of reactants,
reagents, and products in water, the system is an
example of what Sharpless has termed an “on-
water” reaction, whereby the organic components
react in a heterogeneous aqueous suspension.[12,13]
The benefits of conducting on-water chemistry can
be substantial: increased efficiency and rate (as
seen herein), convenient ease of operation,
improved safety profile owing to the excellent
heat capacity of water, in addition to the benefits of
cost and of water as a green solvent. Work-up of
the on-water reactions was straightforward, involv-
ing simple filtration, extraction, and concentration
methods. In a number of cases (for example,
thiazoles 3a,b,d,e, and j) the product sublimed
out of the aqueous mixture and could be isolated
directly, without any extraction, washing, or further
purification being necessary (see the Supporting
Information).
A detailed examination of the arylation of
thiazole 1 with p-chloroiodobenzene (2a) revealed
the reaction to be complete in just 6 h at 60 8C with
5 mol% catalyst loading, compared to 72 h for the
reaction in MeCN (Figure 1A). The loading could
be dropped to 0.5 mol% without significant pen-
alty, providing product 3a in an excellent 90%
yield after 24 h. Similarly, the equivalency of silver
carbonate could be reduced to 0.5 molar equiva-
lents (1 equiv of Ag+, 92% after 24 h). The
reaction even proceeded to completion at room
temperature, but only after a reaction time of
5 days.
The theoretical basis of rate acceleration both
in and on water has been the subject of extensive investiga-
Table 2: Arylation of 2-aryl thiazoles.
Entry Ar1I[a] Thiazole
substrate[c]





1 2a 4a 98 np
2 2b 4a 96 np
3 2c 4a 64 91
4 2d 4a 73 np
5 2a 4b 63 >99
6 2b 4b 32 >99
7 2c 4b 12 79
8 2d 4b 74 82
[a] See the Experimental Section for the reaction procedure. [b] np=not performed.
[c] See the Supporting Information for the arylation of 4c.
Figure 1. HPLC monitoring of the arylation of 1 with 2a. A) Conversion
over time for three methods. B) Conversion after 24 h in water/MeCN
mixtures.
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tion.[14, 15] For the system at hand we note that running the
reaction neat is nearly as effective as running it on water. This
suggests that a substantial increase in the effective concen-
tration of reactants and catalyst system is the main driving
force for rate acceleration in an on-water reaction. Examining
the relative ratio of water/MeCN in the reaction showed that
whilst small amounts of MeCNwere well tolerated, increasing
the proportion of organic solvent led to a rapid decrease in
yield, underlining the requirement for heterogeneity (Fig-
ure 1B). Pending detailed mechanistic investigation, we hold
this concentration effect as our principal hypothesis. From the
point of view of synthetic expediency, the on-water method is
to be recommended over running the reaction neat in all
cases, owing to benefits of reproducibility and safety.
Having established high-yielding on-water arylation con-
ditions for 2-aryl thiazoles, we were interested in exploring
the scope of the methodology with alternative heterocyclic
substrates. Initial results point to a versatile process for high-
yielding direct arylation (Scheme 3). 2-Alkyl-substituted
thiazoles were arylated in excellent yield (6) along with the
more sterically hindered 2,4-disubstituted thiazoles (7 and 8)
and the versatile 2-acyl thiazole (9). Moving away from
thiazoles, the three parent benzazole heterocycles were
effectively phenylated at the 2-position, with the benzimida-
zole and benzothiazole affording quantitative yields of
product (12 and 10). 2-Phenyloxazole and 2-methoxythio-
phene were likewise efficiently functionalized at the 5-
position (13 and 14).
In conclusion, we have developed the first direct arylation
methodology that takes place on water. The procedure is
highly efficient, user-friendly, and has excellent generality,
having been applied to the synthesis of heterocycles display-
ing diverse functionalities of relevance to medicinal, materi-
als, and natural products chemistry. In addition, the reaction is
carried out under conditions substantially milder than those
commonly found in the literature for heteroarene arylation.
Future work will look to apply this methodology to the
synthesis of complex molecules.
Experimental Section
5-(4-Chlorophenyl)-2-phenylthiazole (3a):Representative procedure
for cross-coupling in organic solvents: Ag2CO3 (342.1 mg,
1.240 mmol, 2 equiv), [Pd(dppf)Cl2]·CH2Cl2 (25.3 mg, 0.031 mmol,
5.0 mol%), PPh3 (16.3 mg, 0.062 mmol, 10 mol%), 4-chloroiodoben-
zene (177.5 mg, 0.744 mmol, 1.2 equiv), and 2-phenylthiazole
(100 mg, 0.620 mmol,1 equiv) were combined and dissolved in
MeCN (5 mL) under N2. The reaction was heated at 60 8C for 72 h
and filtered through a pad of celite, washed with acetone (5 mL) and
CH2Cl2 (5 mL), and concentrated under vacuum. The title compound
is obtained following purification by column chromatography in 10%
EtOAc/hexane as a colorless solid (136.5 mg, 81% yield). mp (Et2O):
137 8C; 1H NMR (360 MHz, CDCl3): d = 7.92 (1H, s), 7.90–7.87 (2H,
m), 7.47–7.45 (2H, m), 7.39–737 (3H, m), 7.32–7.30 ppm (2H, m);
13C NMR (90 MHz, CDCl3): d = 167.49, 139.44 (CH), 137.94, 134.10,
133.45, 130.16 (CH), 129.88, 129.28 (2CH), 128.99 (2CH), 127.77
(2CH), 126.36 ppm (2CH); IR (thin film): ñmax= 3054, 2986, 1265,
1095, 896, 739, 705 cm1; HRMS (ES+ ve): calculated for
[C15H10
35ClNS+H]+: 272.0295, found: 272.0293.
Representative procedure for cross-coupling on water: Ag2CO3
(342.1 mg, 1.240 mmol, 2 equiv), [Pd(dppf)Cl2]·CH2Cl2 (25.3 mg,
0.031 mmol, 5.0 mol%), PPh3 (16.3 mg, 0.062 mmol, 10 mol%), and
4-chloroiodobenzene (177.5 mg, 0.744 mmol, 1.2 equiv) were com-
bined and thoroughly mixed in the bottom of a quickfit testtube. 2-
Phenylthiazole (100 mg, 0.620 mmol, 1 equiv) was added, followed by
deionized water (5 mL), and the suspension heated to 60 8C for 24 h.
The reaction mixture was then filtered through a pad of celite,
washing the pad with acetone (10 mL) and CH2Cl2 (10 mL), and the
organic solvents removed under vacuum. The resultant slurry was
partitioned between CH2Cl2 (10 mL) and brine (5 mL), and the
phases separated. The aqueous phase was extracted with CH2Cl2
(10 mL) and the combined organic phases concentrated under
vacuum. The crude product was purified by column chromatography
in 10% EtOAc/hexane to afford 3a as a colorless solid (159.7 mg,
95% yield).
Representative procedure for cross-coupling neat: Ag2CO3
(342.1 mg, 1.240 mmol, 2 equiv), [Pd(dppf)Cl2]·CH2Cl2 (25.3 mg,
0.031 mmol, 5.0 mol%), PPh3 (16.3 mg, 0.062 mmol, 10 mol%), and
4-chloroiodobenzene (295.8 mg, 1.240 mmol, 2 equiv) were combined
and shaken to mix thoroughly. 2-Phenylthiazole (100 mg, 0.620 mmol,
1 equiv) was then added and the mixture heated to 60 8C for 24 h. The
reaction is a melt for the first several hours but as more product forms
it begins to set into a solid cake. CH2Cl2 (10 mL) was added to
suspend the reaction mixture which was mechanically broken down
and filtered through a pad of celite, washed with CH2Cl2 (5 mL) and
acetone (5 mL), then concentrated under vacuum. The crude product
was purified by column chromatography in 10% EtOAc/hexane to
afford 3a as a colorless solid (162.5 mg, 96% yield).
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Scheme 3. Direct arylation of five-membered heterocycles on water.
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